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ABSTRACT 
 
 The current maxim concerning diagnosis and treatment of mood and anxiety disorders is that 
family physicians fail to appropriately respond to patients with anxiety and depression. This 
estimate is based upon a collection of studies that have found that accurate recognition in general 
practice occurred in 9% to 75% of patients with depression, and 34% to 50% of patients with 
anxiety. However, most studies have found that more than half of physicians accurately detected 
depression and anxiety in their patients. 
 This dissertation examined physicians’ responses (detection, treatment, and follow-up) to 
clinical scenarios of patients presenting with symptoms of either depression or anxiety. 
Furthermore, this study evaluated the associations between physicians’ responses and physician 
attributes (personal and professional), organizational setting, information/resource use, and 
barriers to care.  
 A cross-sectional study of Saskatchewan family physicians yielded a response rate of 49.7% 
(N=331/666). The results of this study revealed that most physicians provided appropriate 
depression and anxiety care with respect to recognition of disorders and follow-up care. 
Specifically, 85.4% of physicians provided an accurate tentative diagnosis of depression, and 
86.3% provided an accurate tentative diagnosis of anxiety; 82.5% of physicians suggested 
adequate follow-up depression care while 79.4% offered adequate follow-up anxiety care. 
However, a notable proportion of physicians did not provide effective treatment; 65.6% of 
physicians recommended effective (immediate) anxiety treatment, and 55.6% recommended 
effective (immediate) depression treatment. 
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 This study found that physicians’ provision of care to patients with anxiety and depression 
was more likely to be associated with their personal attributes, organizational setting, and 
information/resource use than with their professional attributes. First, neither tentative diagnosis 
of depression nor tentative diagnosis of anxiety was significiantly associated with any of the 
tested measures. Second, ineffective treatment of depression was significantly more likely 
among physicians who were female, educated at the undergraduate level in Canada (versus 
elsewhere), scored lower on anxiety attitude factor 1 (social context view of anxiety amenable to 
intervention), had a low patient load (< 100 patients/week), and used medical textbooks to make 
specific clinical decisions; ineffective treatment of anxiety was significantly more likely among 
physicians who had completed their undergraduate and postgraduate medical training in Canada 
(versus elsewhere), had a low patient load ( <100 patients/week), did not practice in a private 
office/clinic, and used colleagues within as well as outside their main patient care setting to 
update their general medical knowledge. Third, physicians were significantly more likely to 
provide inadequate follow-up care to the depressed patient if they were in solo practice and used 
drug manuals to update their general medical knowledge, and significantly more likely to 
provide inadequate follow-up care to the anxious patient if they (the physician) were female and 
did not use mental health professionals to update their general medical knowledge. 
 Results indicated that after controlling for the effects of other factors, physicians with low 
patient loads were three times more likely to provide ineffective treatment of depression than 
physicians with high patient loads. Furthermore, when holding the effects of all other factors 
constant, physicians who had completed postgraduate training in Canada were approximately 
five times more likely to provide ineffective treatment of the anxious patient than physicians who 
had completed their postgraduate training outside of Canada. 
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1.0 INTRODUCTION 
 
 This chapter explains the rationale of the research project, supplemented by the most recent 
available Canadian and Saskatchewan data on the epidemiology of mood and anxiety disorders 
and service use for mental health reasons. Furthermore, this chapter states the problem, research 
questions, and hypotheses explored in this dissertation, concluding with an outline of the thesis.  
1.1 Background of the Research Project 
 This project focuses on the provision of care to patients with depression or anxiety by family 
physicians. According to DSM-IV, mood disorders with depressive symptoms include major 
depression (major depressive episode and major depressive disorder), dysthymic disorder, and 
depressive disorder not otherwise specified (APA, 1994; Parikh et al., 2001). A major depressive 
episode (MDE) lasts at least two weeks; two or more MDE episodes occurring 2 months apart 
characterize a major depressive disorder; dysthymic disorder lasts at least two years. Anxiety 
disorders include distinct subcategories of disorders (i.e. panic disorders, phobias, and 
generalized anxiety disorder) identified by “excessive anxiety, fear, worry, avoidance, and 
compulsive rituals” (Canadian Psychiatric Association, 2006, p. 9S). 
 Overall, CCHS 1.2 data indicated that 10.6% of Canadians (2.66 million) experienced a 
mood, anxiety, or substance dependence disorder in a one-year period (Table 1.1). Specifically, 
4.8% of Canadians (1.19 million) experienced at least one major depressive episode (MDE), 
3.0% (746,000) reported a social anxiety disorder, and 1.5% (376,000) reported a panic disorder 
(Statistics Canada, 2004a).  
 Between one-third and one-half of persons experience psychiatric co-morbidity at least once 
in their life, that is, they experience more than one psychiatric disorder or substance disorder at 
2 
some point (Hall et al. 2009). The rates of co-morbidity between anxiety and mood disorders are 
generally higher than between other psychiatric and substance disorders (Merikangas & 
Kalaydjian, 2007). With respect to co-morbidity between substance disorders (e.g. alcohol abuse 
or drug abuse) and affective disorders (e.g. social anxiety disorder or major depressive disorder), 
the causes may be common (e.g. genetic or social), or the disorders themselves may be causally 
related (i.e. persons with affective disorders may become dependent on alcohol or drugs to 
relieve their symptoms) [Hall et al., 2009]. 
 Based on analyses of the 2002 Canadian Community Health Survey1, researchers have been 
able to gain a good picture of the number of Canadians who suffer from mood and anxiety 
disorders, as well as the number who access particular services from service providers for mental 
health reasons. Information from recent national physician surveys further clarifies the 
implications of mood and anxiety disorders for family physicians across Canada who provide 
valuable diagnosis and treatment in their everyday practice. 
 When individuals seek help for mental health reasons, they most often consult their family 
physician. CCHS 1.2 data indicated that approximately the same proportion of Canadians who 
experienced a mental or substance dependence disorder in a one-year period (10.6%, 2.66 
million) accessed some form of service and support for mental health reasons during that same  
one-year period (9.5%, 2.38 million) [Statistics Canada, 2004a]. Based on the same CCHS 1.2  
data, Vasiliadis and colleagues (2005) described the specific type of service and support accessed 
by Canadians for mental health reasons. Specifically, 5.4% of all Canadians used general 
                                                
1 The CCHS 1.2 surveyed 36,984 respondents aged 15 and over from households selected at random during a six-
month period in 2002 (Patten et al. 2006).1 The survey attained an overall response rate of 77 percent. Lay 
interviewers used the WHM-CIDI to diagnose 12-month and lifetime disorders. Diagnoses included two mood 
disorders (major depression and manic episode 12-month/bipolar disorder lifetime), three anxiety disorders (social 
anxiety disorder, panic disorder, and agoraphobia), and two substance disorders (alcohol dependence and drug 
dependence) [Statistics Canada 2004c]. 
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medical services (i.e. general practitioners and other medical specialists) for mental health 
reasons, compared to 3.5% of Canadians who used specialty mental health services (i.e. 
psychiatrists and psychologists) [Vasiliadis et al., 2005].  
 CCHS 1.2 data further revealed that Saskatchewan residents were similarly inclined to access 
general medical services more often than specialty mental services. That is, 9.8% of all 
Saskatchewan residents (74,000) accessed some type of service and support for mental health 
reasons in a one-year period (Statistics Canada, 2004a). Using CCHS 1.2 data, Vasiliadis and 
colleagues (2005) found that 4.5% of Saskatchewan residents used general medical services for 
mental health reasons, while 2.5% used specialty mental health providers. 
 Although approximately 10% of the general population accessed services and support for 
their mental health, the proportion of persons with mental disorders who accessed similar 
services for their mental health was less than fifty percent (Lesage et al., 2006). Specifically, 
Lesage and colleagues (2006) found that only 38.5% of Canadians with a mental or substance 
dependence disorder used health services for mental health reasons.  
 With respect to Saskatchewan, service use by persons with mental disorders was similarly 
disproportionate to the number of persons who needed such services. That is, CCHS 1.2 data 
indicated that 11.5% of all residents (87,000) experienced a mood, anxiety, or substance 
dependence disorder in a one-year period. Specifically, 4.0% of individuals (30,000) experienced 
12-month MDE, 3.5% (26,700) reported a social anxiety disorder, and 1.9% (14,000) 
experienced a panic disorder (Statistics Canada, 2004a). However, only 38% of persons with 
mental or substance dependence disorders reported using health services for mental health 
reasons (Lesage et al., 2006). 
 
 Table 1.1  12-month Prevalence of Mood, Anxiety, and Substance Dependence Disorders by Country and Study 
 
 
 
 Canada International 
 
 
CCHS 1.2a 
2002 
WMH-CIDI 3.0 
U.S. 
NCS-Rb 
2001-03 
WMH-CIDI 3.0 
U.S. 
NCSc 
1990-92 
CIDI 1.0 
U.S. 
NESARCd 
2001-02 
AUDADIS-IV 
Lebanone 
WMH Survey  
2002 
WMH-CIDI 3.0 
Ukrainef 
WMH Survey  
2002-03 
WMH-CIDI 3.0 
Mood       
  Any mood disorderg  9.5 11.3 9.2 6.6 8.9 
  Dysthymia  1.5 2.5 1.8 0.8 1.9 
  Major depressive disorder 4.0h 6.7  5.3 4.9 8.4 
  Bipolar I and II disorder  2.6   1.5  
  Major depressive episode 4.8  10.3    
  Bipolar 1    2.0   
  Manic episode 1.0  1.3    
  Mania    1.7   
  Hypomania    1.2   
       
Anxiety       
  Any anxiety disorderi  18.1 17.2 11.1 11.2 3.8 
  Social anxiety disorder (social phobia) 3.0 6.8 7.9 2.8 1.1 1.5 
  Panic disorder 1.5 2.7 2.3  0.2 1.3 
  Agoraphobia without panic disorder  0.8 2.8  0.3 0.2 
  Agoraphobia with or without panic disorder 0.7      
  Generalized anxiety disorder   3.1 3.1 2.1 1.3 1.2 
  Obsessive-compulsive disorder  1.0   0.1  
  Posttraumatic stress disorder  3.5   2.0  
  Separation anxiety disorder  0.9     
  Simple phobia   8.8    
  Panic disorder with agoraphobia    0.6   
  Panic disorder without agoraphobia    1.6   
  Specific phobia  8.7  7.1 8.2  
       
Substance disorders       
  Alcohol abuse with/out dependence  3.1   1.2 5.8 
  Alcohol dependence 2.6 1.3 7.2 3.8   
  Drug abuse  1.4   0.2  
  Drug dependence 0.8 0.4 2.8 0.6   
       
Any disorder j  26.2 29.5  17.0 17.6 
Any measured disorder or substance dependence 10.6      
4 
 Values are given as % 
 
 
a Statistics Canada 2004a. 
b Kessler et al. 2005 
c Kessler et al. 1994 
d Grant et al. 2006 
e Karam et al. 2006 
f Bromet et al. 2005 
g Any mood disorder (NCS-R) refers to any: dysthymia, major depressive disorder, or bipolar I and II disorders (Kessler et al. 
2005). Any mood disorder (NCS) refers to any: dysthymia, major depressive episode, or manic episode (Kessler et al. 1994). 
Any mood disorder (NESARC) refers to any: major depressive episode, dysthymia, mania, or hypomania (Grant et al. 2006). 
The components of any mood disorder (Lebanon) and any mood disorder (Ukraine) were not specified by the respective 
authors. 
h Patten et al. 2005 
iAny anxiety disorder (NCS-R) refers to any: social anxiety disorder, panic disorder, agoraphobia without panic disorder, 
generalized anxiety disorder, obsessive-compulsive disorder, posttraumatic stress disorder, or separation anxiety disorder 
(Kessler et al. 2005). Any anxiety disorder (NCS) refers to any: social anxiety disorder, panic disorder, agoraphobia without 
panic disorder, generalized anxiety disorder, or simple phobia (Kessler et al. 1994). Any anxiety disorder (NESARC) refers to 
any: panic disorder with and without agoraphobia, social phobia, specific phobia, or generalized anxiety disorder (Grant et al. 
2006). The components of any anxiety disorder (Lebanon) and any anxiety disorder (Ukraine) were not specified by the 
respective authors. 
jAny disorder (NCS-R) refers to any: any anxiety disorder, any mood disorder, any impulse control disorder, or any substance 
disorder (Kessler et al. 2005) as defined in notes g and i. Any disorder (NCS) refers to any: any anxiety disorder, any mood 
disorder, substance abuse or dependence disorder, antisocial personality disorder, or nonaffective psychosis, as defined in notes 
g and i (Kessler et al. 1994). 
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 Within the last few years, the proportion of Canadian and Saskatchewan family physicians 
offering mental health services has increased, while their perceptions regarding patient 
accessibility to specialized mental health services have remained unchanged. Specifically, the 
proportion of family physicians in Saskatchewan who offered psychotherapy/counseling as part 
of their practice rose from 38% in 2004 to 45% in 2007 (College of Family Physicians of 
Canada, 2004 & 2007). During the same three year period, the perception of Saskatchewan 
family physicians regarding patient accessibility to psychiatrists and mental health support 
services remained unchanged, as 30% of family physicians considered accessibility to 
psychiatrists to be poor, as did 18%-19% of family physicians regarding accessibility to 
psychosocial support services (psychologists, social workers, etc).  
 A recent study of Saskatchewan family physicians revealed that the majority of family 
physicians (56%) saw an average of more than 11 patients with mental health problems per week 
(Clatney et al., 2008). While the majority of family physicians (83%) asserted that they were 
interested in providing mental health care, only a minority (46%) were satisfied with the mental 
health care they currently delivered to patients. 
1.2 Problem Statement 
 More persons soliciting mental health help rely upon their family physician than any other 
care provider, and the proportion of family physicians incorporating psychotherapy/counseling 
into their practices is on the rise. However, numerous studies conducted since the 1970s contend 
that family physicians respond inappropriately to the majority of patients who present with 
depression and anxiety in everyday practice. That is, studies show that physicians under-detect, 
under-treat, and inadequately follow-up the majority of such patients (Fitzpatrick et al., 1997; 
Freeling et al., 1985; Johnson, 1973). Specifically, family physicians accurately detect 
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depression and anxiety in less than 50% of the patients who present with these psychological 
disorders in everyday practice (Cepoiu et al., 2007; Ormel et al., 1991; Wittchen et al., 2002). 
Furthermore, family physicians appropriately treat only half of those detected patients (Harris et 
al., 1996; Linden et al., 1999; Olfson et al., 1995; Olsson et al., 2006; Ormel et al.) and let too 
much time elapse before seeing these patients in follow-up (Simon, 2002; Williams et al., 1999). 
 However, relatively few studies have provided estimates of the proportion of physicians who 
provide inappropriate care to patients with mood and anxiety disorders. Studies which have 
addressed this issue indicate that on average, more than 50% of physicians accurately detect 
mood and anxiety disorders in their patients. Specifically, studies estimated that 45% to 100% of 
physicians accurately detect depression and anxiety in their patients (Andersen & Hawthorn, 
1989; Badger et al., 1994; Carney et al., 1999; Kales et al., 2005; Yager et al. 1986). 
 Studies of psychiatric disorders in family practice have examined many factors as possible 
determinants of effective responses. These factors include the medical profession, physicians’ 
organizational settings, information and resource use, and professional and personal attributes of 
physicians. For the most part, previous studies have focused on the isolated associations between 
one or more of these factors and appropriate physician responses. However, few studies have 
compared these associations to one another to estimate their relative importance, or have tried to 
determine their relative importance when accounting for other factors.  
 The central purposes of this thesis were to estimate the proportion of family physicians who 
provide appropriate responses (detection, treatment, and follow-up) to patients with depression 
and anxiety in family practice; to examine the associations between these responses and 
physicians’ attributes (personal and professional), organizational setting, information/resource 
8 
use, and barriers to care; and to determine whether significant associations remained when 
controlling for the associations between physician responses and all factors. 
 This study potentially contributes to the literature in this field by examining a number of 
issues. First, this study employs clinical scenarios to examine the process of physicians’ 
responses to patients presenting with symptoms of a psychiatric disorder. Second, rather than 
focusing on one indicator of care, this study explores three indicators of care: detection, 
treatment, and follow-up. Third, this study elicits physicians’ tentative diagnoses to better 
understand the complex decision-making processes involved when evaluating a patient with a 
possible psychiatric disorder. Fourth, whereas previous studies have focused on the association 
between one response (e.g. detection) and one level of predictor (e.g. individual physician 
variables), this study examines the associations between several physician responses to 
depression and anxiety and factors at several micro (personal and professional), macro 
(organizational) and intersecting predictor levels (information use).  
1.3 Research Questions 
This project is guided by specific research questions: 
1. How do the majority of family physicians respond to (tentatively diagnose, treat, and follow-
up) mood and anxiety disorders presented by patients? 
2. Which factors of physician attributes, organizational setting, and information/resource use are 
directly associated with their responses to mood and anxiety disorders? 
3. What are the best fitting models of factors that predict family physicians’ responses to mood 
and anxiety disorders? 
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1.4 Hypotheses 
1.  The majority of family physicians will respond appropriately to mood and anxiety disorders in 
clinical scenario patients. Specifically, the majority of physicians will accurately detect 
depression and anxiety, suggest effective treatment, and recommend adequate follow-up care. 
2. Physician attributes (professional and personal), organizational setting, and 
information/resource use will be directly associated with physicians’ responses to mood and 
anxiety disorders. 
3. The best fitting models of factors that predict family physicians’ responses to mood and 
anxiety disorders will include physician attributes (professional and personal), organizational 
setting, and information/resource use. 
1.5 Thesis Structure 
 This thesis contains six chapters. Chapter 2 presents a review of the literature regarding 
family physicians’ responses (detection, treatment, and follow-up) to patients’ mood and anxiety 
disorders, with a focus on physicians’ non-detection of depression and anxiety. This chapter also 
includes a discussion of factors proposed to account for physicians’ responses. Chapter 3 is an 
overview of the design and methodologies of the pilot study and main study, a description of the 
measures included in the surveys, and the test statistics employed in analysis of the data. Chapter 
4 provides a description of the pilot study conducted in 2007, and its utility as a method to test 
the survey questionnaires and main study procedures. Study results are presented in Chapter 5. 
Chapter 6 examines the study’s main findings in light of the research hypotheses and relevant 
literature, and concludes with recommendations for future research. The Appendices include the 
pilot and main study survey questionnaires and letters to physicians used in each mailing of these 
studies. 
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 2.0 LITERATURE REVIEW 
 
 This chapter reviews literature concerning diagnosis and management of mood and anxiety 
disorders in family practice. Particular attention is given to studies concerning insufficient 
detection, ineffective treatment, and inadequate follow-up, and the factors associated with 
inappropriate diagnosis and management of depression and anxiety as a whole. These factors 
include the medical profession, physicians’ organizational setting, information and resource use 
in family practice, physicians’ professional attributes, and patient factors. 
 Family physicians and general practitioners have long been criticized for failing to respond 
appropriately to mood and anxiety disorders in their patients (Fitzpatrick et al., 1997; Freeling et 
al., 1985; Johnson, 1973). Researchers generally agree that mood, anxiety, and substance abuse 
disorders in family practice are insufficiently detected (under-recognized and under-diagnosed), 
ineffectively treated, and inadequately followed up. Specifically, patients with depression in 
primary care and family practice receive suboptimal care (Seelig & Katon, 2008). Tylee and 
Jones (2005, p. 800) suggested that “depression is subject to a rule of halves - only half of 
depressed patients seek help from doctors, half are detected in primary care, half receive 
treatment with only half completing it.”  
2.1 Responses to Depression and Anxiety in Family Practice (Detection, Treatment, and 
Follow-up) 
 
2.1.1 Detection 
 
 Regarding the issue of insufficient detection of psychiatric disorders in family practice, the 
popular maxim is that only 50% of patients presenting with depression are correctly recognized 
as such (Seelig & Katon, 2008; Simon, 2002; Tylee & Jones, 2005). This estimate is actually 
high in light of a recent systematic review of depression recognition studies, which concluded 
that the summary sensitivity rate of depression recognition for all of the studies included in the 
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review was 36.4% of patients, for an overall under-recognition rate of 64% (Cepoiu et al., 2007). 
Further investigation based on this review in addition to a second literature review, revealed that 
recognition of depression occurred in anywhere from 9% to 75% of patients seen in general 
practice (Cepoiu et al., 2007; Kosteniuk, 2007). Likewise, anxiety is insufficiently detected in 
family practice. Specifically, recognition of anxiety occurred in approximately 34% to 50% of 
patients seen in general practice (Ormel et al., 1991; Wittchen et al., 2002).  
 The issue of inappropriate care has also been examined by estimating the proportion of 
physicians who correctly detected mood and anxiety disorders in their patients. When examined 
from this perspective, the estimated proportion of physicians who correctly recognized 
depression and anxiety was generally higher than the estimated proportion of patients correctly 
detected with these disorders. Based on studies that used three different methods (i.e. clinical 
scenario, video scenario, and standardized patient) to estimate physician recognition rates, three 
different studies found recognition of depression to range from 81% to 100% of physicians 
(Carney et al., 1999; Kales et al., 2005; Yager et al., 1986), and two studies found that the 
recognition rate ranged from 47% to 53% of physicians (Andersen & Harthorn, 1989; Badger et 
al., 1994). Further, recognition of anxiety ranged from a low of 49% (Andersen & Harthorn, 
1989 ) to a high of 78% of physicians (Yager et al., 1986).  
2.1.2 Treatment 
 
 Ineffective treatment refers to two dilemmas: many patients with detected mood and/or 
anxiety disorders do not receive treatment, and those who do receive treatment receive 
inadequate doses or courses of treatment too short to be effective.  
 With respect to the dilemma of under-treatment, researchers revealed that once diagnosed 
with a mood and/or anxiety disorder by their physician, only slightly more than half of patients 
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received some form of treatment, such as pharmacotherapy (Linden et al., 1999) or psychological 
management (Olfson et al., 1995). The rate of treatment varied from 36% to 65%, depending 
upon the psychological disorder and type of treatment under consideration (Harris et al., 1996; 
Linden et al., 1999; Olsson et al., 2006b; Ormel et al., 1991). For instance, a study of 
Netherlands GPs and their patients found that physicians recommended treatment of some form 
to 60% of patients they diagnosed as depressed and 65% of patients they diagnosed with anxiety 
(Ormel et al.). A study of Australian general practitioners and their patients concluded that 52% 
of patients diagnosed with depression and 56% diagnosed with anxiety received 
pharmacotherapy (Harris et al., 1996). A later World Health Organization study of primary 
health care patients in regional centres across 15 cities worldwide concluded that slightly more 
than half (52%) of patients diagnosed with a mental disorder by their physician received 
psychotropic medication treatment (Linden et al., 1999). Specifically, 60% of patients with 
physician-diagnosed depression and 51% of those with physician-diagnosed anxiety disorders 
received medication treatment (Linden et al.). A study of Norwegian GPs and their patients 
found that overall, GPs recommended treatment in some form to 51% of patients diagnosed with 
major depressive episode, and to 36% of patients diagnosed with generalized anxiety disorder 
(Olsson et al., 2006b).  
 Regarding the second dilemma of under-treatment, at least half of patients who received 
pharmacotherapy received inadequate doses (Simon, 2002; Tylee & Jones, 2005), and most 
physicians ended pharmacotherapy treatment earlier than the recommended minimum 6-month 
time period after recovery (Remick, 2002). For instance, in a study of Ontario primary care 
physicians, Fitch et al., (2005) found that family physicians tended to prescribe shorter courses 
and lower doses of antidepressants to older patients than recommended for full clinical effect. 
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Based on these findings, Fitch et al. suggested that such suboptimal treatment may lead to 
unnecessary medication switches. Docherty (1997) cited a range of ineffective treatment 
strategies practiced by family physicians, including non-adherence to specific referral criteria, 
absence of criteria for psychosocial treatment, ineffective antidepressant treatment with respect 
to absence of such treatment, prescription of second-line rather than first-line antidepressants, 
and low doses of prescribed antidepressants. 
2.1.3 Follow-up 
 
 With respect to inadequate follow-up, the central concern is that too much time elapses before 
patients with detected mood and anxiety disorders return to their physicians for second visits. For 
instance, Williams and colleagues’ (1999) family physician study found that the average time to 
first follow-up for patients with newly diagnosed major depression was 3.6 weeks, and only 50% 
of physicians scheduled a follow-up within a 2-week period for such patients, as recommended 
by clinical guidelines. In a study of internists and family physicians, Carney et al. (1999) found 
that only 60% of physicians recommended follow-up within two weeks for patients with 
recognized major depressive disorder. In a later study, Simon (2002) found that primary care 
patients received inadequate follow-up care when evaluated on the basis of AHCPR (U.S. 
Agency for Health Care Policy and Research) guidelines. AHCPR guidelines recommend that 
follow-up visits for patients receiving antidepressant treatment for depressive illness should 
occur every two weeks during the first eight weeks of treatment (more frequently for those with 
severe depression).  
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2.2 Methods to Estimate Rates of Depression Non-Detection in Family Practice 
2.2.1 Case Comparison  
 
 The case comparison method is the most popular method of calculating non-detection rates of 
mood and anxiety disorders in family practice. This method is used to estimate the proportion of 
patients with psychological disorders (as assessed by diagnostic schedule or dimensional 
screening instrument gold standard) detected by physicians in everyday practice. Other methods 
are generally used to estimate the proportion of physicians who correctly detect psychological 
disorder(s) in their patients. These methods employ clinical case scenarios (vignettes), 
computerized case scenarios, video case scenarios, and standardized patients; researchers 
estimate proportions by using one or more case scenario or standardized patient to represent a 
typical patient. 
 The case comparison method compares physicians’ responses to a gold standard. In one phase 
of a case comparison study, the researchers or their designates diagnose depression or anxiety in 
a sample of physicians’ patients, using a diagnostic schedule or dimensional screening 
instrument with a cutpoint (gold standard). In another phase, the same physicians indicate the 
outcomes of the clinical visits by recognizing, diagnosing, or treating the disorders. Researchers 
then determine physicians’ diagnosis or recognition rates by comparing physicians’ responses to 
the gold standard. Physicians’ responses are typically determined in one of two ways: direct 
physician diagnosis elicited at the time of the study or retrospective chart review (Cepoiu et al. 
2007). Accurate diagnoses or responses typically include at least one of the following: a 
diagnosis of depression or anxiety; recognition by use of the words ‘depression’ or ‘anxiety’ or 
related words (e.g. ‘depressed’, ‘anxious’, and similar related terms); recognition by use of 
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words to describe symptoms of depression or anxiety (e.g. ‘blue’, ‘sad’, and similar symptoms); 
drug prescriptions; or mental health referrals.   
2.2.2 Clinical Case Scenario 
 
 Clinical case scenarios present written cases of patients with somatic symptoms or specific 
medical condition(s) to physicians for evaluation (Andersen & Harthorn, 1989; Meredith et al., 
2007; Ross et al., 1999; Tiemeier et al., 2002; Wilson & Read, 2001). After reading the clinical 
scenario, the physician is prompted to ask questions or state their next steps (Ross et al.). 
Alternatively, the clinical scenario presents further details of the patient’s physical exam 
(Meredith et al., 2007) and test results. Physicians are then asked to choose their diagnosis and/or 
treatment choices from a checklist, or to provide a diagnosis and a management plan. Two early 
studies employing case scenarios conducted by Yager and colleagues (1986) and Andersen & 
Harthorn (1989) provided useful illustrations of how this method has been used to assess 
physician detection of mental disorders. Yager et al. asked physicians to tentatively diagnose two 
case scenario patients, one with symptoms of depression and another with symptoms of anxiety, 
and found that 81% of family physicians (correctly) tentatively diagnosed depression and 84% 
(correctly) tentatively diagnosed anxiety or panic disorder. Andersen & Harthorn presented 
family physicians with 14 vignettes representing patients with 14 different psychological 
disorders; 47% of physicians correctly recognized depression, and 49% correctly recognized 
anxiety. 
2.2.3 Computerized Case Scenario 
 Computerized case scenarios are updated versions of clinical scenarios. Computerized 
scenarios require more active physician participation than clinical scenarios, and more 
realistically simulate the physician-patient interaction. In computerized scenarios, a patient and 
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his/her presenting problem are described in written detail, then the physician is guided through a 
patient assessment based on five quality criteria: taking the patient’s history, performing the 
physical exam, ordering lab tests, making a diagnosis, and stating a treatment plan (Dresselhaus 
et al., 2004; Luck et al., 2006; Peabody et al., 2004). Based on their scores on these five quality 
criteria, Peabody et al. determined that physicians evaluated on the basis of their assessment of a 
clinical case scenario patient with depression scored an average of 65 percent. 
2.2.4 Video Case Scenario 
 Video case scenarios are variations of written case scenarios. A video scenario presents a 
scripted clinical encounter between a physician and a patient actor, with the patient actor 
presenting symptoms typical of a psychological disorder in addition to other symptoms (Kales et 
al., 2005; Kales et al. 2006). Kales and colleagues’ (2005) recent study with four video 
depression case scenarios concluded that 85% of primary care practitioners (correctly) diagnosed 
depressed patients.  
2.2.5 Standardized Patient 
 The standardized patient method refers to using persons trained to act as unannounced 
patients imitating specific medical conditions in physicians’ regular practice (Badger et al., 1994; 
Carney et al., 1999a; Carney et al. 1999b; Franz et al., 2006; Luck & Peabody 2002; Terry et al., 
2007). Physician response to the standardized patient is then evaluated for quality of examination 
and accuracy of diagnosis and treatment. Studies indicated that physician recognition of 
depression with this method was quite variable. For instance, Badger and colleagues’ 
standardized patient study presented physicians with two standardized patients, each presenting 
with different symptoms of major depression. Based on their assessments of these standardized 
patients, 47% to 53% of physicians correctly detected depression. However, a standardized 
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patient study of internists and family physicians by Carney et al. (1999a) concluded that 100% of 
physicians correctly identified standardized patients presenting with major depressive disorder. 
2.3 Systematic Reviews of Depression Non-Detection in Family Practice 
 Two recent systematic literature reviews regarding depression detection in general practice 
found that depression was highly under-detected in general practice, and depression was more 
likely to be under-diagnosed than over-diagnosed (Cepoiu et al., 2007; Kosteniuk, 2007). Both 
review studies that mainly used a case comparison method to estimate patient recognition rates. 
 In the first systematic review1 of depression recognition by non-psychiatric physicians, 
Cepoiu et al., (2007) calculated a summary sensitivity2 rate of depression recognition based on 
all studies included in the review that allowed for these calculations. Sensitivity rates ranged 
from 9% to 75% of patients (under-recognition of 25% to 91% of depressed patients). Cepoiu et 
al. concluded that the summary sensitivity rate was 36% (64% summary under-recognition rate). 
Further analysis revealed that studies published after 1998 reported higher overall sensitivity 
than studies published prior to 1998, as did studies which used the method of direct physician 
diagnosis elicited at the time of the study rather than retrospective chart review. To account for 
the higher sensitivity rates in studies published after 1998, Cepoiu et al. suggested that physician 
training to recognize depression may be improving, and that physicians may not be documenting 
their recognition of patients’ depression. 
                                                
1 All of the included studies met the following criteria: the sample included patients of primary care offices, hospital 
emergency departments, medical and surgical wards, or outpatient clinics; a structured clinical interview or rating 
scale with specific cut point was administered to patients by a psychiatrist or research staff; a non-psychiatric 
physician made a clinical diagnosis of depression, or recognized patients’ depression by prescribing an 
antidepressant, referring to a mental health professional, or noting depressive symptoms. 
2 Sensitivity refers to the proportion of cases which were true positives, and allows for the calculation of a rate of 
under-diagnosis. 
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 In the second systematic review (Kosteniuk, 2007), a comprehensive search of the literature 
was conducted during the period of March 1, 2007 to March 23, 2007.3 This search yielded 9704 
titles and abstracts4, of which 11 articles met a majority of the required methodological and 
design criteria (Table 2.1) and were eligible for inclusion in this review. 
 Rates of under-diagnosis ranged from 28% (Aragones et al., 2004) to 87% (Diminic-Lisica et 
al., 2005) [Table 2.2]. Three of the 11 studies reported rates of under-diagnosis below 50%, 
seven studies reported rates of under-diagnosis over 50%, and one study did not report a rate of 
under-diagnosis. These findings indicated that under-diagnosis of depression in more than 50% 
of patients was more common than under-diagnosis in fewer than 50% of patients, an 
observation that is consistent with a summary under-recognition rate of 64% of patients as 
reported by Cepoiu and colleagues (2007). 
                                                
3 This search included EMBASE (from 1980), HealthSTAR (from 1975), MEDLINE (from 1966), and PsycINFO 
(from 1950) articles for the period January 1, 1950 to December 31, 2006. Search words/terms included: Depress$ 
AND Diag$ or recog$ or treat$ AND physician or practitioner or doctor. (dollar sign ($) after a term indicates that 
all terms that begin with that root were included in the search).  
4 From these studies, 994 study abstracts were retrieved for assessment. From these abstracts, 73 full-text articles 
were retrieved for further review. After assessment against eligibility criteria as outlined in a quality checklist (Table 
2.1), these 73 articles were reduced to 11 articles. 
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Table 2.1   Methodological and Design Criteria for Inclusion in Systematic Review  
 (Kosteniuk, 2007) 
Section/topic Description 
Study design 2-phase cross-sectional study, wherein patients were screened by 
researchers/interviewers with depression scale in one phase, and 
diagnosed by physicians in the other phase. 
Setting Described setting, locations, and dates defining periods of data collection. 
Participants Described inclusion and exclusion criteria, sources and methods of 
selection of participants. Participants were 18 years of age and older. 
Measurement For each variable of interest, described methods of assessment 
(measurement). Patients were classified as depressed on the basis of a 
validated depression screening instrument. 
Sample size Described rationale for study size, including practical and statistical 
considerations. 
Participants Reported the numbers of individuals at each stage of the study, e.g. 
numbers potentially eligible, examined for eligibility, confirmed eligible, 
included in the study, completing follow-up, and analysed. Provided 
reasons for non-participation at each stage. 
Descriptive data Described characteristics of study participants (e.g. demographic, clinical, 
social) and information on exposures and potential confounders. 
For each variable of interest, indicated the completeness of the data. 
Main results For comparisons using categories derived from quantitative variables, 
reported the n and the proportion expressed as a percentage value.  
Limitations Discussed limitations of the study, taking into account sources of potential 
bias or imprecision, and problems that could arise from multiplicity of 
analyses, exposures and outcomes. Discussed both direction and 
magnitude of any potential bias. 
Generalizability Discussed the generalizability (external validity) of the study findings. 
Bias Addressed selection bias, i.e. differences between patients diagnosed 
as depressed, and those not diagnosed as depressed. Addressed 
measurement bias, i.e. patients and physicians blinded to patient’s 
classification on the basis of the validated screening instrument. 
 
Note: Based on STROBE Checklist Version 3 (STROBE, 2005). Points in bold are the 
additions of this author. 
 Table 2.2  Summary of 11 Studies Meeting Systematic Literature Review Eligibility Requirements (Kosteniuk, 2007) 
Title, Authors 
(Year) 
 
 
Data 
collection 
Year/ 
Location 
 
Physician 
sample 
 
Patient sample 
 
Patient RR/exclusion 
criteria 
 
Phase 1 Instruments and 
Process 
 
Phase 2 Instruments and 
Process 
 
Phase 3 Instruments and 
Process 
 
% under 
 
% over 
 
Limitations 
 
The overdiagnosis 
of depression in 
non-depressed 
patients in primary 
care  
Aragones et al. 
(2006) 
not stated/ 
Spain 
n=23 (aged 
27-50; 
48% men, 
52% 
women) 
Phase 1 – n=906 
(aged 18-70) 
 
Phase 2 – n=306 
(age not reported) 
Phase 1 - 89% RR 
(906/1015) / exclusion 
criteria: language, 
coneurrent illness, 
psychotic disorder 
 
Phase 2 – 95% RR 
(306/322) 
Zung self-rating 
depression scale, cut-off 
>55% administered to 906 
patients 
SCID-I administered to all 
pts with positive-Zung plus 
1/7 of negative-Zung (total 
n=306) 
Blind to Phase 2 results, 
physicians evaluated 
patients within unspecified 
time of Phase 2. They then 
answered a questionnaire 
which asked whether their 
“patient was suffering 
currently from a clinically 
significant depressive 
status” 
not reported 27%  
(75 of 186/306 
patients with 
neither major 
depression nor 
dysthymia, were 
diagnosed as de-
pressed by physi-
cians; proportion 
reported by re-
searchers is based 
on weighted data) 
Increased sensitivity and 
decreased specificity, since 
physicians knew which 
patients had qualified for 
Phase 2, and were asked 
specifically about possible 
presence of depression. 
Detection and 
management of 
depressive 
disorders in 
primary care in 
Spain  
Aragones et al. 
(2004) 
not stated/ 
Spain 
n=23 (aged 
27-50; 
48% men, 
52% 
women) 
Phase 1 – n=906 
(aged 18-70) 
 
Phase 2 – n=306 
(age not reported) 
Phase 1 - 89% RR / 
exclusion criteria: 
language, physical 
condition, concurrent 
disease, known psychotic 
disorder 
Zung self-rating 
depression scale, cut-off 
>55% administered to 960 
patients 
SCID-I administered to all 
pts with positive-Zung plus 
1/7 of negative-Zung (total 
n=306) 
Blind to Phase 2 results, 
physicians evaluated 
patients within unspecified 
time of Phase 2. They then 
answered a questionnaire 
which asked whether their 
“patient was suffering 
currently from a clinically 
significant depressive 
status” 
28%  
(34 of 120/306 
patients with 
major depression 
and/or dysthymia 
were not 
diagnosed by 
physicians– 
researchers did 
not weight data) 
not reported Possible bias towards 
overdetection, since 
physicians knew that the 
patients they had to judge had 
been through Phase 2. 
Detection of 
somatization and 
depression in 
primary care 
Becker (2004) 
2000-2001/ 
Saudi 
Arabia 
n=12 Phase 1 – n=431 
 
Phase 2 – n=431 
Phase 1 – RR not stated / 
exclusion criteria not 
stated: patients younger 
than 18 years 
 
Phase 2 – same as Phase 1 
PHQ (Patient Health 
Questionnaire) 
administered to 431 
patients prior to physician 
visit 
Blind to Phase 1 results, 
immediately following the 
visit, physicians rated all 
431 patients as cases or 
non-cases for somatization 
and depression. 
 55.1%  
(actual number of 
patients not 
diagnosed as 
depressed was not 
stated by the 
researchers) 
10.5%  
(actual number of 
patients not 
classified as de-
pressed with the 
PHQ, but diag-
nosed as depressed 
by physicians, was 
not stated by 
researchers 
Given that the sample of 
physicians numbered only 12, 
and the cultural restrictions 
upon the Arabic population, 
the generalizability of these 
results to the other 
populations is questionable.  
The influence of 
depression on 
physician 
interaction in 
primary care 
Callahan et al. 
(1996) 
1990-1993/ 
not stated 
n=105 Phase 1 – n=508  
(aged 18 and over) 
 
Phase 2 – n=508  
(aged 18 and older) 
 
 
Phase 1 – RR not stated / 
exclusion criteria not stated 
 
Phase 2 - same as Phase 1 
BDI (Beck Depression 
Inventory) administered 
to 509 patients 
Physician chart notes were 
used to determine 
physician diagnoses of 
depression, on the basis of 
presence or absence of 
such diagnoses. 
 72.3%  
(94 of 130/508 
patients with 
moderate to 
severe depression, 
as determined by 
the BDI, were not 
diagnosed as 
depressed by 
physicians 
10.8%  
(41 of 378/508 
patients not classi-
fied as moderately 
or severely 
depression with the 
BDI, were 
diagnosed as 
depressed by 
physicians 
The physicians included in 
this study were second- and 
third-year residents, rather 
than family physicians with a 
range of experience in patient 
psychiatric care. This may 
have resulted in a bias toward 
lower recognition of 
depression.  
Recognizing 
depression: A 
comparison of 
family physician 
ratings, self-report, 
and interview 
measures Coyne et 
al. (1991) 
not stated/ 
United 
States 
n=6 Phase 1 – n=266  
(aged 18-76) 
 
Phase 2 – n=266  
(aged 18 and older) 
Phase 1 - >85% (exact 
number of patients not 
stated) / exclusion criteria 
not stated 
 
Phase 2 – RR not stated 
 
Phase 3 – RR not stated / 
exclusion criteria: patients 
scoring below 15 on the 
CES-D 
CES-D (Centre for 
Epidemiological Studies – 
Depression questionnaire) 
Immediately following the 
visit, physicians rated all 
266 patients for depression 
on a 5-point scale, ranging 
from no depression to 
severe depression. 
DSM-III-R criteria of 
duration of mood 
disturbance and presence of 
psychological and 
vegetative symptoms, 
administered by telephone to 
61 patients scoring above 15 
on the CES-D 
52.3% 
 (11 of 21 of 
61/266 patients 
with major 
depression, as 
determined by 
DSM-III-R 
criteria 
not reported The generalizability of these 
results is questionable, given 
that the sample of physicians 
numbers only six. 
The prevalence and 
detection of 
depressive 
disorders in a 
Croatian primary 
care setting 
Diminic-Lisica et 
al. (2005) 
not stated/ 
Croatia 
n=not 
stated 
Phase 1 – n=459  
(aged 18 and older) 
 
Phase 2 – n=459  
(aged 18 and older) 
Phase 1 – 92% (459/500) / 
exclusion criteria: unable 
to participate due to severe 
illness, illiteracy, or 
intellectual insufficiency 
 
Phase 2 – same as Phase 1 
BDI (Beck’s Depression 
Index) completed by 459 
patients prior to physician 
visit 
Medical charts were used 
to determine physician 
diagnoses. Any mention of 
depressive disorder, 
referral to psychiatrist, or 
specific therapy for 
depression were considered 
as depression diagnoses.  
 86.9%  
(192 of 221/459 
patients classified 
as depressed with 
the BDI were not 
diagnosed as 
depressed by 
physicians) 
5.8%  
(13 of 238/459 
patients not 
classified as 
depressed with the 
BDI were 
diagnosed as 
depressed by 
physicians 
The study researchers classify 
patients with mild, moderate 
and severe depression (as 
determined by the BDI) as 
depressed. However, the 
higher sensitivity of the BDI 
appears associated with a 
notable increase in the 
proportion of patients under-
recognized by their 
physicians. 
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GP treatment 
decision for patients 
with depression 
Kendrick et al. 
(2005) 
1999-2000/ 
United 
Kingdom 
n=9 Phase 1 – n=425  
(aged 18 and older) 
 
Phase 2 – n=425 
Phase 1 – RR not stated / 
exclusion criteria: not 
currently taking 
antidepressants or 
receiving psychiatric 
treatment, able to complete 
questionnaire, no terminal 
illness 
 
Phase 2 – same as Phase 1 
HADS (Hospital Anxiety 
and Depression Scale) 
completed prior to 
physician visit, or 
returned by mail after the 
consult by 437 patients 
Blind to Phase 1 results, 
immediately following the 
consultation, physicians 
indicated whether the 
patient was depressed, and 
the severity of the 
depression for 425 patients 
 66.7%  
(38 of 57/425 
patients classified 
as depressed with 
the HADS were 
not diagnosed as 
depressed by 
physicians) 
11.4%  
(42 of 368/425 
patients not 
classified as 
depressed with the 
HADS were 
diagnosed as 
depressed by 
physicians 
Given that the physicians 
were aware that this study 
was focused on the factors 
associated with their 
depression management, they 
may have over corrected their 
behavior, resulting in a 
significant proportion of 
under-diagnosis.  
 Table 2.2  Summary of 11 Studies Meeting Systematic Literature Review Eligibility Requirements (Kosteniuk, 2007) 
Title, Authors 
(Year) 
 
 
Data 
collection 
Year/ 
Location 
 
Physician 
sample 
 
Patient sample 
 
Patient RR/exclusion 
criteria 
 
Phase 1 Instruments and 
Process 
 
Phase 2 Instruments and 
Process 
 
Phase 3 Instruments and 
Process 
 
% under 
 
% over 
 
Limitations 
 
Accuracy of 
diagnosing 
depression in 
primary care: the 
impact of chronic 
somatic and 
psychiatric co-
morbidity Nuyen et 
al. (2005) 
not stated/ 
The 
Netherland
s 
n=195  Phase 1 – n=8191  
(aged 18 and older) 
 
Phase 2 – n=811  
(aged 18 and older) 
 
Phase 3 – n=191  
(aged 18 and older) 
Phase 1 – 64.5% RR 
(8191/12699)  /exclusion 
criteria: not stated 
 
Phase 2 – 58.8% RR 
(811/1379) /  exclusion 
criteria: patients diagnosed 
by GP with dementia, or 
psychotic illness, or had 
not contact with their GP 
within time frame covered 
by the CIDI 
 
Phase 3 – 191/576 / RR not 
stated 
GHQ-12 screening (Dutch 
version) for non-psychotic 
psychiatric morbidity 
administered to 1379 
patients 
 
 
CIDI-auto 2.1 follow up 
(Dutch version) to detect 
any psychiatric disorder in 
past 12 months, 
administered to 811 
patients 
Patients were classified as 
depressed if they were 
diagnosed with 12-month 
major depressive disorder or 
dysthymia.  
71.2%  
(136 of 191/576 
patients classified 
as depressed with 
the Phase 3 CIDI, 
were not 
diagnosed as 
depressed by 
physicians). 
not reported A significant proportion of 
patients were diagnosed with 
major depressive disorder 
and/or dysthymia (33%), 
indicating that the CIDI 
instrument employed in this 
study is highly sensitive, 
rather than highly specific. 
This factor may account for 
the high rate of under-
diagnosis by physicians 
(71.2%).  
Depression in 
Medical Outpatients 
Perez-Stable et al. 
(1990) 
not stated/ 
United 
States 
n=not 
stated 
(n=1544 
chart 
notations; 
the discrete 
number of 
physicians 
who made 
the chart 
notations 
was not 
mentioned) 
Phase 1 – n= 708 
(aged 18-69) 
 
Phase 2 – n=265 
(aged 20-69) 
Phase 1 –RR not stated / 
exclusion criteria: illiteracy 
in English or Spanish, no 
medical chart available at 
institution for min. 6 mos. 
before recruitment, 
terminal illness. 
 
Phase 2 – RR not stated  
20-item CES-D screening 
administered to 708 
patients 
21-item BDI (Beck 
Depression Inventory) and 
DIS (National Institute of 
Mental Health’s Diagnostic 
Interview Schedule) 
administered within 2 
weeks of Phase 1 to 292 
patients. 
 
The medical records of 265 
patients who completed the 
DIS were reviewed for a 
diagnosis of depression by 
the primary physician, 
defined as whether the 
diagnosis was listed as an 
active problem; if the terms 
‘depression’ or ‘depressed’ 
were mentioned in a chart 
note; or if antidepressant 
was prescribed. 
Cognitive behaviour 
variables and CES-D 
administered within 10 days 
of Phase 2. 
64.3% 
(45 of 70/265 
were not 
diagnosed as 
depressed by 
physicians) 
18.5%  
(36 of 195/265 
patients without 
DIS-diagnosed 
current depression 
were diagnosed as 
depressed by 
physicians) 
Given that a high proportion 
of respondents had DIS-
diagnosed depression (25%, 
70/265), it appears that the 
researchers were biased 
toward moving persons who 
were likely to be diagnosed, 
from Phase 1 screening to 
Phase 2 diagnosis. Therefore, 
one obvious study limitation 
is that the sample from Phase 
2 (n=265) was used to 
determine depression 
recognition, rather than the 
sample size from Phase 1 
screening (n=708). 
Identification of 
psychiatric distress 
by primary care 
physicians 
Pini et al. (1997) 
not stated/ 
Italy 
n=not 
stated 
Phase 1 – n=3202  
(aged 18-65) 
 
Phase 2 – n=559 
(aged 18-65). Two 
subsamples were drawn: 
patients with depression 
or dysthymia (n=66), and 
patients with no current 
mental disorders (n=123)  
Phase 1 – 62% RR 
(559/903) / exclusion 
criteria: illness prevents 
screening participation, 
screened on a previous 
visit, not attending clinic 
for medical consult, no 
fixed address, psychotic 
disorder, organic mental 
disorder, pregnancy, 
alcohol or substance abuse, 
undergoing treatment with 
psychiatrist or psychologist 
 
Phase 2 – 62% RR 
(559/903) 
GHQ-12 administered to 
3202 patients 
Stratified random sample 
(weighted toward higher 
GHQ scores) chosen for 
second stage interview 
(SSI) (n=559). In the SSI, 
physicians assessed pts on 
5-point scale for physical 
illness, and 5-point scale 
for psychiatric caseness. 
The latter scale was 
dichotomized into no 
psychiatric distress, and 
psychiatric distress. The 
SSI was based on WHO 
Primary Health Care 
Version of CIDI-PHC 
 28.8%  
(19 of 66/189 
patients who had 
current depression 
or dysthymia 
were not 
diagnosed with 
psychiatric 
distress by 
physicians) 
31.7%  
(39 of 123/189 
patients who were 
mentally healthy 
were diagnosed 
with psychiatric 
distress by 
physicians) 
The time elapsed between the 
first screening of participants 
in Phase 1 and the second 
stage interview in Phase 2 is 
not specified. More 
importantly, it is not clear 
whether the PCP 
identification of current 
depression or dysthymia 
(psychiatric distress) occurred 
in Phase 1 or Phase 2. 
21 
Determinants of the 
diagnosis of 
psychological 
problems by 
primary care 
physicians in 
patients with 
normal GHQ-28 
scores 
Rosenberg et al. 
(2002) 
2002/ 
Canada 
n=40 (aged 
n/a; gender 
n/a) 
Phase 1 – n=1011 
(aged 18 and older) 
 
 
Phase 1 - 77% RR 
(1011/1313) / exclusion 
criteria: language other 
than French or English, 
incapable of giving 
informed consent, younger 
than 18 years, consulting 
for minor trauma or 
psychotherapy 
GHQ-28 administered to 
all 1011 patients. Patients 
also asked: the reason for 
their visit, 
characterization of health 
problem evaluation of 
general health, 
seriousness of problem 
and level of worry about 
it. 
Blind to Phase 1 results, 
immediately following the 
visit, physicians indicated 
whether they detected any 
signs/symptoms of anxiety, 
depression, somatization, 
or other psychosocial 
problems. Detection was 
the equivalent of any 
mention. 
 42.3%  
242 of 572/1011 
patients with high 
GHQ scores were 
not diagnosed 
with a 
psychosocial 
problem by 
physicians) 
38.3% 
(177 of 462/1011 
patients with 
normal GHQ 
scores were 
diagnosed with a 
psychosocial 
problem by 
physicians) 
High sensitivity due to the 
measure of ‘physician 
detection’ employed, may 
have increased bias towards 
overdetection. 
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2.4 Overstatement of Non-Detection in Family Practice 
  Studies that attempt to account for the phenomenon of non-detection of mood and anxiety 
disorders in family practice with the case comparison method have several limitations which 
may result in overstatements of non-detection rates. The first limitation of case comparison 
studies is that the small physician samples typically employed in these studies are unlikely to be 
representative of the general population of physicians (Thompson et al., 2001). For instance, six 
of the eight studies described in one systematic review (Table 2.2; Kosteniuk, 2007), had fewer 
than 100 physicians in their samples. Without a representative physician sample in terms of age, 
gender, and years in practice, it is difficult to generalize rates of non-detection to a wider 
population of physicians.  
 Second, the case comparison method typically bases non-detection rates upon one patient-
physician encounter. However, physicians may require more than one visit to recognize or 
diagnose their patient with a psychological disorder (Lemelin et al., 1994). For instance, based 
on a qualitative study with family physicians, Thomas-Maclean et al., (2005) concluded that 
diagnosing depression is a time-consuming process that requires more than one visit, and may 
require several lengthy visits. Siriwardena (2008) contended that a diagnosis of depression is an 
outcome of negotiation between patient and physician; further, when patients present with both 
depression and physical illness, a premature diagnosis of depression may prevent further 
necessary investigation of the physical illness. Lemelin et al., (1994, p. 106) noted, “A final 
diagnosis for many problems, including depression, will often be made only after several visits... 
Most studies of diagnostic accuracy evaluate only one visit and might, therefore, overestimate 
the number of missed diagnoses in primary care.”  
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 Third, not all case comparison method researchers use the same instrument to detect 
depression in their patient samples. The use of different instruments may lead to classifications 
of persons as depressed by one instrument who would not be classified as such by another 
instrument. For instance, in a comparison of the self-rated PHQ-9 (Patient Health Questionnaire), 
against the SCID (Structural Clinical Interview for Depression), Gilbody et al. (2007) found that 
the PHQ-9 instrument had sensitivity of 91.7% (rate of true positives) and specificity of 78.3% 
(rate of true negatives). The implication for case comparison studies of non-detection is that 
diagnosis rates may vary more than expected if the construct being measured varies from scale to 
scale.  
 Fourth, not all case comparison method researchers who use dimensional scales to detect 
psychological disorders use the same scoring methods, possibly leading to inconsistent 
classifications of persons as depressed or anxious. Dimensional scales are best used to assess the 
number and nature of depressive symptoms in order to rate a person on symptom severity, rather 
than to diagnose (Switzer et al., 1999). For instance, the Beck Depression Inventory (BDI) is a 
dimensional scale widely used in case comparison studies to diagnose depression. In a review of 
the first and second editions of the BDI, Dozois et al. (1998) concluded that the cutoff score for 
depression should be > 20, such that a person scoring below 20 is not considered depressed. 
However, Cepoiu et al., (2007) indicated that four of 36 studies in their review employed the 
BDI as the gold standard diagnosis, all of which used a cutoff score of 10 and below. The use of 
a cutoff score below the recommended number may have resulted in exaggerated rates of 
depression non-detection.  
 Fifth, specific diagnostic schedules, such as the CIDI (Composite International Diagnostic 
Interview) indicate high rates of false positives (Kurdyak & Gnam 2005). For instance, 
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Wakefield (1999) noted that persons suffering symptoms due to losses, such as unemployment, 
separation, and terminal medical diagnoses, are not excluded by diagnostic instruments. In this 
way, diagnostic instruments create false positives by classifying persons experiencing normal 
depressive reactions as pathologically depressed. The ‘problem of false positives’ (Wakefield, p. 
40), whereby a diagnostic instrument does not accurately distinguish depression from sadness, 
may significantly inflate the number of persons with depression in case comparison studies.  
 Lastly, the use of rating scales (diagnostic schedules) to detect depression in case comparison 
studies runs counter to the social negotiation of diagnosis between physician and patient 
(Siriwardena, 2008). That is, false negatives (of psychological disorder detection) may be 
exaggerated if physicians know patients are depressed but do not make a diagnosis on the basis 
of patient preferences or cues. Further, researchers’ diagnoses on the basis of screening 
instruments have the potential to elicit more cases of depression than physicians’ diagnoses in 
regular patient care. That is, researchers conducting a case comparison study seek patients with 
depression and are focused on such; however, physicians in the same study are concerned with 
the overall well-being of their patients. 
 In sum, the limitations of case comparison studies include small physician samples, 
expectation of detection based on one patient-physician encounter, different gold standard 
instruments, inconsistent gold standard scoring methods, and the problems of false positives and 
false negatives. In contrast, clinical scenario studies offer the opportunity to use large physician 
samples; focus on physicians’ decision-making processes (Veloski et al., 2005); allow physicians 
to offer tentative rather than absolute diagnoses; and remove the problems of false positives and 
false negatives by eliminating the element of comparison between physician diagnosis and 
researcher diagnosis. However, clinical scenarios are also somewhat limited as a method for 
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estimating physician detection of psychological disorders in key ways: physicians cannot elicit 
information from a clinical case scenario to support their decision-making processes; physician 
responses to clinical scenarios are expected to approximate their responses to encounters with 
patients (Yager et al., 1986); and physicians are expected to detect psychological disorders based 
on one clinical case scenario. In summary, given equal strengths and limitations, the use of 
clinical case scenarios rather than case comparisons to examine detection of psychological 
disorders in family practice is justified when the goal is to estimate the proportion of physicians 
who correctly detect psychological disorders. 
2.5 Factors Associated with Responses to Depression and Anxiety in Family Practice 
 Many factors may contribute to physicians’ diagnosis and treatment strategies in response to 
patients’ psychological problems. These factors include the medical profession as a whole, the 
organizational settings of physicians, information and resource use by physicians, physician 
professional attributes (e.g. beliefs/attitudes, knowledge/skills) and patient factors. 
2.5.1 Medical Profession 
 The evidence-based medicine movement emphasizes the value of scientific evidence over 
clinical judgement in patient diagnosis and treatment (Biller-Andorno et al., 2002; Eitel et al., 
2000). Clinical practice guidelines represent a move toward standardization and formalization of 
clinical processes, including diagnostic and treatment decisions, in order to account for the 
quality and cost of health care (James et al., 1997). Some researchers within the mental health 
care field believe that evidence-based practice, based on clinical epidemiology, is preferable to 
uninformed clinical practice (Tanenbaum, 2003). However, the goal of effectiveness within 
evidence-based medicine may clash with physicians’ attempts to do what they think is right 
given constraints of time, resources, and patients’ demands for care (Tanenbaumm). 
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 Recent research suggests that physicians still value personal experience and negotiation as 
important tools in the decision process. Although the shift within the medical profession is 
toward the use of guidelines and checklists in everyday practice, segments of the physician 
population believe that relying upon personal experience saves more time than accessing clinical 
practice guidelines or using a diagnostic manual. For instance, authors of a qualitative study of 
11 GPs concluded that physicians generally viewed clinical practice guidelines and their use as 
inflexible, irrelevant, overwhelming in their number, and unrealistic (Smith et al., 2004). 
2.5.2 Organizational Setting 
 Organizational setting factors cited most often as relevant to diagnosing and treating 
psychiatric disorders included case loads, time to spend with patients (AAFP, 2001; Arean et al., 
2003; Baik et al., 2005; Docherty 1997; Levinson et al., 2000), group versus solo practice, and 
practice setting. Although family physician remuneration issues have also been suggested as 
determinants of effective mental health care (Collaborative Working Group on Shared Mental 
Health Care, 2000), little evidence of this association exists in the Canadian literature. 
 Primary care providers typically have little time to spend with individual patients, given their 
large caseloads (Borus et al., 1988). For instance, a recent study of Saskatchewan family 
physicians concluded that the majority of family physicians (56%) saw more than 10 patients 
with mental problems on a weekly basis (Clatney et al., 2008). Physicians face the difficult 
challenge of responding to patients’ mental health issues while maintaining productivity via short 
patient visits (Levinson et al., 2000). The pressure to work quickly may hinder physicians’ 
abilities to uncover psychological illnesses that require more time and effort to diagnose, such as 
depression and anxiety (Baik et al., 2005). Given the nature of short consultations, Lemelin et al. 
(1994, p.106) characterized dealing with a secondary psychosocial problem akin to ‘opening a 
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can of worms’ when faced with primary physical problems. Martin-Agueda and colleagues 
(2005) found that the majority of physicians (85%) believed they need more time to diagnose 
depression than to diagnose other illnesses.  
 Family physicians spend an average of 13 minutes with each patient, compared to 30 minutes 
spent by psychiatric professionals (AAFP, 2001). During these short visits, patients present an 
average of six problems (AAFP, 2001). Martin-Agueda et al., (2005) found that first visits 
generally lasted longer than follow-up visits, with physicians spending an average of 14.5 
minutes on a first consultation and an average of 11 minutes on follow-up consults. Given the 
frequency with which family physicians cite lack of time as a barrier to effectively managing 
patients with mental problems (Dew et al., 2005; Hartley et al., 1998), there is a surprising dearth 
of studies which examined the association between visit duration and rate of diagnosis or 
recognition. However, one such study used 1991-1994 data from the U.S. National Ambulatory 
Medical Care Survey to conclude that visit duration was not significantly associated with a 
mental-health related diagnosis by a physician (Glied, 1998). 
 Based on a retrospective study of patients referred to psychiatric hospitals by their general 
practitioners in a major city in Ireland, Fitzpatrick et al., (1997) determined that solo practice was 
negatively associated with diagnostic accuracy, in so far as physicians in group practice were 
significantly more likely to accurately diagnose patients presenting with a common psychiatric 
disorder. 
     Although urban physicians may see a greater volume of patients with psychological disorders 
on a weekly basis, rural physicians may be more likely to treat patients within their practice 
rather than refer them to distant specialists. That is, practice setting may influence physicians’ 
diagnosis and treatment plans for patients with mood and anxiety disorders. For instance, an 
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early study concluded that rural physicians were more likely to treat patients in their practice, 
rather than refer them to a mental health care provider located some distance away (Hartley et 
al., 1998). However, rural physicians tended to see fewer patients per week with mental 
problems than urban physicians (Clatney et al. 2008). Practice setting as a determinant of 
physician diagnosis encompasses the issues of wait times to see psychiatrists and other mental 
health professionals (Docherty, 1997), communication problems between psychiatrists and 
physicians (Martin-Agueda et al., 2005), patients’ negative attitudes toward psychiatry (Martin-
Agueda et al.), as well as lack of access to specialty services (Smith et al., 2004).  
2.5.3 Information and Resources 
    Researchers found that physicians were more likely to use information and resources which 
they perceived to be physically accessible (easy to access), intellectually accessible (easy to 
understand), reliable (trustworthy), and applicable (relevant to their needs) [Curley et al., 1990; 
Dawes & Sampson, 2003; Gonzalez-Gonzalez et al., 2007; Verhoeven et al., 1995]. However, 
physical accessibility is likely the paramount determinant of information that is sought for 
specific clinical decision-making purposes. For instance, Curley et al. found that physicians 
ranked colleagues high on physical and intellectual accessibility, and preferred to use colleagues 
over text-based sources for immediate problem solving purposes.  
     A large gap in the literature exists regarding the relationship between effective responses to 
mood and anxiety disorders in family practice and physicians’ information and resource use. In 
particular, the question remains whether physicians who use formal research-based sources (e.g. 
medical journals, medical textbooks, clinical practice guidelines, personal digital assistant 
programs, and drug manuals) or more informal sources (e.g. colleagues, psychiatrists, mental 
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health professionals, and pharmacists) are more or less effective in their responses to patients 
with mood and anxiety disorders.  
2.5.4 Physician Professional Attributes 
 Professional factors cited most often as relevant to diagnosis and treatment of psychiatric 
disorders include resistance to formal diagnosis, knowledge of issues regarding effective 
diagnosis and management of depression and anxiety, and attitudes and beliefs concerning 
depression and anxiety and individuals who may be suffering with these disorders. 
2.5.4.1 Resistance to Formal Diagnosis 
 For several reasons, physicians recognize patient presentations of depression or anxiety, yet 
choose to not record a diagnosis. These reasons include the need to rule out physical causes, 
diagnostic uncertainty, problems with reimbursement for services, avoiding jeopardizing 
patients’ future health insurance claims, desire to avoid stigma (Hartley et al., 1998), and 
perceived patient unwillingness to accept such a diagnosis (Dew et al., 2005; Goldman et al., 
1999). Physicians use strategies to avoid formal diagnoses, including delaying formal diagnosis 
(Baik et al., 2005; Goldman et al.), recording ‘queries’ rather than definitive diagnoses (Dew et 
al.), and substituting alternative diagnostic codes (Rost et al., 1998).  
 Although presentation may point to a psychological cause, or physicians suspect a 
psychological cause, the initial course of action is to first eliminate physical causes (Baik et al., 
2005; Borus et al., 1988; Dew et al., 2005; Lemelin et al., 1994). Although patients present with 
symptoms that have possible physical and/or psychological causes, physicians are trained to 
prioritize the physical. The need to rule out physical causes results in differential diagnoses that 
are combinations of psychological and physical causes (Baik et al.). 
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The psychological symptoms of anxiety are generally accompanied by multiple 
physical complaints that have no identifiable physiologic basis, such as chest pain, 
irritable bowel symptoms (IBS), headache, hyperventilation, or fatigue, that often 
cause the patient to seek help. GAD may therefore be confused with insomnia and 
various functional somatic disorders, including palpitations and IBS….PCPs, even 
in the absence of an appropriate diagnosis, will prescribe treatment (Allgulander, 
2006, p. S105) 
 
 Although physicians may delay their diagnoses until follow-up, at which point they can assess 
the lab results, physicians may still provide their patients with mental health treatment in the 
meantime (Hartley et al., 2008). Patients do not need to be diagnosed in order to receive 
treatment, (Mirowsky & Ross, 2002); consequently, more patients than are diagnosed might 
actually receive effective treatment. 
2.5.4.2 Physician Knowledge  
 Physicians’ knowledge and skills have often been cited as critical determinants of successful 
diagnosis and treatment of psychiatric disorders in primary care patients (Andersson et al., 2002; 
Docherty, 1997; Katerndahl & Ferrer, 2004; Smith et al., 2003; Tinsley et al., 1998). Baik et al. 
(2008) described three types of knowledge that may improve patient care: professional role 
(clinical experience and familiarity with illness patterns), self-awareness (mindfulness and 
confidence), and patient knowledge (familiarity with particular patients).  
 Studies of physician knowledge and skills typically focus on technical and work knowledge. 
Technical knowledge (i.e. explicit/declarative/theoretical) contains mainly research-based 
information produced and presented in a scientific fashion, whereas work knowledge (i.e. 
tacit/procedural/experiential) derives from verbal and written communication between physicians 
and their colleagues or patients (Kosteniuk et al., 2006).  
 Physicians with a high degree of technical knowledge understand what should be done to 
achieve successful outcomes; work knowledge requires advanced capabilities to apply technical 
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knowledge to achieve those successful outcomes (Brown, 1990). Technical knowledge includes 
an understanding of the specific criteria that must be met, the interviews that should be 
conducted, and the tasks to be completed to accomplish successful outcomes. This knowledge is 
required to understand how to successfully manage patients (e.g. the criteria of a patient 
interview), based on evidence from prior research and from patients’ presentation and lab results 
which comprise medicine’s ‘knowledge base’ (Florance & Welch, 1992). Work knowledge 
includes the capacity to accomplish patient management through decision-making processes 
based largely on heuristics and experience using the technical knowledge base (Florance & 
Welch).   
 Physicians often employ heuristics (i.e. mental short-cuts) to make clinical decisions (Smith et 
al., 2003). The term ‘heuristics’ has been used to “…account for discrepancies between … 
rational strategies and actual human thought processes” (Goldstein & Gigerenzer, 2002, p.75); 
heuristics are essential during the application of technical knowledge in the clinical setting. For 
instance, physicians employ the recognition heuristic to make inferences from patterns of 
missing knowledge (Goldstein & Gigerenzer), a useful technique during diagnosis considering 
that physicians for the most part do not use a depression rating scale or a diagnostic criteria 
checklist (Andersson et al., 2001). 
 Intervention studies are most often used to address the question of whether physicians’ 
knowledge or skills are associated with effective diagnosis and treatment of patients with mood 
and anxiety disorders. Gilbody and colleagues (2003) conducted a systematic review of studies 
which explored primary health care interventions associated with depression care at the 
organizational and educational level. Based on the results of 36 studies, Gilbody et al. concluded 
that educational interventions and guidelines offered without organizational support are less 
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effective in improving practice and patient outcomes than integrated educational and 
organizational strategies.   
2.5.4.3 Physician Attitudes 
 The three major etiological theories of mental illness include social context, psychology, and 
medical model perspectives. Physicians’ beliefs regarding the etiology of mental illness have 
been linked to their attitudes toward patients presenting with such disorders (Andersson et al., 
2001; Gallo et al., 1999; Martin-Agueda et al., 2005), and to their abilities to diagnose such 
patients in everyday practice (e.g. Dowrick et al., 2000 found that GPs who subscribed to the 
social context etiological model were less likely to correctly diagnose their patients). Based on a 
qualitative study of family physicians, Thomas-Maclean & Stoppard (2004) concluded that 
although the wider medical community understands depression as a biomedical condition which 
can be diagnosed with the assistance of guidelines and checklists, family physicians are 
constrained by the medical model which does not readily account for the social and 
psychological aspects of depression. 
Social context 
 The social context theories of mental illness include social causation, social selection, labeling 
theory, and sociology of diagnosis. Theories of social context challenge the medical model view 
that mental illness is rooted in physical causes. In contrast to the emphasis placed on individual 
risk factors by medical and psychological theories of mental illness, social theories focus on 
population risk factors (Aneshensel, 2005). Social context theorists also examine classifications 
of mental illness as products of social, political, and historical forces (Bendelow, 2004). 
 From the social causation perspective, mental illness is a product of one’s role in society, and 
as such, is distributed throughout social groups. These social groups may be organized around 
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income, education, age, or gender. The roles and life events associated with social groups tend to 
produce stress (Link & Phelan, 2001). For instance, individuals in social groups with low income 
and low education are more likely to experience ongoing (i.e. chronic) stressors and negative life 
events related to their personal and work roles (Thoits, 1999; Cockerham, 2006). These stressors 
and events may include working in a job with low decision-making authority, worrying about 
meeting everyday expenses, or facing rental increases. Without financial and emotional 
resources to mediate the effects of chronic stressors and negative life events, persons in 
disadvantaged social groups may experience anxiety, depression, and even the onset of 
schizophrenia (Thoits).  
 The social selection perspective suggests that mental status predicts location on the social 
ladder. From this perspective, lower social status positions are filled by those with a lower 
capacity for mental functioning (Eaton & Muntaner, 1999). Further, higher status jobs which 
require higher education and levels of functioning preclude those with social impairment caused 
by depression or alcohol abuse. 
 From the perspective of labeling theory, mental illness is not a real and measurable social fact 
(Brown, 1995). Rather, mental illness encompasses behavior that violates social rules and is 
consequently devalued within society (Horwitz & Scheid, 1999). Once labeled as mentally ill, 
individuals’ deviant behavior confirms the label. Labeling theorists emphasize the social and 
economic control exercised by the medical profession, (Cockerham, 2006) and suggest that the 
Diagnostic and Statistical Manual of Mental Disorders supports and perpetuates such control 
(Cockerham).  
 Sociology of diagnosis blends social causation and labeling theories (Brown, 1995). Brown 
proposed a typology of four categories including routinely defined conditions, medicalized 
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definitions, contested definitions, and potentially medicalized definitions. Diagnoses can shift 
from one category to another over time, given enough social pressure. Most diagnoses, including 
depression, are routinely defined conditions. Social benefits and social costs are associated with 
each of the four diagnostic categories. For instance, a diagnosis of depression may require a 
leave of absence from work (benefit) and result in increased insurance premiums (cost). 
Psychology model 
 Behaviorist (social learning) and psychoanalytic perspectives form the basis of the 
psychology model of mental illness. According to the behaviorist perspective, situations that 
confound our processes of thinking and learning (Peterson, 1999) lead to mental illness. For 
instance, experiences in early childhood that produce ‘unconscious psychic conflicts’ or 
unresolved fixations (Leventhal & Martel, 2006) may result in mental illness in adulthood. 
However, since behavior is learned, socially inappropriate behavior can be replaced with 
appropriate behavior (Cockerham, 2006). For instance, cognitive behavioral therapy (CBT) 
involves treating depressive and anxiety disorders by changing negative to positive thoughts in 
order to change negative to positive behavior, and vice versa (Peterson). Early psychoanalytic 
treatment has evolved to include more short-term therapies which focus less on patients’ history 
and more on current difficulties, with the goal of providing insight to patients and helping them 
make positive adjustments (Leventhal & Martel). 
Medical model 
 The medical model of mental illness (e.g. genetics, neurochemical, and neuroanatomy) 
contends that mental disorders have underlying physical causes (Leventhal & Martel, 2006). 
Diagnosis and treatment of mental illnesses is similar to that for physical illnesses such as heart 
disease and cancer, insofar as pathological symptoms indicate illness (Gallagher, 1995).       
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 Evidence of increased risk of mental disorders among first-degree relatives and identical 
twins of individuals with mental disorders supports the genetics model (Berrettini, 2000), which 
explains mental illness as an outcome of heredity (Gallagher, 1995; Mechanic, 1999). Behavioral 
genetics theory suggests that environmental factors, such as stress, trigger mental illness in those 
with a genetic predisposition to mental illness (Cockerham, 2006). 
 According to the neurochemical model, mental illness is an outcome of an imbalance of 
neurotransmitters (Gallagher, 1995). From this perspective, mental illness symptoms are 
attributed to too few or too many neurotransmitters at receptor sites (Cockerham, 2006). For 
example, from this perspective, depression is a result of decreased levels of the neurotransmitters 
norepinephrine and serotonin (Leventhal & Martel 2006, Cockerham).  
 Currently, the common usage of pharmacotherapy to treat mental illness signals the 
dominance of the medical model within psychiatry and general medicine (Leventhal & Martel, 
2006). The medical model of mental illness continues to dominate in part due to the success of 
pharmacotherapy to relieve symptoms, which allows patients with mental illness to live in their 
communities rather than in hospitals (Cockerham, 2006).  
2.5.5 Patient Factors 
 Patient factors include characteristics and cues which physicians take into consideration 
during patient care, willfully or otherwise. Certain factors are readily apparent to physicians, 
such as gender and age, while others need to be elicited (employment status and treatment 
preferences) (Schaik et al., 2004). Physicians take into account an average of two patient factors 
concerning symptoms, gender and patient preference for treatment, before deciding whether or 
not to prescribe an antidepressant (Smith et al., 2003). About half of primary care doctor-patient 
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interactions include at least one factor relating to patients’ psychological and family issues 
(Levinson et al., 2000). 
  Studies largely agree patient factors play a role in physicians’ diagnosis and treatment of 
depression and anxiety in everyday practice. For instance, women are more likely than men to be 
diagnosed with anxiety (Smolders et al., 2008) and with depression (Borowsky et al., 2000; 
Harman et al., 2001; Lecrubier, 1998; Schwenk et al., 1996), and are more likely to receive 
treatment for anxiety disorders (Linden et al., 1999). Also, older individuals are more likely than 
younger individuals to receive depression diagnoses (Borowsky et al.; Bower et al., 2000; 
Klinkman et al., 1998; Lecrubier) and pharmacological treatment for anxiety disorders (Harris et 
al., 1996; Smolders et al.). Socioeconomic status may also influence a diagnosis of depression if 
physicians assign more weight to the physical rather than emotional problems presented by 
patients of lower status, or believe that such patients are less able to afford the service of mental 
health professionals (Dew et al., 2005; Harris et al.; Linden et al.).  
2.5.6 Perceived Requirements for Effective Management  
 Given the number of factors proposed to account for differences between patients who are and 
are not accurately diagnosed in family practice, it is not surprising that physicians cite a number 
of requirements to provide effective patient management. These requirements include better 
access to mental health professionals (Smith et al., 2004) and psychiatrists’ (Ansseau et al., 2004; 
Clatney et al., 2008; Dew et al., 2005, Docherty, 1997; Hartley et al., 1998); affordable 
medication (Simon et al., 2004); patient time (Dew et al.; Hartley et al.; Wong et al., 2006); 
counselling training (Telford et al., 2002); personal experience (Baik et al., 2005; Wong et al.); 
and information on effective pharmacological (Katerndahl & Ferrer, 2004; Lin et al., 2001; 
Tiemens et al., 1999) and non-pharmacological treatments (Goldman et al., 1999). 
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2.6 Conceptual Model  
 The conceptual framework for this study is presented in Figure 1. Family physicians respond 
to psychiatric disorders presented by patients (i.e. diagnose, treat, and follow-up), within the 
context of societal attitudes, the medical profession, and physicians’ organizational settings. 
Ultimately, physicians’ particular responses emerge at the intersection of professional attributes, 
personal attributes, characteristics (beliefs/attitudes, knowledge/skills, and attributes), and the 
information and resources at hand. These factors are diagrammed in the following figure and 
discussed in the following sections of the proposal. 
2.7 Summary 
 Based on an examination of the literature as provided in this chapter, a number of 
observations can be made. First, family physicians do not effectively care for patients with 
depression and anxiety. That is, mood and anxiety disorders are insufficiently detected, 
Figure 2.1: Conceptual Framework of Family Physicians’ Responses to Depression and Anxiety  
 Presented by Patients 
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ineffectively treated, and inadequately followed up in more than 50% of patients who present 
with these disorders. However, more than 50% of physicians typically detect depression and 
anxiety in their patients in everyday practice. Further, family physicians provide treatment to 
only slightly more than half of patients they detect with depression and anxiety. When treatment 
is provided, the recommended dosage may be inadequate and the course of treatment too short. 
Follow-up to diagnosis visits generally occur too late to be effective, as only 50%-60% of 
physicians typically recommend follow-up to occur within two weeks of initial visit.  
 Second, factors proposed to account for inappropriate depression and anxiety care include the 
medical profession as a whole, which still relies mainly on the use of clinical judgement rather 
than evidence-based clinical guidelines; physicians’ organizational setting, particularly heavy 
case loads, short visit durations, solo versus group practice, and urban versus rural practices; 
information and resource use, with the implication that physicians who use a greater number of 
informal (non-research based) sources, or with greater frequency, are more likely to provide 
ineffective care; and professional attributes, specifically physician resistance to formal 
diagnosis, as well as insufficient knowledge regarding appropriate care and ambivalent attitudes 
toward depressed and anxious patients. 
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3. METHODS 
 
 This chapter outlines the methodology for the main study, including details of the study 
design and population and the pilot study conducted to evaluate initial drafts of the survey 
questionnaires and data collection procedures. The chapter also provides details of the main 
study conducted in early 2008, including data collection procedures, the final survey 
questionnaire measures, a discussion of validity and reliability of the surveys, and data analysis.  
3.1 Study Population 
 The study population included all Saskatchewan family physicians actively practicing in 
Saskatchewan as of December, 2007, as identified by the Canadian Medical Directory and 
verified against the College of Physicians and Surgeons of Saskatchewan mailing list (N=892), 
less 100 family physicians included in the 2007 pilot study for this project (N=792). 
3.2 Study Design 
 Data were collected using a cross-sectional mail survey of family physicians actively 
practicing in Saskatchewan, using Dillman’s Tailored Design Method (Dillman, 2007) with 
repeated and personalized contacts. Physicians who responded to the first mailout received three 
mailings, and physicians who did not respond at all received a maximum of six mailings. 
3.3 Ethical Considerations 
 This study received approval from the Behavioural Research Ethics Board of the University 
of Saskatchewan (BEH #07-41, Appendix A). 
3.4 Questionnaire Evaluation 
 First drafts of the two questionnaires were reviewed for content validity by four family 
physicians, two of whom were practicing in Saskatchewan, one in Nova Scotia, and one in New 
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Zealand. Two of the four physicians reviewed the Anxiety Questionnaire, and two reviewed the 
Depression Questionnaire. On the basis of these evaluations (Appendix B), the questionnaires 
were modified to reduce response burden and increase response rate in the pilot study phase. 
Subsequently, the second drafts of the two questionnaires were used in the pilot study. 
3.5 Pilot Study 
 The purposes of the pilot study were to assess the mail survey procedures for the main study 
(Appendices C-L), test the second drafts of the two questionnaires (Appendices M and N) 
provide an estimate of the response rate for the main study, and assess the impact of an incentive 
($5) on the rate of return. The pilot study of 100 Saskatchewan family physicians was conducted 
during a four-month period, from June to October, 2007 (see Chapter 4 for a full description of 
the pilot study methods and results).  
 The pilot study sample was drawn from a contact list of 950 family physicians created by 
verifying a customized list of Saskatchewan family physicians provided by the Canadian 
Medical Directory, against the College of Physicians and Surgeons of Saskatchewan mailing list 
updated to May, 2007. The contact list was sorted by physicians’ last names, and every tenth 
person was selected in order to create the pilot study sample. 
 Of 100 physicians surveyed, 78 were eligible to participate, and 22 physicians were deemed 
ineligible, had moved, or retired. Of the 78 eligible physicians, 15 refused (19%), 33 did not 
respond (42%), and 30 returned completed questionnaires (38% response rate).  
 Based on the results of the pilot study, the third drafts of the questionnaires were reprinted in 
color for the main study data collection, and contained fewer and modified questions. In order to 
improve the response rate in the main study, the incentive to participate was increased from $5 to 
$10, and data collection took place prior to summer holidays. In addition, the clinical scenarios 
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and additional measures were interchanged for the main study. The rationale for this decision 
was to minimize the possibility of cuing phyicians to the correct responses regarding the clinical 
scenarios. Specifically, whereas the Depression Questionnaire in the pilot study contained an 
MDE clinical scenario and measures of caring for patients with depression (Appendix M), the 
Depression Questionnaire in the main study contained a GAD clinical scenario and measures 
concerning caring for patients with depression (Appendix V).  
3.6 Data Sources 
 In 2006, 32,241 physicians were eligible to practice in general practice and family medicine 
in Canada (Canadian Medical Association, 2006). In Saskatchewan, 1,093 family physicians 
were eligible to practice (CMA, 2006), including 297 physicians in rural settings of fewer than 
10,000 population (CMA, 2006; Society of Rural Physicians of Canada, 2005), and 796 in urban 
settings of 10,000 or greater population.   
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Health Regions of Study Population (N = 792) 
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 Contact information was available for only 950 Saskatchewan family physicians. The contact 
list of 950 family physicians used to create the pilot study sample of 100 physicians was verified 
against and updated with the College of Physicians and Surgeons of Saskatchewan mailing list 
monthly updates up to December 2007, leaving a population of 892 physicians with contact 
information. After removing the 100 pilot study physicians from this updated list, 792 names and 
addresses remained. One in three physicians (33%, n = 259/792) practiced in Saskatoon Health 
Region, 28% (n = 226/792) in Regina Qu’Appelle Health Region, and 39% (n = 307/792) 
practiced in one of the other 11 health regions (Figure 3.1). 
3.7 Data Collection 
 Data collection occurred January through April of 2008. Eligible physicians were family 
physicians or locum tenens, in full-time or part-time medical practice, currently practicing/on 
leave of absence in Saskatchewan. Ineligible persons were specialists, medical students, 
residents, retired, employed primarily in medically related fields (i.e. administration, teaching, 
research), and those who were included in the pilot study sample.  
 Of 792 family physicians surveyed, 666 were deemed eligible to participate and 126 
physicians were ineligible, had moved, retired, or were deceased. Of the 666 eligible physicians, 
129 refused (19%), 206 did not respond (31%), and 331 returned completed questionnaires 
(49.7% response rate).  
 Mail data collection procedures followed Dillman’s Tailored Design Method (Dillman, 2007), 
which emphasizes repeated and personalized contacts for the purpose of improving the rate of 
response. The first contact mailing invited physicians to participate in a study of diagnosis and 
treatment of mood and anxiety disorders in Saskatchewan family practice (Appendix O). The 
initial letter further described the purpose of the study, detailed the author’s methods of obtaining 
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their contact information, and emphasized confidentiality and anonymity of responses. The 
second contact occurred two weeks later with the first questionnaire package, which included a 
cover letter with guidelines for participation and non-participation, a questionnaire, a self-
addressed stamped envelope, and a $10 incentive to participate (Appendix P). One month after 
the first contact, the third contact mailing included a letter that thanked physicians who had 
responded by this time, and served as a reminder to those who had not yet responded (Appendix 
Q). Six weeks after the first contact, the second questionnaire package was the fourth contact 
with physicians (Appendix R). This package included a cover letter thanking physicians who had 
responded and providing guidelines for those who chose to not participate, a questionnaire, and a 
self-addressed stamped envelope. The fifth contact mailing was sent 10 weeks after the first 
contact. In this mailing, non-participants received a package which included a cover letter 
indicating that this would be the last invitation to participate, as well as a questionnaire and a 
self-addressed stamped envelope (Appendix S). Participants who had returned a completed 
survey received a letter thanking them for their participation (Appendix T).  
3.8 Questionnaires  
 Respondents received either an Anxiety Questionnaire (Appendix U) or a Depression 
Questionnaire (Appendix V). Each questionnaire contained a clinical scenario and relevant 
measures, including tentative diagnosis, treatment plan, follow-up return, and barriers to care 
(Table 3.1). The Depression Questionnaire included a clinical scenario of a patient presenting 
with Generalized Anxiety Disorder; the Anxiety Questionnaire contained a clinical scenario of a 
patient presenting with Major Depressive Episode1. Each questionnaire also contained 
                                                
1 In order to minimize the possibility of cuing physicians to the correct responses regarding the clinical scenarios, 
the GAD scenario was included in the Depression Questionnaire, and the MDE scenario was included in the Anxiety 
Questionnaire.  
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professional attribute measures specific to providing care to patients with either depression or 
anxiety. Specifically, the Depression Questionnaire contained professional attribute measures 
relevant to providing care to patients with depression; the Anxiety Questionnaire contained 
professional attribute measures relevant to providing care to patients with anxiety. In addition,  
Table 3.1 
Study Questionnaire Measures 
Depression Questionnaire Anxiety Questionnaire 
GAD clinical scenario - tentative 
diagnosis, treatment plan, follow-up return, 
barriers to care 
MDE clinical scenario - lab tests, tentative 
diagnosis, treatment plan, follow-up return, 
barriers to care 
Personal attributes Personal attributes 
Organizational setting Organizational setting 
Information/resource use Information/resource use 
Professional attributes (regarding 
patients with depression) - duration of 
visits, average weekly number of visits, 
requirements for effective 
management, diagnosis resistance, 
depression attitude scale, depression 
knowledge scale, patient factors in 
treatment decisions 
Professional attributes (regarding patients 
with anxiety) - typical treatment, 
consideration of patient cues, duration of 
visits, average weekly number of visits, 
depression attitude scale, diagnosis 
resistance, resources required for effective 
management, depression knowledge scale, 
anti-anxiety prescriptions  
 
 
 
each questionnaire contained identical measures of respondents’ personal attributes, 
organizational setting, and information and resource use.  
3.8.1 Clinical Scenarios 
 On the basis of one of two clinical scenarios, physicians were asked to list their specific 
tentative diagnoses, offer an initial treatment plan, specify when they would like the patient to 
return for their first follow-up (number of weeks after 1st visit), and list one or more reasons they 
might not be able to provide the best possible care for the clinical scenario patient (barriers to 
Identical measures Different measures 
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care). The measures of tentative diagnosis and initial treatment plan were adapted from an early 
study by Yager and colleagues (1986). 
3.8.1.1 Generalized Anxiety Disorder (GAD) Clinical Scenario 
 The GAD scenario was adapted from two studies (Kielbasa et al., 2004; Yager et al., 1986). 
The scenario presented a patient with symptoms that characterize GAD, as according to the 
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders IV, 1994). These underlined 
symptoms include worries that have lasted longer than 6 months, restlessness, edginess, and 
apprehension, with aching muscles and joints, multiple worries, concentration problems, and 
difficulty controlling these worries. The scenario included additional information regarding age, 
marital status and physical symptoms, and physical exam results to help respondents rule out 
physical causes. 
History 
• 31 year-old man 
• married, 2 young children 
• muscle and joint discomfort, heart palpitations, dizziness of more than one year duration 
• restless and edgy most of the time, believes he’s “losing it” because he’s constantly 
apprehensive 
• mind races and he “can’t seem to pin them (the thoughts) down” 
• concerned that his health is deteriorating to the point that sometimes he has to leave work 
when the symptoms become intolerable 
• has given up many social contacts aside from family and close friends 
• has cut coffee intake to 1 cup/day 
Physical exam 
• General - alert and oriented 
• Skin - moist, Color - good 
• HEENT (head, eyes, ears, nose, throat) - unremarkable 
• Chest - grade II murmur 
• Abdomen - unremarkable, extremities – unremarkable 
• Reflexes - brisk bilaterally 
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3.8.1.2 Major Depressive Episode (MDE) Clinical Scenario 
 The MDE scenario was adapted from four studies (Kielbasa et al., 2004; Price, 2002; Farid, 
2000; Yager et al., 1986). The scenario presented a patient with MDE as defined in the DSM-IV 
(Diagnostic and Statistical Manual of Mental Disorders IV, 1994). Underlined symptoms include 
loss of pleasure, fatigue, insomnia, loss of appetite, and decreased concentration, lasting more 
than two weeks. Additional information includes age, marital status, physical symptoms, and 
brief physical exam results.  
History 
• 42 year-old employed woman 
• married 21 years, 2 adult children 
• four-week history of fatigue, insomnia, headache and abdominal pain generalized over 
the abdomen, constant in nature 
• denies signs and symptoms of an acute infectious process and was in relatively good 
health before the previous month 
• has obtained intermittent relief from headache by using acetaminophen, and takes a 
multivitamin regularly 
• complains “food just doesn’t taste good anymore” 
• finding it harder to concentrate at work, and to socialize with friends and family 
• wonders if she will ever feel normal again, yet denies any stress or significant problems 
in her life.  
• non-smoker, drinks 2 cups of coffee/day, denies alcohol intake. 
Physical exam 
• General - tired but in no acute distress 
• Skin - normal, color - good 
• HEENT (head, eyes, ears, nose, throat) - unremarkable 
• Pelvic exam - normal 
• Abdomen - generalized tenderness  
• Extremities – unremarkable 
 
3.8.2 Clinical Scenario Measures 
 The Depression Questionnaire included a clinical scenario of a patient presenting with 
symptoms of generalized anxiety disorder (GAD) and the Anxiety Questionnaire presented a 
clinical scenario of a patient presenting with symptoms of major depressive episode (MDE). As 
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detailed in the following sections, each scenario was followed by questions regarding tentative 
diagnosis, treatment plan, follow-up return, and barriers to care concerning the scenario patient. 
3.8.2.1 Tentative Diagnosis 
 Based on the clinical scenario of a patient presenting with either GAD or MDE, this open-
ended question asked respondents to list the specific tentative diagnoses they were considering. 
Accurate tentative diagnoses of the GAD clinical scenario patient included one or more of the 
following terms: anxiety, anxiety disorder, generalized anxiety disorder, GAD, panic, panic 
disorder, or panic attack. Accurate tentative diagnoses of the MDE clinical scenario patient 
included one or more of the following terms: depression, major depression, depressive disorder, 
depressive illness, major depressive disorder, MDD, MDE, mood, mood disorder, or dysthymia. 
3.8.2.2 Treatment Plan 
 Based on the clinical scenario of a patient presenting with either GAD or MDE, this open-
ended question asked family physicians to describe the treatment plan they would initiate at this 
point. Responses which referred to delaying treatment until lab results were received, delaying a 
decision regarding treatment, or mention of ‘none’, were considered indicative of ineffective 
(delayed/no) treatment. Statements that did not refer to delayed/no treatment indicated effective 
(immediate) treatment. 
3.8.2.3 Follow-up Return 
 Respondents were asked to specify the time of first follow-up (number of weeks after the first 
visit), of the clinical scenario patient. Follow-up two weeks or sooner was considered effective; 
follow-up was considered ineffective if the physician wanted to see the patient return more than 
two weeks after the initial visit. 
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3.8.2.4 Barriers to Care 
 In an open-ended formatted question, respondents were asked to provide one or more reasons 
they may not be able to provide the best possible care for the clinical scenario patient. Responses 
fell into one of three themes: system access, physician issues, and patient issues.  
3.8.3 Additional Questionnaire Measures 
 Measures of physicians’ personal attributes, organizational setting, information and resource 
use, and professional attributes are summarized in Table 3.1, and detailed in the following 
sections. Complete details regarding all additional questionnaire measures, including those not 
analysed in the present study, are available in Appendix W. 
3.8.3.1 Personal Attributes 
 Personal attributes of physicians included gender, age, and three attributes sourced from the 
National Physician Survey (College of Family Physicians of Canada, 2004): years in practice as 
a family physician, country of undergraduate medical training, and country of postgraduate 
medical training. ‘Age’ was coded as a continuous as well as categorical variable (<35, 35-39, 
40-49, 50-59, 60-69, and 70 and over). Years in practice was also coded as both a continuous and 
categorical variable (<10, 10-19, 20-29, 30-39, and 40 and over). For multivariate analysis 
purposes, country of medical training was recoded as ‘in Canada’ and ‘outside Canada’. 
3.8.3.2 Organizational Setting 
 The National Physician Survey (College of Family Physicians of Canada, 2004) served as the 
basis for the measure of main patient care setting. The original 11 categories of main patient care 
setting detailed in the NPS survey were reduced to seven in this study; for multivariate analysis 
purposes, these seven were further reduced to two categories (private office/clinic vs. other 
office). The NPS also provided the measure of solo, group, or other practice, which were reduced 
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to two categories for the purposes of multivariate analysis (solo and group/other). Solo practice 
has been found to be negatively associated with accurate diagnosis of five types of psychiatric 
illness (Fitzpatrick et al., 1997). Additional measures included internet access (access or no 
access), internet access during patient consultations (Mousseau, personal communication, 
November 13, 2007), and the population of the main patient care setting (for multivariate 
analysis purposes, urban >10,000, rural <10,000). Hartley et al. (1998) found that among rural  
physicians, knowledge and attitudes were significant barriers to effective management of patients 
with depression. 
3.8.3.3 Information and Resource use 
 To evaluate physicians’ use of information and resources, this study asked respondents to 
identify those specific sources they regularly used (at least once per month) for two separate 
purposes: to update general medical knowledge and to make specific clinical decisions. 
Physicians indicated regular use by checking items from a list of 14 sources (identified as 
information sources preferred by physicians in previous research (Coumou & Meijman, 2006; 
Dovey et al., 2006; Haug, 1997). Responses were coded as ‘use regularly’ or ‘do not use 
regularly’. 
 Given this same list (with the addition of ‘CME/CPD/CPL courses/programs, and the removal 
of ‘other’), physicians were asked to indicate information sources and resources which 
demonstrated reliability, ease of access, relevance, and ease of understanding. Responses were 
coded as ‘reliable’ or ‘not reliable’, ‘easy to access’ or ‘not easy to access’, ‘relevant’ or ‘not 
relevant’, and ‘easy to understand’ or ‘not easy to understand’ (Connelly et al., 1990). 
 Respondents were asked to indicate the actions that they might take to confirm their decision 
if they were unsure about diagnosing a patient (with depression or anxiety). These actions 
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comprised conducting a thorough patient interview, using a screening instrument, consulting a 
diagnostic manual, consulting a colleague, consulting a psychiatrist, consulting a mental health 
professional, and basing their decision on experience. Responses were coded as ‘use’ or ‘do not 
use’. Five of these choices were further recoded into two categories for multivariate analysis 
purposes: explicit information (‘use’ or ‘do not use’ either a screening instrument or diagnostic 
manual) and tacit information (‘use’ or ‘do not use’ a colleague, psychiatrist, or mental health 
professional).  
3.8.3.4 Professional Attributes 
Length of time in new and follow-up consultations  
 Martin-Agueda et al. (2005) reported that general practitioners spend a greater amount of time 
with depressed patients in initial visits than in follow-up consultations. Based on this research, 
this study included an open-ended question asking physicians to report the average length of time 
(minutes) spent with patients presenting with symptoms of anxiety or depression in new and 
follow-up consultations. Given the question’s open-ended structure, respondents were free to 
indicate the average range of minutes they spent with patients. For this reason, the results for 
these measures are presented as discrete categories rather than as means (1-14, 15-29, 30-44, 45 
and longer). Responses that fell across these ranges were coded accordingly (e.g. ‘10-15’ as 1-
14, ‘10-20’ as 15-29, ‘15-30’ as 15-29, and ‘20-30’ as 15-29). 
Number of patients diagnosed and treated on weekly basis 
 These open-ended questions allowed physicians to indicate a range for the number of patients 
they diagnosed and treated/managed for anxiety or depression on a weekly basis (Wright et al., 
2005), as well as the total number of patient visits per week. Responses with a discernible 
midpoint were recoded accordingly (e.g. ‘1-3’ as 2); otherwise, responses were recoded 
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conservatively (e.g. ‘1-2’ as 1). Recodes included only whole values. For multivariate analysis 
purposes, the total number of patient visits per week were recoded as low (<100), medium (100-
150), and high (151-450). These measures allowed a calculation of the estimated proportion of 
patients diagnosed and treated on a weekly basis (number of patients diagnosed or treated per 
week divided by the total number of patients per week) [Hartley et al., 1998].  
Requirements for effective management  
 Family physicians were asked to indicate their level of agreement with 10 requirements to 
manage patients presenting with symptoms of anxiety or depression. Physicians indicated their 
agreement on a five-point scale ranging from ‘strongly agree’ to ‘strongly disagree’.  
 While the full 10-item scale is unique to this study, most of the individual items were derived 
from previous research regarding factors associated with effective diagnosis and treatment of 
psychiatric disorders: ‘improved access to psychiatrists’ (Clatney et al., 2008); ‘to be able to 
prescribe affordable medication’ (Simon et al., 2004); ‘more time to spend with my patients’ 
(Hartley et al., 1998; Dew et al., 2005); ‘improved access to mental health professionals other 
than psychiatrists’ (Smith et al., 2004); ‘more training on counselling techniques’ (Telford et al., 
2002); ‘more personal experience managing patients with mental disorders’ (Baik et al., 2005; 
Wong et al., 2006); ‘up-to-date information on effective pharmacological treatments’ (Tiemens 
et al., 1999; Lin et al., 2001; Katerndahl & Ferrer, 2004); and ‘up-to-date information on 
effective non-pharmacological treatments’ (Goldman et al., 1999). 
Resistance to formal diagnosis of patient 
  This study asked physicians to indicate whether nine possible reasons might contribute to 
their decision to not make a formal diagnosis of a patient presenting with symptoms of 
depression. Responses were coded as ‘yes, reason for not making formal diagnosis’ or ‘no, not a 
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reason for not making formal diagnosis’. For multivariate analysis purposes, ‘yes’ responses to 
eight of these nine items (‘other’ was excluded) were summed to calculate an overall summary 
score of diagnostic resistance.  
Knowledge 
 The depression knowledge questionnaire (DKQ) (Meredith et al., 1999, 2000, 2007) was a 12-
item scale designed to measure physicians’ knowledge of depression on four dimensions, 
including knowledge of effective treatment (e.g. phases, duration), types of treatment (e.g. 
antidepressant medication, cognitive behavior therapy, and psychotherapy), types of 
antidepressant medication (e.g. SSRIs, tricyclics, and tranquilizers), and general knowledge. 
Physicians indicated their response to each item on a 5-point scale from ‘definitely true’, to 
‘mostly true’, ‘don’t know’, ‘mostly false’, and ‘definitely false’.  
 An overall summary score was calculated by summing correct responses on 11 of the 12 items 
(i.e. item #6 was excluded, since the author judged that it was not an appropriate measure of 
knowledge). Correct items were scored as ‘1’, incorrect as ‘0’, and missing items as ‘0’. This 
summary score was then divided by 11 (i.e. the number of possible correct responses) to 
compute a final depression knowledge score based on a 100-point scale.  
 The anxiety knowledge scale (AKQ) was a 12-item scale designed by the author to measure 
physicians’ knowledge of anxiety based on the Canadian Psychiatric Association’s Clinical 
Practice Guidelines for Management of Anxiety Disorders (2006). Similar to the DKQ, the AKQ 
measured physicians’ knowledge of anxiety on four dimensions: effective treatment, types of 
treatment, types of medication, and general knowledge. 
 An overall summary scale was computed by summing correct responses to all 12 items, with 
correct items scored as ‘1’, incorrect as ‘0’, and missing as ‘0’. The summary score was then 
 53 
divided by 12 (i.e. the number of possible correct responses) to arrive at a final anxiety 
knowledge scale based on a 100-point scale. 
Attitudes  
 The depression attitude questionnaire (scale) was designed by Botega and Silveira (1996) and 
adapted for use in studies of various health professionals, including nurses in the USA (Haddad 
et al., 2007); general practitioners in Australia (Richards et al., 2004), general practitioners in 
Scotland (Ross et al., 1999), nurses in the UK (Payne et al., 2002), and general practitioners in 
the UK (Dowrick et al., 2000; King et al., 2002; Oladinni, 2002). A psychometric analysis of a 
20-item version of the depression attitude scale administered to 189 nurses resulted in 
Cronbach’s alpha 0.68 (Haddad et al., 2007). Haddad et al.’s study (2007) is the only published 
study to report a measure of internal scale consistency for the depression attitude scale. 
 The anxiety attitude scale was created for this study by modifying the depression attitude 
questionnaire. The terms ‘depressive’, ‘depression’, ‘depressed’ were replaced with the terms 
‘anxiety’ and ‘anxious’. Where the original depression attitude scale referred to treatment, 
similar treatment for anxiety disorders was substituted (e.g. ‘pharmacotherapy’ for 
‘antidepressants’).   
 In this study, the depression attitude scale (22-items) and the anxiety attitude scale (22-items) 
asked respondents to indicate their agreement with 22 statements. Responses included ‘strongly 
agree’, ‘agree’, ‘neutral’, ‘disagree’, or ‘strongly disagree’. For multivariate analysis purposes, 
only respondents with valid responses to all 13 items in the final four-factor model of depression 
attitudes were included in the analysis. Likewise, only respondents with valid responses to all 13 
items in the final four-factor model of anxiety attitudes were included in the analysis. 
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3.8.3.5 Patient Factors 
 Physicians were asked to indicate those patient factors they used (all, most, some, a little, 
none of the time) when deciding on the best treatment for a patient (with depression or anxiety). 
Patient factors included age, gender, marital status, children, employment status, preference for 
treatment, and (patient’s) family’s preference for treatment. 
3.9 Validity and Reliability 
 Content validity of the surveys was reinforced in several ways. First, the surveys employed 
clinical scenarios adapted from previous studies, and standardized scales where possible. For 
instance, the surveys included demographic measures used in the National Physician Survey 
(College of Family Physicians of Canada, 2004), a depression knowledge questionnaire used in a 
previous study (Meredith et al., 1999, 2000, 2007), and a Depression Attitude Questionnaire used 
in several international studies (Botega & Silveira, 1996; Dowrick et al., 2000; Haddad et al., 
2007; Payne et al., 2002; Richards et al., 2004). Second, drafts of the surveys were reviewed by 
family physicians prior to a pilot study, and their comments included in further revisions. Third, 
a pilot study of 100 Saskatchewan family physicians was conducted, the results of which were 
incorporated into the methodology for the main study. 
3.10 Data Analysis 
 Data analysis included simple univariate descriptives, as well as bivariate analyses with 
nonparametric tests of significance and binary logistic regression tests of significance, 
exploratory factor analyses, and multivariate analysis with binary logistic regression. 
 Simple univariate descriptives were generated for respondents’ personal attributes and 
organizational settings (frequencies and means). These descriptives were compared with the 
most recent information from the Saskatchewan component of the 2007 National Physician 
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Survey (College of Family Physicians of Canada, 2007). This comparison allowed for an 
evaluation of sample representativeness. Simple descriptive analysis was also used to describe 
physicians’ responses to the clinical scenarios, their information and resource use, and their 
professional attributes. 
 Bivariate analyses of associations between each independent variable and each of the three 
outcome variables (tentative diagnosis, treatment plan, and follow-up return) were conducted. 
These analyses included chi-square nonparametric tests of significance for associations between 
categorical independent variables (e.g. gender and internet access) and the three categorical 
dependent variables (tentative diagnosis, treatment plan, and follow-up return); Mann-Whitney 
nonparametric tests of significance for associations between continuous independent variables 
(e.g. age, knowledge scores, attitude scores) and two of the three categorical dependent variables 
(tentative diagnosis and follow-up return);  and binary logistic regression tests of significance for 
associations between continuous independent variables (e.g. age, knowledge score, attitude 
scores) and one of the three categorical dependent variables (treatment plan). 
 Exploratory factor analysis of the 22-item depression attitude scale and the 22-item anxiety 
attitude scales allowed for the identification of particular attitude dimensions (subscales) within 
each scale. Support for the use of factor analysis for these two scales was evaluated with the 
Kaiser-Meyer-Olkin measure, and Bartlett’s Test of Sphericity. This analysis includes a 
discussion of the percent of variance accounted for by each subscale, the cumulative percent of 
variance accounted for by the reduced models, Cronbach’s alpha to evaluate internal consistency 
reliability for each subscale, as well as Cronbach’s alpha for the reduced subscales (Dixon, 
2005). 
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 Multivariate analysis of the association between each of the independent variables 
significantly associated with treatment plan at the bivariate level (p<.05) involved use of binary 
logistic regression. This analysis employed the enter method, in which all variables significantly 
associated with treatment plan at the bivariate level were entered simultaneously. The fit of each 
model was assessed with the Hosmer and Lemeshow goodness-of-fit chi-square and Nagelkerke 
R-square test.  
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4. PILOT STUDY 
 
4.1 Introduction 
 The pilot study of 100 Saskatchewan family physicians had four main purposes: to test the 
survey questionnaire, to evaluate the mail survey procedures for the main study, to estimate the 
response rate of the main study, and to evaluate the impact of an incentive to participate on the 
response rate. The pilot study was conducted to improve the quality of the main study by 
revealing shortcomings in the research design, such as deficiencies in the mail-out procedures 
and the survey instrument. One of two questionnaire versions was mailed to each physician 
(Appendix M and N). Each version of the questionnaire contained a clinical scenario of a patient 
presenting with symptoms of MDE or GAD plus queries regarding physician response to the 
scenarios, as well as measures of physician attributes (personal and professional), organizational 
setting, patient cues, and information and resource use.  
 Testing the survey questionnaire involved examining whether the questions were understood 
in the manner intended; whether instructions to respondents lacked clarity; whether some 
questions had a high rate of non-response; whether the questionnaire could be improved by 
transforming some open-ended questions into closed-ended questions; and whether some 
questions could be eliminated without losing important information.  
 The mail survey procedures to be followed in the main study were followed in the pilot study. 
The design of the pilot study followed Dillman’s Tailored Design Method, which applies the 
concept of social exchange to ultimately reduce survey error and attain high response rates 
(Dillman, 2007). Specifically, respondents received a minimum of three and a maximum of six 
contacts. These contacts included one pre-letter (Appendix D); one initial survey package 
including a consent form (Appendix C), letter (E), and questionnaire (Appendix M or N); one 
 58 
thank you letter (Appendix F or H), two replacement packages with reminder letters (Appendices 
I and K) and a questionnaire (Appendix M or N); and a final thank-you letter (Appendix L).  
 The rate of response to the pilot study was 38%, with surveys completed by 30 of 78 eligible 
family physicians. This response rate is low, even in light of notoriously low response rates 
observed among physicians targeted by previous mail surveys (Kellerman & Herod, 2001). 
Furthermore, a recent survey of the entire Saskatchewan family physician population, also 
concerning mental health, had a higher response rate of 48% (Clatney et al., 2008). However, the 
pilot study response rate was targeted for improvement in the main study by revising and 
eliminating survey questions to shorten the survey length, printing the survey instrument with 
color pages, revising aspects of the mail survey procedures, and including the incentive to 
respond in earlier rather than later survey packages.   
4.2 Questionnaire Development 
 Two questionnaires were developed for the pilot study in anticipation of their implementation 
in the main study. The content domains of the dependent variables were effective diagnosis 
decision, work knowledge and technical knowledge. The domains of the independent variables 
were organizational setting, patient cues, physician characteristics, and information and resource 
use. The two questionnaires had many identical items of organizational setting and information 
use, as well as questions specific to caring for patients with either depression or anxiety. Where 
possible, relevant items from published studies of physician surveys were included in the 
questionnaires, without modifications. Other questionnaire measures were developed specifically 
for this project. All of the measures included in the two questionnaires are described in Table 
4.1. 
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Table 4.1 
Measures included in Pilot Study Questionnaire 
   
Content Domain 
Depression Questionnaire with 
clinical scenario of patient with 
Major Depressive Episode (MDE)  
Anxiety Questionnaire with 
clinical scenario of patient with 
Generalized Anxiety Disorder 
(GAD) 
Dependent Variables   
Effective Diagnosis 
Decision 
Correct diagnosis (based on clinical 
scenario of MDE) 
 
Correct diagnosis (based on 
clinical scenario of GAD) 
Work Knowledge Correct treatment and management 
(based on clinical scenario of MDE  
Correct treatment and 
management (based on clinical 
scenario of GAD) 
Technical 
Knowledge 
Effective Treatment of Depression 
(ETD) - 12 item Index (Meredith et 
al., 1999) 
 
 
 
 
Two treatment interventions used 
for severe vs moderate depression 
(choice of 7 treatment 
interventions) 
First choice of medication to treat 
depression, starting dosage and 
duration of treatment, stratified by 
age group (based on study of 
psychotropic prescribing practices) 
(Tinsley et al. 1998) 
Effective Treatment of Anxiety 
(ETA) - 12 item Index developed 
for this study based on Clinical 
Practice Guidelines for the 
Management of Anxiety Disorders 
(Canadian Psychiatric Association, 
2006) 
 
Two treatment interventions used 
for severe vs moderate anxiety 
(choice of 7 treatment 
interventions) 
First choice of medication to treat 
anxiety, starting dosage and 
duration of treatment, stratified by 
age group (based on study of 
psychotropic prescribing 
practices) (Tinsley et al. 1998) 
Independent Variables 
 
Organizational 
setting 
 
Practice setting  
⋅ Main patient care setting is private office vs 6 other types  
⋅ Solo or group practice 
⋅ Urban (population > 10,000) vs Rural (population < 10,000) 
⋅ Internet access in main patient care setting and during patient 
consultations 
Collegial network  
⋅ Disciplines, number, accessibility, and primary mode of contact 
⋅ Patient care is shared with other health professionals 
Patient cues 
 
⋅ Patient symptoms considered in clinical scenario diagnosis decision 
⋅ Patient factors considered in decision of best treatment (age, gender, 
marital status, children, employment status, patient preference for 
treatment, and family preference for treatment) 
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Content Domain 
Depression Questionnaire with 
clinical scenario of patient with 
Major Depressive Episode (MDE)  
Anxiety Questionnaire with 
clinical scenario of patient with 
Generalized Anxiety Disorder 
(GAD) 
Physician 
characteristics 
  
Attitudes and 
beliefs 
Depression Attitude Questionnaire 
[DAQ] (Botega and Silveira, 1996) 
Depression – 22 item index  
 
Anxiety Attitude Questionnaire 
[adapted from the DAQ, for this 
study] (Botega and Silveira, 1996) 
– 22 item index  
 Resistance to diagnosis of 
depression 
⋅ Choice of 7 reasons for not 
diagnosing depression (Yes/No) 
Resistance to diagnosis of anxiety 
⋅ Choice of 7 reasons for not 
diagnosing anxiety (Yes/No) 
Attributes Socio-demographics 
⋅ Gender 
⋅ Age 
⋅ Years in practice as a family physician 
Education – undergraduate and postgraduate medical 
Information and 
Resource Use 
 
 
 
 
 
 
Purpose is to update general medical knowledge 
⋅ 13 information sources and resources – regular use in past month 
(Yes/No) 
Purpose is to make specific clinical decision 
⋅ 13 information sources and resources – regular use in past month 
(Yes/No) 
Purpose is to confirm decision regarding depression diagnosis 
⋅ 6 information sources and resources (Yes/No) 
Physical accessibility (easy to access in general) 
⋅ 14 information sources and resources (Yes/No) 
Intellectual accessibility (easy to understand in general) 
⋅ 14 information sources and resources (Yes/No) 
Reliability (trustworthy in general) 
⋅ 14 information sources and resources (Yes/No)  
Relevance (to physician’s needs in general) 
14 information sources and resources (Yes/No) 
 
 The two clinical scenarios were adapted from vignettes originally used in a study concerning 
the effect of payment method on choice of diagnostic categories by American psychologists 
(Kielbasa et al., 2004). Kielbasa et al.’s original anxiety vignette did not require significant 
modification, beyond changing details regarding the patient’s age, occupation, and the criterion 
of generalized anxiety disorder relating to worrying about more than one thing. Patient details in 
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the Kielbasa and colleagues’ original depression vignette were also modified to completely 
satisfy the criteria of major depressive episode; the most significant modifications were the 
addition of two symptoms and the specification of 4-week symptom duration.  
 One set of questions included in both questionnaires concerned the physician’s first choice of 
medication to treat depression, and duration of treatment (weeks) by three patient age groups 
(10-17, 18-65, and >65 years). This item was based on a study of family physicians’ and 
psychiatrists’ psychotropic prescribing practices (Tinsley et al., 1998), which examined group 
differences in starting dosage stratified by patient’s age. For the present study, duration of 
treatment was added. 
 In the depression questionnaire, a 12-item index measuring Effective Treatment of Depression 
(ETD) (Meredith et al., 1999) was included verbatim. This index was created by Meredith and 
colleagues to measure physicians’ knowledge of effective pharmacologic and psychological 
treatment approaches to major depression. To include an equivalent index for the Effective 
Treatment of Anxiety (ETA), a 12-item index based on Clinical Practice Guidelines for the 
Management of Anxiety Disorders (Canadian Psychiatric Association, 2006) was created 
specifically for this study. Similar to the ETD, the ETA was created to measure knowledge of 
treatment approaches. In addition, one item regarding the knowledge of the epidemiology of 
anxiety disorders was created. 
 The depression questionnaire also included The Depression Attitude Questionnaire (DAQ) 
Index (Botega & Silveira, 1996), with a wording change in one item, and two completely new 
questions added to the original 20 items. The DAQ was further modified and incorporated into 
the anxiety questionnaire as the Anxiety Attitude Questionnaire (AAQ). In 16 of the 22 
questions, the modifications simply involved changing the wording to refer to patients presenting 
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with anxiety rather than depression. The remaining six questions required further re-wording to 
refer to treatments specific to patients with anxiety disorder. 
 Four questions based on the National Physician Survey (The College of Family Physicians of 
Canada, 2004) were also slightly modified and incorporated into the questionnaires. These 
questions concerned status as a physician (e.g. full-time, student, on a leave of absence), type of 
main patient care setting (e.g. private office, community clinic, emergency department), 
organization of main patient care setting (e.g. solo, group, other), and sharing patient care with 
other health professionals (e.g. psychiatrists, nurse practitioners, and occupational therapists).  
4.3 Questionnaire Evaluation Prior to Pilot Study Data Collection  
 Prior to the pilot study, questionnaire evaluation began with distribution of the questionnaires 
by a faculty member of the Department of Psychiatry to two Saskatchewan family physicians 
with a known interest in managing patients with psychiatric disorders. Draft questionnaires were 
also distributed to family physicians who were fellow TUTOR-PHC students (Transdisciplinary 
Training and Understanding on Research in Primary Care). In total, four questionnaires were 
returned. Of the four, two questionnaires were completed by physicians practicing in Saskatoon, 
one practicing in Nova Scotia, and one practicing in New Zealand.  
 Based on these four completed questionnaires, measures were added, modified, or eliminated 
altogether, trimming the questionnaires from 11 to eight pages. The first added measure dealt 
with the two most popular treatment interventions used for patients presenting with moderate and 
severe depressive or anxiety disorders. The second added measure asked physicians to report 
their first choice of medication to treat depression, and duration of treatment (weeks) by three 
patient age groups (10-17, 18-65, and >65 years).  
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 Several small modifications were also made to reduce response burden and in turn, reduce 
item non-response. For instance, some items were compacted to reduce the overall page count. 
Other items were trimmed, in order to require the physician to offer fewer examples. The 
following comments arose from an open-ended question which was modified to one that asked 
the physician when s/he would like the patient to return for 1st, 2nd, 3rd, and 4th follow-ups: 
 
Survey: If you have recommended treatment, what are the reasons for your 
recommendations? (Regarding clinical scenario patient presenting with depression). 
 Physician #3: All have been suggested to improve symptoms. 
 Physician #4: Odd question. Obviously because of illness. 
 
 Modifications were also made to the measure which asked physicians to provide five 
examples each of specialist and other health professional colleagues available to call on for 
consultation. Physicians provided the following comments when they came upon this section: 
 
Survey: Please indicate the profession(s) of colleagues in your support network, their level of  
 accessibility, and your primary mode of contact with these professionals. 
 Physician #3: Can’t say #. 
 Physician #4: Too much information to ask for. Need to streamline. 
 
 These comments prompted a trimming of the number of the maximum number of expected 
examples, within each category, from five to two colleagues. 
 Although many questions were trimmed and compacted to lower the response burden upon 
physicians, the two sets of measures which were added required balance by the eliminating two 
sets in turn. For this reason, the entire section regarding patients exhibiting mental distress was 
eliminated. Contained in this section was a set of measures which asked respondents to estimate 
the average number of minutes spent with patients with mental distress for new and follow-up 
visits, and the average number of patients/week recognized, diagnosed, and treated for 
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depression or anxiety. This section also contained eight items which asked physicians to indicate 
their level of agreement with statements regarding the resources they required to effectively 
manage patients exhibiting mental distress. 
 At the end of the questionnaire, physicians were given an opportunity to provide comments 
about the questionnaire. Physicians responded with the following comments: 
 
Survey: Do you have any comments about this questionnaire? 
 Physician #3: Info use questions hard to answer eg some (journals CMS/CPGs) better 
   than others. Search engines again vary. Easy to read Qs. Easy to understand Qs. 
 Physician #4: Too long for most family docs. Some redundancies. 
  
4.4 Sample 
 The pilot study population of 100 physicians was drawn from the Canadian Medical Directory 
(CMD), and verified against information from the College of Physicians and Surgeons of 
Saskatchewan mailing list. The CMD Directory was accessed via a CD-ROM purchased from 
MD:Select, and customized by the vendor to contain contact and other information for 
Saskatchewan family physicians only. Given that the CMD purchase did not include ongoing 
updates, and the College’s mailing list is updated monthly, it was logical to combine the two 
resources. The information contained in the Directory which was relevant for the pilot and main 
studies included first and last names, mailing addresses, gender, and year of graduation for all 
Saskatchewan family physicians. 
 The Directory contained information for a total of 918 individuals. Based on the College’s 
mailing list, I added 36 family physicians identified as locum tenens and removed four 
physicians identified as no longer actively practicing. The total population prior to deriving the 
pilot study list was 950 individuals. The pilot study population of 100 physicians was derived by 
sorting the larger file alphabetically by physicians’ last names, and selecting every tenth person. 
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Once the list of 100 persons was created, the College’s updates were consulted to ensure that the 
physicians were actively practicing and that their contact information was current.  
 Characteristics of the physicians comprising the pilot study population are summarized in 
Table 4.2. Sixty percent of the population were male and 73% practiced in urban settings. Half of 
the population (50%) received a depression questionnaire concerning the topic of depression; the 
other half received an anxiety questionnaire. 
 
  Table 4.2  
   Gender and Setting of Pilot Study Population 
Characteristic Physicians  
N 
Gender  
   Male 60 
   Female 40 
Practice location  
   Urban (<10,000) 73 
   Rural (>10,000)  27 
Questionnaire topic  
   Anxiety 50 
   Depression 50 
Total 100 
 
 
 In order to classify physicians as either rural (<10,000) or urban (>10,000) on the basis of 
their practice location, I accessed the populations of their cities/towns using the 2007 
Saskatchewan Population Report (Statistics Canada, 2007). The majority of the sample practiced 
in urban locations (n=73); 27 practiced in rural settings (Table 4.3). Physicians from 25 
communities were surveyed. Fifty-four of the physicians practiced in either Saskatoon (n=33) or 
Regina (n=21). The remaining 46 physicians practiced in one of 23 communities. 
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Table 4.3 
 Location of Practice of Pilot Study Population, Based on 2006 Census 
Location of 
Practice 
Physicians 
Surveyed 
n 
Population 
 
Rural 
n 
 
Urban 
n 
Battleford 1 3,685 1  
Beechy 1 243 1  
Cabri 1 439 1  
Esterhazy 1 2,336 1  
Fort Qu’Appelle 1 1,919 1  
Humboldt 2 4,998 2  
Indian Head 1 1,634 1  
Kamsack 1 1,713 1  
Kelvington 1 866 1  
Kindersley 1 4,412 1  
Lloydminster 3 8,118 3  
Meadow Lake 3 4,771 3  
Melfort 1 5,192 1  
Moose Jaw 8 32,132  8 
Moosomin 1 2,257 1  
Nipawin 1 4,061 1  
North Battleford 2 13,190  2 
Paradise Hill 1 483 1  
Prince Albert 6 34,138  6 
Regina 21 179,246  21 
Saskatoon 33 202,340  33 
Shellbrook 1 1,215 1  
Swift Current 3 14,946  3 
Unity 1 2,147 1  
Weyburn 4 9,433 4  
Total 100  27 73 
 
4.5 Data Collection 
 Pilot study data collection spanned 4 months, beginning June 14, 2007 with a pre-letter and 
ending October 10th with a thank-you letter to respondents to the last wave of surveys. The 
survey involved a maximum of six contacts with physicians, from pre-letter, to the first package, 
thank-you or reminder, thank-you or second package, thank-you or third package, and reminder 
letter (Table 4.4). Physicians selected for the pilot study were contacted two to six times, 
depending upon the point at which they responded to the survey. 
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Table 4.4 
Dates and Description of Contacts With Pilot Study Population 
                           Description of Contact 
Date First Second Third Fourth Fifth Sixth 
June 14 Pre-letter      
June 21  1
st Package 
invitation     
July 6   
Thank-you 
& and 
reminder 
   
July 20    
Thank-
you & 2nd 
package 
  
August 29     
Thank-you & 
3rd package 
(w/ $5) 
 
October 10      Thank-you 
 
 All letters were printed on University of Saskatchewan letterhead signed by the author, 
supervisor, and representative for the Head of the Department of Psychiatry. Additionally, all 
letters and envelopes were personalized with the physician’s name and address. Each package 
contained a self-addressed stamped envelope without return address to protect the identity of 
physicians responding to the survey. No incentives to respond were used until the 3rd survey 
package. At that point, $5 was enclosed with each package to physicians who had not yet 
responded.  
4.6 Response Rate 
 Figure 4.1 presents a summary of the number of contacts with physicians, and the number of 
respondents and non-respondents after each contact. Of the original 100 physicians surveyed, 30 
physicians returned completed questionnaires, 15 refused to participate, 22 were 
ineligible/moved/retired, and 33 did not respond (Table 4.5). 
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 In total, 78 physicians were eligible for this study (100 – 22). The response rate for this study 
was 38%, based on 30 of 78 eligible physicians returning completed questionnaires. The rate of 
refusal to participate was 19% (15/78), and the non-response rate was 42% (33/78). The total 
non-response rate was 62% (48/78). 
 
     
        
 
 
Figure 4.1 
 Description of Contact with Pilot Study Population 
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 Table 4.5 indicates that of the physicians surveyed, men accounted for 60% and women 
for 40%. However, women constituted a greater proportion of respondents (57% vs. 43%). 
Correspondingly, a greater proportion of non-respondents were men (63% vs. 37%). 
Furthermore, urban physicians comprised 73% and rural physicians accounted for 27% of the 
original sample. In the end, 67% of respondents were urban and 33% were rural. Lastly, an 
equal number of anxiety and depression questionnaires were distributed, and an equal number 
of each was returned completed (n=15). 
Table 4.5 
Characteristics of Pilot Study Respondents and Non-respondents 
 Non-respondents N=48 
 
 
Characteristic 
 
 
Population 
N=100 
N 
 
 
Respondent 
N=30 
n (%) 
Refusal 
N=15 
n (%) 
Non-response 
N=33 
n (%) 
Total 
N=48 
n (%) 
Gender      
    Male 60 13 (43) 6 (40) 24 (73) 48 (63) 
    Female 40 17 (57) 9 (60) 9 (27) 18 (37) 
Practice location      
    Urban (<10,000) 73 20 (67) 14 (93) 26 (79) 40 (83) 
    Rural (>10,000) 27 10 (33) 1 (7) 7 (21) 8 (17) 
Questionnaire topic      
    Anxiety 50 15 (50) 6 (40) 20 (61) 26 (54) 
    Depression 50 15 (50) 9 (60) 13 (39) 22 (46) 
Number of contacts      
     (1st package)  8 (27) 1 (7)  1 (2) 
    3 (Thank-you/ 
reminder)  6 (20) 0  0 
    4 (Thank-you/  
        2nd package)  9 (30) 3 (20)  3 (6) 
    5 (Thank-you/  
        3nd package)  7 (23) 11 (73) 33 (100) 44 (92) 
 
 Nearly half (47%) of all respondents returned their completed questionnaires after three 
contacts (i.e. before the second package was sent); 53% (16/30) of respondents were contacted 
four to five times before they returned their completed questionnaires.  
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 Rural physicians were more likely to complete the survey than their urban counterparts. For 
instance, 37% (10/27) of rural physicians completed the survey, compared to 27% (20/73) of 
urban physicians. Likewise, 55% (40/73) of urban physicians refused to participate/did not 
respond, compared to 30% (8/27) of rural physicians. 
4.7 Respondent Comments 
 Physicians who chose not to complete and return their questionnaires were encouraged to 
indicate the reason on the front cover, or first inside page, of their returned questionnaires. Only 
one of the 15 physicians who refused to participate indicated their reasoning (i.e. she did not like 
the questionnaire and did not want to skew the results by participating). Of the 22 individuals 
who indicated their ineligibility, one had retired, one had never practiced in the location on 
record, eight had moved, and 12 were not family physicians.  
 On the last page of the questionnaire, respondents were asked to provide general comments 
about the questionnaire. The basis for this question was to give respondents a legitimate space in 
which to note what they did or did not like about the survey. Six of the 29 respondents took this 
opportunity to provide comments. For the purposes of revising questionnaire content with a view 
to the main study, the comments related to survey length and the difficulty of providing concise 
survey responses in comparison to actual practice. Specific comments regarding survey length 
were as follows: 
Survey: Do you have any general comments about this questionnaire? 
 Physician: …Took 15-20 minutes (made me depressed). 
 Physician: It was too long. 
Physician: …You deceived us with the time it takes to do this long questionnaire. It took over  
 30 mins for me. 
 
Comments regarding the difficulty of answering survey questions based on actual practice 
included the following: 
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Survey: Do you have any general comments about this questionnaire? 
 Physician: At times difficult to answer esp. compared to actual practise... 
Physician: Some poor questions – not enough information to provide proper answers (i.e.  
 the case, weeks to follow-up, first choice in medication. There are many variables  
 that need to be evaluated prior to selection. 
 
4.8 Pilot Study Results 
 One hundred percent of physicians diagnosed the clinical scenario patient correctly. 
Physicians reported that they may not be able to provide the best possible care to the clinical 
scenario patient due to cost barriers for patients to access medication and counseling, patient 
non-compliance, physicians’ lack of skill, training, or interest in psychiatric problems, and time 
constraints to give adequate counseling and instructions regarding medication use. Medical 
journals were the most frequently used information source to update general medical knowledge, 
and colleagues was the information source most frequently used by physicians when making a 
specific clinical decision. Physicians were asked to rate information sources on reliability (trust), 
ease of access, relevance, and ease of understanding. CME courses and psychiatrists consistently 
ranked in the top three on all criteria, with the exception of ease of access. The majority of 
physicians indicated medication as their first choice of treatment intervention for patients with 
severe anxiety or depressive disorders, as well as for patients with moderate depressive 
disorders. Counselor/psychological referral was the first treatment choice for patients with 
moderate anxiety disorders. 
4.9 Revisions to Main Study 
 To summarize, the pilot study aided tremendously in identifying weaknesses and strengths in 
the survey method and instrument. The main weaknesses of the pilot study were questionnaire 
design and failing to include an incentive to participate earlier in the survey process. The primary 
strength of the pilot study was the low rate of survey item non-response. That is, nearly all 
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physicians completed the questionnaires in their entirety without skipping a single question; only 
one physician skipped two full pages of questions. 
 For the main study, the first issue addressed subsequent to the pilot study was questionnaire 
revision. Specifically, the questionnaires were revised by trimming the overall survey length and 
adding color to improve the attractiveness of the survey. The second issue addressed was the 
inclusion of the incentive to participate ($10) in the 1st package. When the incentive was 
included in the 3rd package of the pilot study, the number of physicians who replied to the survey 
increased, regardless of whether they completed the survey, refused, or were ineligible. For this 
reason, it was logical to offer this incentive to physicians as early in the process as possible.  
 The secondary weaknesses of the pilot study concerned the overlap with summer holidays and 
the inclusion of locum tenens in the pilot sample. Consequently, the main study began with pre-
letters mailed during the second week of January, 2008. It was hoped that a greater number of 
physicians would respond in some fashion if the main study did not coincide with summer 
holidays. In addition, given that only one of the five locum tenens added to the pilot study 
sample completed the survey, locum tenens were excluded from the main study population.  
 Lastly, the clinical scenarios and additional measures within the questionnaires were 
interchanged for the main study. Specifically, whereas the Depression Questionnaire in the pilot 
study contained an MDE clinical scenario and measures of caring for patients with depression 
(Appendix M), the Depression Questionnaire in the main study was revised to contain a GAD 
clinical scenario and measures concerning caring for patients with depression (Appendix V). 
Given that 100% of pilot study respondents diagnosed the clinical scenario patient correctly, the 
rationale for this decision was to minimize the possibility of cuing physicians to the correct 
responses regarding the clinical scenarios in the main study.  
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5.0 MAIN STUDY RESULTS 
 
 
 This chapter presents the results of the main study, including a description of the study 
response rate, personal and professional attributes of respondents, their organizational settings, 
and information and resource use. In addition, this chapter explores family physicians’ responses 
to depression and anxiety clinical scenarios included in the survey questionnaire, and presents 
bivariate analyses of responses to the clinical scenarios by personal and professional attributes, 
organizational setting, and information/resource use. The chapter concludes with a logistic 
regression analysis of respondents’ treatment plan (of clinical scenario patients) by personal and 
professional attributes, organizational setting, and information/resource use. 
5.1 Response Rate 
 Of the 792 family physicians initially contacted to participate in the main study, 87 were 
ineligible, 30 had incorrect addresses on record, eight were retired, and one physician was 
deceased (Figure 5.1). Of the remaining 666 eligible physicians, 129 (19%) refused to participate 
and 206 (31%) did not respond. A total of 331 eligible family physicians completed and returned 
surveys, for a response rate of 49.7 percent (331/666). 
 The rate of response for this study (49.7%, N=331) compares favorably to the rate of response 
to the 2007 National Physician Survey, Saskatchewan sample (NPSSS), of 29.25%  
(N=303/1036), and to the response rate of 48% obtained by a mail survey of Saskatchewan 
family physicians’ regarding their mental health care perspectives (Clatney et al., 2008). The 
response rate was highest among physicians in the province’s three remote health regions, 53% 
of whom (n=9/17) completed the survey (Figure 5.2). The lowest response rates were contributed 
by physicians in the Heartland (n=7/23) and Sunrise (n=10/33) health regions, 30% of whom 
completed the survey. 
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Figure 5.1 
Description of Contact With Main Study Population 
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5.2 Demographics of Respondents 
 Comparison with the 2007 National Physician Survey NPS, Saskatchewan sample (NPSSS), 
indicates that the current study slightly under-represented male physicians and physicians who 
completed their undergraduate and postgraduate training outside Canada. Furthermore, this study 
over-represented physicians who had been in practice for a longer period of time. However, this 
study was fairly representative in terms of physicians’ age. 
 According to the 2007 NPSSS Masterfile, 72.1% of Saskatchewan’s family physicians in 
2007 were men, and 27.9% were women; in comparison, this study had fewer men (69.8%) and 
more women (29.6%). Men comprised a greater proportion of Depression Questionnaire (DQ) 
Figure 5.2 Health Regions of Respondents (N=331/792) 
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respondents than Anxiety Questionnaire (AQ) respondents (Table 5.1). Specifically, 74.4% of 
DQ respondents were men, compared to 65.5% of AQ respondents. Conversely, a greater 
proportion of women responded to the AQ than to the DQ (33.9% vs. 25.0%). However, the 
gender difference in respondents was not significant (p=.076). 
 According to the 2007 NPSSS, the average age of Saskatchewan’s family physicians was 50.1 
years (27-77, SD=11.3). In comparison, the average age of physicians in this study was 49.6 
years (28-88, SD=11.8). This comparison indicates that the average age of respondents in this 
study was representative of the age of Saskatchewan family physicians as a whole. Overall, 
11.2% of respondents were under 35 years of age, 20.5% were 60 years and over, and 65.3% 
were 35 to 60 years of age. DQ respondents were slightly older (M=50.4) than AQ respondents 
(M=48.8); however, this difference was not significant (p=.287).  
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Table 5.1 
Personal Attributes of Respondents  
 
 Anxiety  
Questionnaire 
(N=171) 
Depression 
Questionnaire 
(N=160) 
 
Total 
N=331 
Personal Attribute n (n%) n (n%) n (n%) 
Gender    
 Male 112 (65.5) 119 (74.4) 231 (69.8) 
 Female 58 (33.9) 40 (25.0) 98 (29.6) 
  Missing 1 (0.6) 1 (0.6) 2 (0.6) 
Age mean (range, sd) 48.8 (28-81, 11.6) 50.4 (28-88, 12.0) 49.6 (28-88, 11.8) 
 <35 21 (12.3) 16 (10.0) 37 (11.2) 
 35-39 21 (12.3) 12 (7.5) 33 (10.0) 
 40-49 49 (28.7) 47 (29.4) 96 (29.0) 
 50-59 43 (25.1) 44 (27.5) 87 (26.3) 
 60-69 26 (15.2) 26 (16.3) 52 (15.7) 
 70 and over 6 (3.5) 10 (6.3) 16 (4.8) 
 Missing 5 (2.9) 5 (3.1) 10 (3.0) 
Years in practice mean 
(range, sd) 
18.1 (1-43, 11.4) 20.3 (1-50, 11.8) 19.2 (1-50, 11.6) 
 <10 48 (28.1) 34 (21.2) 82 (24.8) 
 10-19 39 (22.8) 34 (21.3) 73 (22.1) 
 20-29 45 (26.3) 47 (29.4) 92 (27.8) 
 30-39 30 (17.5) 31 (19.4) 61 (18.4) 
 40+ 6 (3.5) 9 (5.6) 15. (4.5) 
 Missing 3 (1.8) 5 (3.1) 8 (2.4) 
Education undergraduate    
 In Canada 71 (41.5) 66 (41.3) 137 (41.4) 
 Outside Canada 84 (49.1) 84 (52.5) 168 (50.8) 
 Missing 16 (9.4) 10 (6.3) 26 (7.9) 
Education postgraduate    
 In Canada 72 (42.1) 60 (37.5) 132 (39.9) 
 Outside Canada 56 (32.7) 57 (35.6) 113 (34.1) 
 Missing 43 (25.1) 43 (26.9) 86 (26.0) 
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5.3 Personal Attributes 
 In addition to the personal attributes of age and gender, this analysis considered additional 
personal attributes such as years in practice as a family physician, country of undergraduate 
education, and country of postgraduate education (Table 5.1).   
 The 2007 NPSSS indicated that Saskatchewan family physicians had been in practice an 
average of 15.4 years (1-49, SD=12.0). In comparison, physicians in this study had been in 
practice an average of 19.2 years (1-50, SD=11.6). This comparison indicates that family 
physicians included in the present study had been in practice an average four years longer than 
family physicians included in the NPSSS.  
 Family physicians responding to the AQ had been in practice an average of 18.1 years 
(SD=11.4), compared to an average of 20.3 years (SD=11.8) for DQ respondents; this difference 
was not significant (p=.112). The proportion of physicians who had been in practice fewer than 
20 years (AQ 50.9%, DQ 42.5%) was roughly equivalent to the proportion who had been in 
practice more than 20 years (AQ 47.3%, DQ 54.4%). 
 According to the 2007 NPSSS, 58.2% completed their undergraduate medical training outside 
Canada, and 42.4% completed their postgraduate medical training outside Canada. In contrast, 
50.8% of physicians in this study obtained their undergraduate education outside Canada, and 
34.1% obtained their postgraduate education outside Canada. These comparisons indicate that 
this study under-represents physicians who completed their undergraduate and postgraduate 
training outside Canada. 
 A minority of physicians (AQ 41.5%, DQ 41.3%) completed their undergraduate education in 
Canada; approximately half received their undergraduate education outside Canada (AQ 49.1%, 
DQ 52.5%). Of those physicians who completed their undergraduate training outside of Canada, 
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53% completed their training in Africa, 23% in Europe, 18% in Asia, and 6% in other or multiple 
countries. 
 Similar proportions of respondents (AQ 42.1%, DQ 37.5%) indicated that they completed 
their postgraduate education in Canada, while fewer noted that their postgraduate degree was 
obtained in a country other than Canada (AQ 32.7%, DQ 35.6%). Of note is the large proportion 
of respondents (AQ 25.1%, DQ 26.9%) who did not indicate the country of their postgraduate 
education. 
5.4 Organizational Setting 
 With respect to organizational setting, this analysis considered physicians’ practice setting 
(private office or other setting); practice type (solo or otherwise); population of practice setting 
(urban or otherwise); and internet access (Table 5.2). 
5.4.1 Practice Setting and Practice Type 
 Most family physicians practiced in private offices (AQ 66.1%, DQ 66.9%), while a minority 
practiced in community clinics (AQ 9.9%, DQ 10.0%), or other settings (AQ 17.5%, DQ 16.3%). 
Physicians were most likely to practice in group settings (Q 78.9%, DQ 76.3%); a sizable 
minority were in solo practice (Q 15.8%, DQ 20.2%). 
 Approximately 7 of 10 physicians practiced in urban environments with populations of 10,001 
or greater (AQ 68.4%, DQ 71.9%), and 3 in 10 practiced in small towns (AQ 27.5%, DQ 22.5%) 
or rural settings (AQ 4.1%, DQ 5.6%). 
5.4.2 Internet Access 
 A large majority of physicians had internet access in their main patient care setting (AQ 
86.0%, DQ 78.8%); however, a smaller proportion had internet access during patient 
consultations (AQ 45.6%, DQ 40.0%). 
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Table 5.2 
Organization of Main Patient Care Setting 
 
 Anxiety 
Questionnaire 
(N=171) 
Depression 
Questionnaire 
(N=160) 
 
Total 
N=331 
Organizational setting n (n%) n (n%) n (n%) 
Practice setting    
 Private office 113 (66.1) 107 (66.9)  220 (66.5) 
 Community clinic 17 (9.9) 16 (10.0) 33 (10.0) 
 Walk-in clinic 2 (1.2)  5 (3.1) 7 (2.1) 
 Academic health 
 sciences centre 8 (4.7) 4 (2.5) 12 (3.9) 
 Community hospital 0 (0)  2 (1.3) 2 (0.6) 
 Othera 30 (17.5) 26 (16.3) 56 (16.9) 
 Missing 1 (0.6) 0 (0) 1 (0.3) 
Practice type    
 Solo 27 (15.8) 32 (20.2) 59 (17.8) 
 Group 135 (78.9) 122 (76.3) 257 (77.6) 
 Otherb 7 (4.1) 6 (3.8) 13 (3.9) 
 Missing 2 (1.2) 0 (0) 2 (0.6) 
Practice setting    
 Rural (< 1,000) 7 (4.1) 9 (5.6) 16 (4.8) 
 Small town (1,001-10,000) 47 (27.5) 36 (22.5) 83 (25.1) 
 Urban (>10,001) 117 (68.4) 115 (71.9) 232 (70.1) 
Internet access     
 Yes 147 (86.0) 126 (78.8) 273 (82.5) 
 No 22 (12.9) 34 (21.3) 56 (16.9) 
 Missing 2 (1.2) 0 (0) 2 (0.6) 
Internet access during patient 
consultations 
   
 Yes 78 (45.6) 65 (40.0) 142 (42.9) 
 No 91 (53.2) 96 (60.0) 187 (56.5) 
 Missing 2 (1.2) 0 (0) 2 (0.6) 
aIncluded multiple and unspecified practice settings 
bIncluded multiple, solo with one other physician or non-physician colleague, and unspecified 
types of practice 
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5.4.3 Duration of New and Follow-up Consultations 
 Family physicians generally reported spending more time with patients with anxiety and 
depression in new visits than in follow-up visits.  Specifically, a large proportion of physicians 
reported spending 30 minutes or longer in new visits with anxious (31.6%) and depressed 
(40.0%) patients, compared with follow-up visits with anxious (8.2%) and depressed patients 
(12.5%). Likewise, physicians generally spent less time in follow-up visits than in new visits 
with patients. Specifically, a greater proportion of physicians spent 1 to 14 minutes with anxious 
(35.7%) and depressed (30.6%) patients in follow-up visits, compared with new visits with 
anxious (8.8%) and depressed (3.8%) patients. Overall, physicians were equally likely to spend 
15 to 29 minutes in new visits with anxious (59.6%) and depressed (55.0%) patients and in 
follow-up visits with anxious (55.6%) and depressed (55.6%) patients.  
 
 Table 5.3 
 Duration of New and Follow-up Visits 
Minutes 
New visit 
n (n%) 
Follow-up 
n (n%) 
 Anxiety Questionnaire (N=171) 
1-14  15 (8.8)  61 (35.7) 
15-29 102 (59.6) 95 (55.6) 
30-44 49 (28.7) 12 (7.0) 
45 and longer 5 (2.9) 2 (1.2) 
Missing 0 1 (0.6) 
 Depression Questionnaire (N=160) 
1-14  6 (3.8) 49 (30.6) 
15-29 88 (55.0) 89 (55.6) 
30-44 55 (34.4) 17 (10.6) 
45 and longer 9 (5.6) 3 (1.9) 
Missing 2 (1.3) 2 (1.3) 
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5.4.4 Number of Patients Diagnosed and Treated on Weekly Basis 
 Physicians reported treating more patients with anxiety and depression than they diagnosed, 
on a weekly basis (Table 5.4). Physicians diagnosed an average of 4.3 patients per week with 
anxiety, and treated an average of 8.0 patients. Patients diagnosed with anxiety accounted for 
approximately 4.1% of total weekly patient visits, and patients treated for anxiety accounted for 
7.3% of their total patient visits. 
 Similarly, physicians reported diagnosing an average of 3.7 patients per week with 
depression, and treated an average of 8.6 patients. Patients diagnosed with depression comprised 
3.0% of total weekly patient visits, and those treated for depression accounted for 7.4% of total 
patient visits. 
Table 5.4 
Average Number of Diagnosis, Treatment, and Total Patient Visits per Week 
Number 
Anxiety Questionnaire 
(N=171) 
n (n%) 
Depression 
Questionnaire (N=160) 
n (n%) 
Diagnosis visits   
 0 3 (17.5) 5 (3.1) 
 1-5 132 (77.2) 120 (75.0) 
 6-10 23 (13.5) 18 (11.3) 
 11-15 7 (4.1) 4 (2.5) 
 16-20  3 (1.8) 3 (1.9) 
 More than 20 1 (0.6) 1 (0.6) 
 Missing 2 (1.2) 9 (5.6) 
Diagnosis visits mean (range, sd) 4.3 (0-25, 4.3) 3.7 (0-30, 4.3) 
Treatment Visits   
 0 1 (0.6) 3 (1.9) 
 1-5 92 (53.8) 66 (41.3) 
 6-10 43 (25.1) 45 (28.1) 
 11-15 17 (9.9) 19 (11.9) 
 16-20  9 (5.3) 9 (5.6) 
 More than 20 7(4.1) 8 (5.0) 
 Missing 2 (1.7) 10 (6.3) 
Treatment visits mean (range, sd) 8.0 (0-60, 8.8) 8.6 (0-50, 8.0) 
Total patient visits   
 Fewer than 50 15 (8.8) 11 (6.9) 
 50-99 25 (14.6) 21 (13.1) 
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Number 
Anxiety Questionnaire 
(N=171) 
n (n%) 
Depression 
Questionnaire (N=160) 
n (n%) 
 100-149 38 (22.2) 40 (25.0) 
 150-199  39 (22.8) 34 (21.3) 
 200 and more 31 (18.1) 24 (15.0) 
 Missing 24 (14.0) 30 (18.8) 
Total patient visits mean (range, sd) 137.5 (20-450, 69.1) 133.3 (20-350, 64.3) 
Diagnosis visits as proportion of total patient 
visits    
 0.1-0.9 17 (9.9) 22 (13.8) 
 1.0-1.9 37 (21.6) 32 (20.0) 
 2.0-2.9 32 (18.7) 25 (15.6) 
 3.0-3.9 11 (6.4) 13 (8.0) 
 4.0-4.9 6 (3.5) 6 (3.8) 
 5.0 -9.9 27 (15.8) 19 (11.9) 
 10.0 and over 12 (7.0) 7 (4.4) 
 Missing 28 (16.4) 36 (22.5) 
Diagnosis visits as proportion mean (range, sd) 4.1 (0-40.0, 5.3) 3.0 (0-14.3, 3.0) 
Treatment visits as proportion of total 
patient visits   
 0.1-0.9 9 (5.3) 4 (2.5) 
 1.0-1.9 17 (9.9) 7 (4.4) 
 2.0-2.9 21 (12.3) 16 (10.0) 
 3.0-3.9 10 (5.8) 8 (5.0) 
 4.0-4.9 12 (7.0) 10 (6.3) 
 5.0 -9.9 44 (25.7) 43 (26.9) 
 10.0 and over 33 (19.3) 36 (22.5) 
 Missing 25 (14.6) 36 (22.5) 
Treatment visits as proportion mean (range, sd) 7.3 (0-66.7, 8.8) 7.4 (0-33.3, 6.1) 
   
 
5.5 Responses to Clinical Scenarios 
 Family physicians were asked to consider a clinical scenario of a patient presenting with 
symptoms of either generalized anxiety disorder (Anxiety Patient, N=160) or major depressive 
episode (Depression Patient, N=171). With respect to the patient presented in the clinical 
scenario, physicians were asked to respond to the following statements presented in open-ended 
format: the tentative diagnosis(es) they were considering; the treatment plan they would initiate; 
the number of weeks until they required the scenario patient to return for the first follow-up; and 
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one or more reasons they may not be able to provide the best possible care for the scenario 
patient. Physician responses are outlined in Table 5.5; effective and appropriate responses are 
highlighted (also see Chapter 3 for complete descriptions of the two clinical scenarios and the 
following measures based on these scenarios). 
Table 5.5 
Responses to Clinical Scenarios 
 Anxiety Patient (AP) 
N=160 
Depression Patient (DP) 
N=171 
Physician Response n (n%) n (n%) 
TD - Tentative Diagnosis    
 Accuratea,b 138 (86.3) 146 (85.4) 
 Inaccurate 16 (10.0) 21 (12.3) 
  Missing 6 (3.8) 4 (2.3) 
TP – Treatment Plan   
 Immediatec  105 (65.6) 95 (55.6) 
 Delayed/No treatment 48 (30.0) 71 (41.5) 
 Missing 7 (4.4) 5 (2.9) 
FR – Follow-up Return   
 Two weeks or sooner 127 (79.4) 141 (82.5) 
 After two weeks 18 (11.3) 18 (10.5) 
 Missing 15 (9.4) 12 (7.0) 
BTC – Barriers to Care   
 Any responsed 107 (66.9) 111 (64.9) 
  System 30 (18.8) 36 (21.1) 
  Physician 63 (39.4) 68 (39.8) 
  Patient 40 (25.0) 38 (22.2) 
 No response 53 (33.1) 60 (35.1) 
aAn accurate diagnosis of the generalized anxiety disorder clinical scenario patient included one 
or more of the following: anxiety, anxiety disorder, generalized anxiety disorder, GAD, panic, 
panic disorder, or panic attack. 
bAn accurate diagnosis of the major depressive epidsode clinical scenario patient included one or 
more of the following: depression, major depression, depressive disorder, depressive illness, 
major depressive disorder, MDD, MDE, mood, mood disorder, or dysthymia.  
cStatements which did not refer to delaying treatment, delaying a decision regarding treatment, or 
awaiting lab results, were considered indicative of ‘immediate’ treatment. 
dRespondents may have noted more than one barrier. Therefore, categories of ‘any response’ do 
not total 100 percent. 
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5.5.1 Tentative Diagnosis 
 A significant majority of physicians accurately detected depression and anxiety in the 
clinical scenario patients (Table 5.5). Specifically, 85.4% of physicians provided an accurate 
tentative diagnosis of depression, and 86.3% provided an accurate tentative diagnosis of anxiety. 
One in ten physicians suggested an inaccurate tentative diagnosis of the anxiety patient (10.0%) 
and of the depression patient (12.3%). 
 Given the open-ended nature of the question concerning tentative diagnosis, physicians were 
free to list more than one possible diagnosis (Table 5.6). Accurate tentative diagnoses of the 
clinical scenario patient presenting with symptoms of generalized anxiety disorder included 
mention of one of the following: anxiety, anxiety disorder, generalized anxiety disorder, GAD, 
panic, panic disorder, or panic attack. Accurate tentative diagnosis of the clinical scenario patient 
presenting with symptoms of major depressive episode included mention of one of the following: 
depression, major depression, depressive disorder, depressive illness, major depressive disorder, 
MDD, MDE, mood, or mood disorder.  
 With respect to the patient presenting with symptoms of generalized anxiety disorder, the five 
most popular tentative diagnoses offered by physicians (Table 5.6) included anxiety (82.5%), 
hyperthyroid (48.1%), depression (38.1%), panic disorder (20.6%), and bipolar disorder (16.9%). 
For the patient depicted in the clinical scenario as presenting with symptoms of major depressive 
episode, the five most popular tentative diagnoses included depression (84.2%), anxiety (32.7%), 
other (31.6%), hypothyroid (29.8%), and irritable bowel syndrome (22.2%). 
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Table 5.6 
Tentative Diagnosis of Clinical Scenario Patients 
 
 
Anxiety Patient 
N=160 
Depression Patient 
N=171 
Tentative diagnosis n (n%) n (n%) 
Anxietya 132 (82.5) 56 (32.7) 
Panic disorder 33 (20.6) 0 
Depressionb 61 (38.1) 144 (84.2) 
Dysthymia 0 8 (4.7) 
Bipolar disorder 27 (16.9) 1 (0.6) 
Schizophrenia 3 (1.9) 0 
Other psychiatric disorderc 12 (7.5) 0 
Hyperthyroid 77 (48.1) 2 (1.7) 
Hypothyroid 8 (5.0) 51 (29.8) 
Thyroid 7 (4.4) 5 (2.9) 
Drug use 19 (11.9) 3 (1.8) 
Alcohol use 6 (3.8) 1 (0.6) 
Menopause 0 15 (8.8) 
Irritable bowel syndrome 0 38 (22.2) 
Abdominal pain not yet diagnosed 0 9 (5.3) 
Anemia 7 (4.4) 24 (14.0) 
Cardiac arrhythmia 20 (12.5) 0  
Auto-immune disorder 4 (2.5) 0 
Gastroesophageal reflux disease 0 7 (4.1) 
Cancer 0 20 (11.7) 
Diabetes 2 (1.3) 17 (9.9) 
Somatization 0 10 
Bacterial endocarditis 3 (1.9) 0 
Rheumatoid arthritis 3 (1.9) 0 
Mitral valve prolapse 6 (3.8) 0 
Thyrotoxicosis 5 (3.1) 1 (0.6) 
Other  27 (16.9) 54 (31.6) 
aIncluded anxiety, anxiety disorder, generalized anxiety disorder, or GAD 
bIncluded depression, major depression, depressive disorder, depressive illness, major depressive 
disorder, MDD, MDE, mood, or mood disorder 
cIncluded attention-deficit hyperactivity disorder, agoraphobia, hypochondria, mania, obsessive 
compulsive disorder, phobic disorder, post traumatic stress disorder, seasonal affective disorder, 
schizoaffective disorder, and social phobia. 
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5.5.2 Treatment Plan 
  Only a slight majority of physicians suggested effective (immediate) versus delayed/no 
treatment for the clinical scenario patients (Table 5.5). A slightly greater proportion suggested 
effective treatment for the anxious than for the depressed patient. Specifically, 65.6% of 
physicians indicated that they would immediately initiate treatment for the anxious patient, 
compared to 55.6% of physicians who would immediately initiate treatment for the depressed 
patient. In contrast, 30.1% reported that they would delay treatment until follow-up or offer no 
treatment to the anxious patient, and 41.5% would delay or offer no treatment to the depressed 
patient. 
 Physicians were asked to detail the treatment plan they would initiate ‘at this point’ for the 
clinical scenario patient presenting with symptoms of either generalized anxiety disorder or 
major depressive episode (Table 5.7). Responses were considered indicative of ‘delayed/no 
treatment’ if they contained mention of: delaying treatment until lab results were received, 
delaying a decision regarding treatment, or ‘none’. 
 Of those physicians who offered delayed/no treatment (AP 30.1%, DP 41.5%), most indicated 
that they would await the results of lab tests before deciding how to treat (AP 15.6%, DP 24.0%). 
A smaller proportion of physicians would await the results of lab tests before implementing a 
specific treatment (AP 12.6%, DP 10.6%), or would offer no treatment (AP 1.9%, DP 7.0%). 
 Physicians’ immediate treatment plans for the AP patient most frequently included 
pharmacology (26.3%) or pharmacology and counseling combined (25.0%). Immediate 
treatment plans for the DP patient most frequently referred to pharmacology and counseling 
combined (15.8%) or pharmacology (12.9%). Delayed treatment plans most often specified 
pharmacology, regardless of the patient under consideration (AP 7.5%, DP 4.1%). 
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 Table 5.7 
 Treatment Plan for Clinical Scenario Patients 
 
Anxiety 
Patient 
N=160 
Depression 
Patient 
N=171 
Treatment plan n (n%) n (n%) 
Immediatea   
 Pharmacology 42 (26.3) 22 (12.9) 
 Pharmacology and other 2 (1.3) 0  
 Counselling 6 (3.8) 12 (7.0) 
 Counselling and other  4 (2.5) 8 (4.7) 
 Pharmacology and counselling 40 (25.0) 27 (15.8) 
 Pharmacology and counseling and other 8 (5.0) 10 (5.8) 
 Other 3 (1.9) 16 (9.4) 
 Total Immediate 105 (65.6) 95 (55.6) 
   
Delayed (await results before implementing)   
 Pharmacology 12 (7.5) 7 (4.1) 
 Pharmacology and other 0 1 (0.6) 
 Counselling 3 (1.9) 1 (0.6) 
 Counselling and other  2 (1.3) 1 (0.6) 
 Pharmacology and counselling 3 (1.9) 6 (3.5) 
 Pharmacology and counseling and other 0 1 (0.6) 
 Other 0 1 (0.6) 
 Total Delayed (await results before implementing) 20 (12.6) 18 (10.6) 
   
Delayed (await results before deciding how to treat) 25 (15.6) 41 (24.0) 
   
No treatment 3 (1.9) 12 (7.0) 
Delayed/no treatment 48 (30.1) 71 (41.5) 
   
Missing 7 (4.4) 5 (2.9) 
aStatements which did not refer to delaying treatment, delaying a decision regarding 
treatment, or awaiting lab results, were considered indicative of ‘immediate’ treatment. 
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 A significant majority of family physicians who accurately diagnosed the clinical scenario 
patients reported that they would initiate immediate treatment, while a minority indicated that 
they would offer delayed/no treatment (Table 5.8). Furthermore, the results indicate that family 
physicians who accurately diagnosed the anxiety patient were somewhat more likely than 
physicians who accurately diagnosed the depressed patient, to immediately initiate treatment. 
Specifically, 71.7% of physicians who accurately diagnosed the anxiety patient reported that they 
would immediately treat the patient; 28.3% of those physicians would delay/offer no treatment. 
In addition, 59.6% of physicians who accurately diagnosed the depressed patient reported that 
they would immediately treat the patient (39.7% of those physicians would delay/offer not 
treatment. 
 
 
  Table 5.8 
Treatment Plan for Clinical Scenario Patients, by Accurate versus Inaccurate 
Diagnosis 
 
 Accurate tentative 
diagnosis 
Inaccurate tentative 
diagnosis 
Treatment plan n (n%) n (n%) 
 Anxiety Patient (N = 160) 
Immediate 99 (71.7) 6 (37.5) 
Delayed/no treatment 39 (28.3) 9 (56.3) 
Missing 0 1 (6.3) 
 Depression Patient (N =171) 
Immediate 87 (59.6) 8 (38.1) 
Delayed/no treatment 58 (39.7) 13 (61.9) 
Missing 1 (0.7) 0 
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5.5.3 Follow-up Return 
 Physicians were asked to indicate the time of first follow-up (weeks after first visit) of the 
clinical scenario patient. Overall, approximately eight in 10 physicians noted that they would like 
the clinical scenario patient to return for their first follow-up within two weeks of their initial 
visit (AP 79.4%, DP 82.5%) [Table 5.5]. One in 10 physicians suggested that the patients should 
return for follow-up after two weeks (AP 11.3%, DP 10.5%). 
 Although a significant majority of physicians suggested that the patients should return within 
two weeks, most physicians suggested returning within one to two weeks (AP 45.0%, DP 48.0%) 
rather than within one week (AP 34.3%, DP 34.5%) [Table 5.9].  
  
 
 Table 5.9 
 Follow-up Return for Clinical Scenario Patients 
 
 
Anxiety Patient 
N=160 
Depression Patient 
N=171 
Time elapse until first follow-up n (n%) n (n%) 
1 week or sooner 55 (34.3) 59 (34.5) 
1 week to 2 weeks 72 (45.0) 82 (48.0) 
3 weeks to 4 weeks 8 (5.0) 7 (4.1) 
4 weeks to 5 weeks 10 (6.3) 10 (5.8) 
6 weeks 0  1 (0.6) 
Missing 15 (9.4) 12 (7.0) 
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5.5.4 Barriers to Care 
 Several issues emerged in physicians’ responses regarding to an open-ended question 
regarding barriers to providing the best possible care for the clinical scenario patient. These 
responses were grouped into categories of system access, physician issues, and patient issues 
(Table 5.5). Physicians referred to issues concerning themselves more frequently (physician 
issues) than they referred to other issues (AP 39.4%, DP 39.8%). An equivalent proportion of 
respondents referred to patient issues (AP 25.0%, DP 22.2%) and system access issues (AP 
18.8%, DP 21.1%), while a notable proportion offered no response (AP 33.1%, DP 35.1%) to the 
question of barriers to providing the best possible care to the clinical scenario patient.  
 System access issues noted by physicians as barriers to care included lack of services, limited 
access to services, and long wait times for services (Table 5.10). System barriers with respect to 
services included those associated with counseling (AP 8.8%, DP 9.4%) and psychiatrists (AP 
4.4%, DP 4.7%). Physicians considered themselves barriers to care insofar as they were ‘too 
busy’ (AP 17.5%, DP 15.8%), required specialist referral/consult (AP 7.5%, DP 6.4%), and 
might lack knowledge/skills/experience to provide the best possible care (AP 6.3%, DP 0.6%). 
Patient issues regarded as barriers to providing care involved non-compliance (AP 7.5%, DP 
5.8%), resistance to treatment (AP 2.5%, DP 6.4%), and resistance to diagnosis (AP 3.8%, DP 
5.3%). 
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Table 5.10 
Barriers to Care of Clinical Scenario Patients 
 
 
Anxiety Patient 
N=160 
Depression Patient 
N=171 
Barriers to Care n (n%) n (n%) 
Any barrier mentioneda 107 (66.9) 111 (64.9) 
   
System access 30 (18.8) 36 (21.1) 
     Counselling 14 (8.8) 16 (9.4) 
     Psychiatrist 7 (4.4) 8 (4.7) 
     Specialist 1 (0.6) 4 (2.3) 
     CBT provider 3 (1.9) 2 (1.2) 
     Lab results 3 (1.9) 8 (4.7) 
     Other 6 (3.8) 7 (4.1) 
Physician 63 (39.4) 68 (39.8) 
     Too busy 28 (17.5) 27 (15.8) 
     Cannot immediately diagnose 1 (0.6) 9 (5.3) 
     Diagnostic uncertainty 3 (1.9) 3 (1.8) 
     Need to rule out organic cause 2 (1.3) 5 (2.9) 
     Needs more information 4 (2.5) 7 (4.1) 
     Lack of knowledge /skills/  
  experience 10 (6.3) 1 (0.6) 
     Require specialist referral/consult 12 (7.5) 11 (6.4) 
     Does not provide counseling 8 (5.0) 6 (3.5) 
     Other 7 (4.4) 14 (8.2) 
Patient 40 (25.0) 36 (21.1) 
     History incomplete 2 (1.3) 3 (1.8) 
     Resists diagnosis 6 (3.8) 9 (5.3) 
     Non-compliant 12 (7.5) 10 (5.8) 
     Resists treatment 4 (2.5) 11 (6.4) 
     Wants physical diagnosis 2 (1.3) 1 (0.6) 
     Condition is co-morbid 2 (1.3) 1 (0.6) 
     Condition is complex 6 (3.8) 2 (1.2) 
     Condition persists 3 (1.9) 6 (3.5) 
     Has drug addiction 7 (4.4) 1 (0.6) 
     Cannot afford treatment 5 (3.1) 7 (4.1) 
     Suicidal 4 (2.5) 3 (1.8) 
     Other 1 (0.6) 3 (1.8) 
   
No response 53 (33.1) 60 (35.1) 
aRespondents may have noted more than one barrier. Therefore, categories of ‘any response’ 
do not total 100 percent. 
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5.6 Information and Resource Use 
 Respondents were asked to identify those specific sources they regularly used (at least once 
per month) to 1) update their general medical knowledge and 2) make specific clinical decisions. 
This study asked physicians to indicate regular use of information sources and resources from a 
list of fourteen items. Based on this list, respondents were further asked whether these sources 
and resources exhibited four dimensions thought to increase the likelihood of their use. 
5.6.1 Information/Resource Use to Update General Medical Knowledge 
 To update their general medical knowledge, physicians most frequently used medical journals 
(93.0%) [Table 5.11]. A much smaller proportion of physicians updated their general medical 
knowledge by using clinical practice guidelines (70.0%), a favorite internet website (49.4%), 
medical textbooks (47.3%), and pharmaceutical sales representatives (45.5%).  
5.6.2 Information/Resource Use to Make Specific Clinical Decisions 
 To make specific clinical decisions, physicians were most likely to use medical textbooks 
(66.4%), followed closely by colleagues in their main patient care setting (62.4%), psychiatrist(s) 
(59.7%), clinical practice guidelines (56.7%), and colleagues outside their main patient care 
setting (53.0%) [Table 5.11]. 
5.6.3 Characteristics of Information Sources/Resources 
 This study asked physicians to consider their perceptions of 14 information sources/resources 
on each of four separate dimensions. These dimensions included reliability (trustworthiness), 
physical accessibility (easy to access), applicability (relevance), and intellectual accessibility 
(easy to understand). Given a list of 14 specific information sources/resources, physicians 
indicated those information sources and resources which they found, in general, exhibited each 
of these dimensions (Table 5.12). 
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Table 5.11 
Regular Use of Information Sources and Resources 
 
Information Source/Resource 
To update general 
medical knowledge 
n (n%) 
To make specific 
clinical decisions 
n (n%) 
Medical journals 307 (93.0) 83 (25.2) 
Medical textbooks 156 (47.3) 219 (66.4) 
Colleagues in main patient care setting 145 (43.9) 206 (62.4) 
Colleagues outside main patient care setting 124 (37.6) 175 (53.0) 
Pharmaceutical sales representatives 150 (45.5) 14 (4.2) 
Clinical practice guidelines 231 (70.0) 187 (56.7) 
Personal digital assistant  104 (31.5) 114 (34.5) 
Other decision aids 62 (18.8) 60 (18.2) 
Drug manuals 126 (38.2) 161 (48.8) 
Psychiatrists 107 (32.4) 197 (59.7) 
Mental health professionals (other than 
psychiatrists) 72 (21.8) 128 (38.8) 
Pharmacist(s) 96 (29.1) 132 (40.0) 
Favorite internet website 163 (49.4) 123 (37.3) 
Other 29 (9.3) 28 (8.9) 
  
 The 14 information sources/resources are ranked by the frequency of physicians who 
perceived the particular information source/resource to generally exhibit each of four 
dimensions. The top three information sources/resources in terms of reliability were medical 
textbooks (82.7%), CME/CPD/CPL courses/programs (80.9%), and medical journals (76.4%). 
With respect to physical accessibility, the top three information sources/resources were 
colleagues in the main patient care setting (69.1%), medical journals (64.5%), and medical 
textbooks (63.6%). The top three information sources/resources with respect to applicability 
were CME/CPD/CPL courses/programs (73.6%), medical journals (64.8%), and clinical practice 
guidelines (63.8%). Regarding intellectually accessibility, the top three information 
sources/resources were CME/CPD/CPL courses/programs (69.4%), medical journals (65.2%), 
and clinical practice guidelines (61.0%).
 Table 5.12 
Dimensions of Information Sources and Resources 
 
Information/Resource 
 
Reliability 
n (n%) 
 
 
Rank 
Physical 
accessibility 
n (n%) 
 
 
Rank 
 
Applicability 
n (n%) 
 
 
Rank 
Intellectual 
accessibility  
n (n%) 
 
 
Rank 
Medical journals 252 (76.4) 3 213 (64.5) 2 214 (64.8) 2 215 (65.2) 2 
Medical textbooks 273 (82.7) 1 210 (63.6) 3 204 (61.8) 4 189 (57.3) 5 
CME/CPD/CPL 267 (80.9) 2 135 (40.9) 8 243 (73.6) 1 229 (69.4) 1 
Colleagues in main patient care 
setting 187 (56.7) 6 
 
 228 (69.1) 
 
1 
 
189 (57.3) 
 
5 
 
196 (59.4) 
 
4 
Colleagues outside main patient 
care setting 167 (50.6) 7 
 
63 (19.1) 
 
11 
 
161 (48.8) 
 
7 
 
132 (40.0) 
 
8 
Pharmaceutical sales 
representatives 35 (10.6) 13 
 
88 (26.7) 
 
10 
 
81 (24.5) 
 
13 
 
101 (30.6) 
 
12 
Clinical practice guidelines 238 (75.6) 4 184 (58.4) 4 201 (63.8) 3 192 (61.0) 3 
Personal digital assistant  122 (37.0) 12 130 (39.4) 9 119 (36.1) 12 103 (31.2) 11 
Other decision aids 27 (8.2) 14 38 (11.5) 14 36 (10.9) 14 24 (7.3) 14 
Drug manuals 165 (50.0) 8 150 (45.5) 7 143 (43.3) 10 106 (32.1) 10 
Psychiatrists 204 (61.8) 5 55 (16.7) 13 167 (50.6) 6 119 (36.1) 9 
Mental health professionals 
(other than psychiatrists) 107 (32.4) 11 
 
62 (18.8) 
 
12 
 
121 (36.7) 
 
11 
 
89 (27.0) 
 
13 
Pharmacist(s) 164 (49.7) 9 179 (54.2)  5 151 (45.8) 8 144 (43.6) 7 
Favorite internet website 154 (46.7) 10 172 (52.1) 6 148 (44.8) 9 147 (44.5) 6 
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5.6.4 Information/Resource Use During Diagnostic Uncertainty 
     Respondents were asked to indicate the actions that they might take to confirm their decision 
if they were unsure about diagnosing a patient (with depression or anxiety). These actions 
comprised conducting a thorough patient interview, using a screening instrument, consulting a 
diagnostic manual, consulting a colleague, consulting a psychiatrist, consulting a mental health 
professional, and basing their decision on experience.   
 When faced with uncertainty when diagnosing a patient, the majority of physicians reported 
that they would conduct a thorough patient interview (AQ 95.3%, DQ 93.1%) [Table 5.13]. With 
respect to diagnostic uncertainty regarding a patient with anxiety, after conducting a thorough 
patient interview, respondents indicated that they would consult a psychiatrist (67.3%), consult a 
mental health professional (48.5%), and base their diagnosis on experience (46.2%).  
 Regarding diagnostic uncertainty faced when considering a patient with depression, after 
conducting a thorough patient interview, respondents were most likely to consult a psychiatrist 
(77.5%), use a screening instrument (50.6%), and base the diagnosis on experience (43.1%). 
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 Table 5.13 
 Information Use During Diagnostic Uncertainty 
 
 Yes No 
Action n (n%) n (n%) 
 Anxiety Questionnaire (N = 171) 
Conduct thorough patient interview 163 (95.3) 8 (4.7) 
Use screening instrument 48 (28.1) 123 (71.9) 
Consult diagnostic manual 38 (22.2) 133 (77.8) 
Consult colleague 57 (33.3) 114 (66.7) 
Consult psychiatrist 115 (67.3) 56 (32.7) 
Consult mental health professional 83 (48.5) 88 (51.5) 
Base on experience 79 (46.2) 92 (53.8) 
Other 8 (4.7) 163 (95.3) 
 Depression Questionnaire (N =160) 
Conduct thorough patient interview 149 (93.1) 11 (6.9) 
Use screening instrument 81 (50.6) 79 (49.4) 
Consult diagnostic manual 44 (27.5) 116 (72.5) 
Consult colleague 39 (24.4) 121 (75.6) 
Consult psychiatrist 124 (77.5) 36 (22.5) 
Consult mental health professional 63 (39.4) 97 (60.6) 
Base on experience 69 (43.1) 91 (56.9) 
Other 13 (8.1) 147 (91.9) 
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5.7 Professional Attributes 
 This analysis considered three professional attributes of physicians, and the associations 
between these attributes and physicians’ responses to mood and anxiety disorders (detection, 
treatment, and follow-up). These professional attributes included physician resistance to formal 
diagnosis, knowledge regarding depression and anxiety, and attitudes regarding depression and 
anxiety. 
5.7.1 Resistance to Formal Diagnosis 
 Physicians indicated the reasons that accounted for their decisions to not formally diagnose a 
patient with depression or anxiety. The most popular reason, when ranked by frequency of 
response, was that physical causes first need to be completely ruled out (AQ 88.3%, DQ 88.1%) 
[Table 5.14]. In addition, a sizable proportion of respondents cited patient refusal to accept 
diagnosis (AQ 53.2%, DQ 63.1%), patient non-compliance (AQ 34.5%, DQ 24.4%), and the low 
likelihood that a patient would be seen in time if referred to a specialist (AQ 22.2%, DQ 14.4%) 
as reasons for not diagnosing their patients with depression and anxiety. Approximately one in 
10 physicians indicated that they might not make a formal diagnosis on account of the stigma of 
such a diagnosis (AQ 11.7%, DQ 12.5%). A further one in twenty physicians noted that they 
might not diagnose because they did not want the diagnosis to appear on the patient’s medical 
record (AQ 5.8%, DQ 4.4%), and they believed that patients work through it on their own (AQ 
7.0%, DQ 5.0%). 
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Table 5.14 
Reasons for Resistance to Formal Diagnosis 
 
 Yes No 
Reasons n (n%) n (n%) 
 Anxiety Questionnaire (N = 171) 
Physical causes need to be completely ruled out first 151 (88.3) 20 (11.7) 
Patient refusal to accept diagnosis 91 (53.2) 80 (46.8) 
Patient noncompliance 59 (34.5) 112 (64.5) 
Patient will work through it on their own 12 (7.0) 159 (93.0) 
Unlikely that patient will be seen in time if referred to    
specialist 38 (22.2) 133 (77.8) 
Patient lives too far away from mental health specialist 19 (11.1) 152 (88.9) 
I don’t want the diagnosis to show up on patient’s 
medical record 10 (5.8) 161 (94.2) 
Stigma that patient may suffer 20 (11.7) 151 (88.3) 
Other 16 (9.4) 155 (90.6) 
 Depression Questionnaire (N =160) 
Physical causes need to be completely ruled out first 141 (88.1) 19 (11.9) 
Patient refusal to accept diagnosis 101 (63.1) 59 (36.9) 
Patient noncompliance 39 (24.4) 121 (75.6) 
Patient will work through it on their own 8 (5.0) 152 (95.0) 
Unlikely that patient will be seen in time if referred to 
specialist 23 (14.4) 137 (85.6) 
Patient lives too far away from mental health specialist 7 (4.4) 153 (95.6) 
I don’t want the diagnosis to show up on patient’s 
medical record 7 (4.4) 153 (95.6) 
Stigma that patient may suffer 20 (12.5) 150 (93.8) 
Other 13 (8.1) 147 (91.9 
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5.7.2 Knowledge 
5.7.2.1 Depression Knowledge Scale 
 Correct responses on 11 of the 12 items in the depression knowledge scale were summed to 
calculate an overall depression knowledge score (item #6 was excluded, since it was judged to 
not be an appropriate measure of knowledge). Correct items were scored as ‘1’, incorrect as ‘0’, 
and missing items as ‘0’. This summary score was then divided by 11 (i.e. the number of 
possible correct responses) to compute a final depression knowledge score based on a 100-point 
scale.  
 The mean depression knowledge score was 72.8 (range 27-100, sd 14.5). Most physicians 
identified 8 of the 11 knowledge statements correctly (Table 5.15).  Of the 11 items included in 
the depression knowledge score, physicians were most knowledgeable about the purpose of the 
treatment maintenance phase, the appropriate length of treatment with antidepressants, and the 
efficacy of medication and psychotherapy in the elderly (items 1, 3, and 5). Physicians were least 
likely to have knowledge of the approximate proportion of patients who experience side effects 
from antidepressants, the definition of dysthymic disorder, and when psychotherapy with a 
trained therapist is appropriate (items 4, 7, and 11). 
 Cronbach’s alpha of the 11-item depression knowledge scale was .46, which is inadequate. 
An alpha co-efficient greater than .70 generally demonstrates acceptable reliability and internal 
consistency of a scale (Cortina, 1993). 
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Table 5.15 
Responses to the Depression Knowledge Scale (N=160) 
Statement 
True 
n (n%) 
Do not  
know 
n (n%) 
False 
n (n%) 
 
Missing 
n (n%) 
1. The maintenance phase of treatment for major  
 depression focuses on preventing recurrence. 146 (91.3) 5 (3.1) 7 (4.4) 2 (1.3)  
2. If psychotherapy for major depression has no  
 effect within 6 weeks of regular sessions,  
 medication is recommended. 104 (65.0) 31 (19.4) 23 (14.4) 2 (1.3)  
3. An appropriate trial of antidepressant  
 medication for major depressive disorder 
 requires use of therapeutic dosages daily for at 
 least 4-6 weeks. 151 (94.4) 3 (1.9) 6 (3.8) 0 
4. Side effects occur only in a small percentage 
 of patients taking any antidepressant 
 medication. 77 (48.1) 10 (6.3) 73 (45.6) 0 
5. Medication and psychotherapy are efficacious  
 for depression in elderly adults as well as for  
 the non-elderly. 140 (87.5) 11 (6.9) 8 (5.0) 1 (0.6) 
6a Evidence suggests that primary care clinicians  
 prescribe appropriate  dosages of  
 antidepressants to fewer than a third of  
 patients with a current major depressive  
 disorder. 72 (45.0) 76 (47.5) 10 (6.3) 2 (1.3)  
7. Dysthymic disorder is mild, brief depression. 47 (29.4) 16 (10.0) 91 (56.9) 6 (3.8) 
8. The goal of cognitive therapy is to remove  
 symptoms of depression by identifying and  
 correcting patients’ distorted, negatively  
 biased thinking. 111 (69.4) 26 (16.3) 21 (13.1) 2 (1.3)  
9 In general, antidepressant medication can be  
 discontinued after 4-9 months for patients with 
 a single major depressive episode who no  
 longer have symptoms of depression. 99 (61.9) 9 (5.6) 50 (31.3) 2 (1.3)  
10. Anxiolytics and sedatives (minor tranquilizers)  
 have equivalent efficacy in major depression 
 as antidepressant medications. 8 (5.0) 13 (8.1) 138 (86.3) 1 (0.6) 
11. Psychotherapy with a trained therapist is  
 appropriate as the sole treatment for moderate  
 major depression that is not chronic, psychotic 
 or melancholic. 77 (48.1) 23 (14.4) 46 (28.8) 4 (2.5) 
12. Tricyclic antidepressants and SSRIs have  
 equivalent side effect profiles. 13 (8.1) 11 (6.9) 133 (83.1) 2 (1.3)  
Note. Statements in bold are false. 
aStatement not included in Depression Knowledge Score  
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5.7.2.2 Anxiety Knowledge Scale 
 An anxiety knowledge score was computed by summing correct responses to 12 items, with 
correct items scored as ‘1’, incorrect as ‘0’, and missing as ‘0’. The summary score was then 
divided by 12 (i.e. the number of possible correct responses) to arrive at a final anxiety 
knowledge score based on a 100-point scale.  
 Physicians’ mean anxiety knowledge score was 73.1 (range 42 to 100; sd 13.3). Most 
physicians identified 11 of the 12 statements correctly (Table 5.16). Most physicians were 
knowledgeable about the length of time patients should be monitored, when it is best to combine 
pharmacotherapy and psychotherapy treatments, the purpose of CBT, and the length of time for 
an SSRI to take effect (items 2, 4, 5, and 6). Physicians were least likely to be knowledgeable 
about the relative efficacy of pharmacotherapy and psychotherapy, waiting to refer a patient to a 
specialist after more than one trial of a first line agent, and the appropriate length of time to wait 
to follow up a patient receiving pharmacotherapy (items 7, 8, and 9).  
 Cronbach’s alpha of the 12-item anxiety knowledge scale was .57, which is inadequate in 
light of the general understanding that an alpha co-efficient greater than .70 generally 
demonstrates acceptable reliability and internal consistency of a scale (Cortina, 1993). 
103 
Table 5.16 
Responses to the Anxiety Knowledge Scale (N=171) 
Statement 
True 
n (n%) 
Do not  
know 
n (n%) 
False 
n (n%) 
 
Missing 
n (n%) 
1. Anxiety disorders, with the exception of  
 OCD, are more common in men than women. 24 (14.0) 27 (15.8) 117 (68.4) 3 (1.8) 
2. Monitoring and follow-up of an anxiety 
 disorder should occur for at least 12 months, 
  regardless of whether treatment is  
 pharmacological or psychological.  152 (88.9) 10 (5.8) 7 (4.1) 2 (1.2) 
3. Elderly patients are no more sensitive than  
 adult patients to the side effects of  
 benzodiazepines.  39 (22.8) 1 (0.6) 128 (74.9) 3 (1.8) 
4. Pharmacotherapy and psychotherapy  
 approaches to anxiety may be combined when 
 a single treatment method is not effective.      163 (95.3) 2 (1.2) 3 (1.8) 3 (1.8) 
5. Cognitive behavior therapy (CBT) focuses on  
 intervening in the patient’s thoughts and  
 behaviours that have a strong influence on  
 their experience of emotion.  152 (88.9) 13 (7.6) 2 (1.2) 4 (2.3) 
6. Relief of anxiety symptoms takes 2 to 4  
 weeks when the average patient is treated with 
 a selective serotonin reuptake inhibitor  
 (SSRI).      151 (88.3) 2 (1.2) 16 (9.4) 2 (1.2) 
7. Pharmacotherapy and psychotherapy  
 approaches are not equivalent in effectiveness 
 for the average patient undergoing treatment  
 for anxiety.      47 (27.5) 62 (36.3) 59 (34.5) 3 (1.8) 
8. When a patient fails to respond to a first-line  
 agent, s/he should be referred to a specialist.      55 (32.2) 17 (9.9) 95 (55.6) 4 (2.3) 
9. The first follow-up for a patient receiving  
 pharmacotherapy for an anxiety disorder  
 should be at one month. 64 (37.4) 7 (4.1) 98 (57.3) 2 (1.2) 
10. Full response to pharmacotherapy for an  
 anxiety disorder can be expected after 12  
 weeks.           117 (68.4) 15 (8.8) 36 (21.1) 3 (1.8) 
11. Cognitive behaviour therapy for a patient with 
 an anxiety disorder includes weekly contact 
 with a therapist for about 12 to 20 weeks.     103 (60.2) 52 (30.4) 12 (7.2) 4 (2.3) 
12. The most common side effects of SSRIs are  
 gastrointestinal and sleep disturbances.  141 (82.5) 5 (2.9) 18 (10.5) 7 (4.1) 
Note. Statements in bold are false 
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5.7.3 Attitudes 
5.7.3.1 Depression Attitude Scale 
 Twenty-two items comprised the depression attitude scale (Table 5.17). Most physicians 
reported that the number of patients presenting with depressive symptoms had increased in the 
last 5 years (73%), and agreed that the “community nurse could be a useful person to support 
depressed patients” (84%). With respect to their ease in dealing with patients with mental 
disorders, the majority of respondents felt “comfortable in dealing with depressed patients’ 
needs” (78%). However, the majority of physicians also found that “working with depressed 
patients is heavy going” (67%), and only 56% of physicians found it “rewarding to spend time 
looking after depressed patients”. Physicians were fairly split on the belief that “depressed 
patients are more likely to have experienced deprivation in early life” (31%), and that most cases 
of depression are the result of “patients’ recent misfortunes” (29%). In sum, physicians agreed 
with eight of the 22 items (1, 3, 8, 11, 13, 15, 18, and 20), disagreed with eight items (6, 9, 10, 
14, 16, 17, 19, and 21), and were neutral on six items (2, 4, 5, 7, 12, and 22).  
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Table 5.17 
Responses to the Full 22-Item Depression Attitude Scale (N=160) 
Statement 
Strongly 
Agree/ 
Agree 
n (n%) 
Neutral 
n (n%) 
Strongly 
Disagree/ 
Disagree 
n (n%) 
 
 
Missing  
n (n%) 
1. During the past 5 years I have seen an  
 increase in the number of patients  
 presenting with depressive symptoms.  117 (73.1) 36 (22.3) 6 (3.8) 1 (0.6) 
2. The majority of depression seen in general  
 practice originates from patients’ recent  
 misfortunes.  47 (29.4) 48 (30.0)  65 (40.6) 0 
3. An underlying biochemical abnormality is  
 the basis of severe cases of depression.  119 (74.4) 30 (18.8) 11 (6.9) 0 
4. It is difficult to differentiate whether  
 patients are presenting with unhappiness or  
 a clinical depressive disorder that needs 
 treatment. 59 (36.9) 29 (18.1) 72 (45.0) 0 
5. It is possible to distinguish two main groups 
 of  depression, one psychological in origin  
 and the other caused by biochemical  
 mechanisms.  41 (25.6) 51 (31.9) 68 (42.5) 0 
6. Becoming depressed is a way that people  
 with poor  stamina deal with life difficulties. 15 (9.4) 24 (15.0) 120 (75.0) 1 (0.6) 
7. Depressed patients are more likely to have 
 experienced deprivation in early life than  
 other people. 50 (31.3) 52 (32.5) 58 (36.3) 0 
8. I feel comfortable in dealing with depressed  
 patients’ needs. 125 (78.1) 25 (15.6) 9 (56.3) 1 (0.6) 
9. Depression reflects a characteristic response 
 in patients that is not amenable to change. 16 (10.0) 27 (16.9) 115 (71.9) 2 (1.3) 
10. Becoming depressed is a natural part of  
 being old. 7 (4.4) 15 (9.4) 138 (86.3) 0 
11. The community nurse could be a useful  
 person to support depressed patients.  135 (84.4) 16 (10.0) 7 (4.4) 1 (0.6) 
12. Most depressive disorders seen in general  
 practice improve without medication.  39 (24.4) 47 (29.4) 73 (45.6) 1 (0.6) 
13. Working with depressed patients is heavy  
 going. 107 (66.9) 25 (15.6) 28 (17.5) 0 
14. There is little to be offered to those  
 depressed patients who do not respond to 
 what general practitioners do. 18 (11.3) 18 (11.3) 123 (76.9) 1 (0.6) 
15. It is rewarding to spend time looking after  
 depressed patients. 90 (56.3) 47 (29.4) 21 (13.1) 2 (1.3) 
16. Psychotherapy tends to be unsuccessful with 
 anxious patients. 15 (9.4) 24 (15.0) 118 (74.8) 3 (1.9) 
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Statement 
Strongly 
Agree/ 
Agree 
n (n%) 
Neutral 
n (n%) 
Strongly 
Disagree/ 
Disagree 
n (n%) 
 
 
Missing  
n (n%) 
17. If depressed patients need antidepressants, 
 they should be started on tricyclics as first- 
 line treatment. 6 (3.8) 15 (9.4) 136 (85.0) 3 (1.9) 
18. If depressed patients need antidepressants,  
 they should be started on selective serotonin  
 reuptake inhibitors as first-line treatment. 125 (78.1) 19 (11.9) 4 (2.5) 2 (1.3) 
19. If depressed patients need antidepressants,  
 they are better off with a psychiatrist than 
 with a general practitioner. 11 (6.9) 29 (18.1) 118 (73.8) 1 (0.6) 
20. Antidepressants usually produce a  
 satisfactory result in the treatment of  
 depression in general practice. 126 (78.8) 27 (16.9) 5 (3.1) 2 (1.3) 
21. Psychotherapy for depressed patients should 
  be left to a specialist.  36 (22.5) 34 (21.2) 88 (55.0) 2 (1.3) 
22. If psychotherapy were freely available, this 
 would be more beneficial than  
 antidepressants for most depressed patients. 65 (40.6) 53 (33.1) 40 (25.0) 2 (1.3) 
     
 
 After principal components analysis (exploratory factor analysis), the four-factor model which 
best fit these data explained 57.2% of the variance. These four factors included 13 of the original 
22 items (Table 5.18). Mean scores above 2.5 on individual items suggested agreement with the 
item, and scores below suggested disagreement. Consequently, higher mean scores on the 
following factors suggested stronger agreement with each attitude dimension represented by the 
factor.  
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Table 5.18 
Responses to the Reduced 13-Item Depression Attitude Scale (n = 152) 
Statement 
Strongly 
Agree/ 
Agree 
n (n%) 
Neutral 
n (n%) 
Strongly 
Disagree/ 
Disagree 
n (n%) 
 
 
 
Mean (SD) 
3. An underlying biochemical abnormality is  
 the basis of severe cases of depression.  113 (74.3) 29 (19.1) 10 (6.6) 4.0 (1-5, 0.90) 
4. It is difficult to differentiate whether  
 patients are presenting with unhappiness or  
 a clinical depressive disorder that needs 
 treatment. 53 (34.9) 28 (18.4) 71 (46.7) 2.9 (1-5, 1.00) 
6. Becoming depressed is a way that people  
 with poor  stamina deal with life difficulties. 14 (9.2) 20 (13.2) 118 (77.6) 1.9 (1-5, 1.03) 
8. I feel comfortable in dealing with depressed  
 patients’ needs. 121 (79.6) 23 (15.1) 8 (5.3) 3.9 (2-5, 0.68) 
9. Depression reflects a characteristic response 
 in patients that is not amenable to change. 15 (9.9) 26 (17.1) 111 (73.0) 2.1 (1-5, 0.91) 
10. Becoming depressed is a natural part of  
 being old. 6 (3.9) 15 (9.9) 131 (86.3) 1.7 (1-5, 0.84) 
12. Most depressive disorders seen in general  
 practice improve without medication.  37 (24.3) 45 (29.6) 70 (46.0) 2.7 (1-5, 0.97) 
14. There is little to be offered to those  
 depressed patients who do not respond to 
 what general practitioners do. 18 (11.8) 16 (10.5) 118 (77.6) 2.1 (1-5, 1.01) 
15. It is rewarding to spend time looking after  
 depressed patients. 87 (57.2) 46 (30.3) 19 (12.5) 3.5 (2-5, 0.83) 
17. If depressed patients need antidepressants, 
 they should be started on tricyclics as first- 
 line treatment. 5 (3.3) 15 (9.9) 132 (86.8) 1.7 (1-4, 0.77) 
18. If depressed patients need antidepressants,  
 they should be started on selective serotonin  
 reuptake inhibitors as first-line treatment. 130 (85.5) 18 (11.8) 4 (2.6) 4.1 (1-4, 0.70) 
20. Antidepressants usually produce a  
 satisfactory result in the treatment of  
 depression in general practice. 123 (80.9) 24 (15.8) 5 (3.3) 3.9 (2-5, 0.61) 
22. If psychotherapy were freely available, this 
 would be more beneficial than  
 antidepressants for most depressed patients. 62 (40.8) 50 (32.9) 40 (26.3) 3.2 (1-5, 0.99) 
Note. No items in this table have been reversed     
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 Factor 1, “Social context view of depression not amenable to intervention” represented the 
attitude that depression is a natural outcome of difficult experiences and becoming old that is not 
readily responsive to treatment. A sum mean of 7.8 (range 4-17) on this subscale indicated that 
physicians strongly disagreed with the social context view of depression (Table 5.19). Factor 2, 
“Professional ease” indicated confidence in diagnosing and managing patients with depression. 
A sum mean of 10.5 (range 6-15) is evidence that physicians were neutral in their confidence in 
caring for patients with depression. The third factor, “Psychotherapy and no treatment are more 
effective than pharmacology” reflected the beliefs that severe depression is rooted in causes 
other than biochemical abnormalities, and that psychotherapy or no treatment at all are more 
effective than medication. A sum mean of 8.0 (range 3-14) suggested that physicians strongly 
disagreed with the suggestion that psychotherapy or no treatment at all were superior to 
pharmacology. Factor 4, “Pharmacologic treatment knowledge” indicated knowledge of current 
guidelines for treating depression with antidepressants. A sum mean of 12.2 (range 7-15) is 
evidence that physicians were knowledgeable about current antidepressant treatment guidelines. 
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Table 5.19 
Rotated Component Matrix of the Reduced 13-Item Depression Attitude Scale 
 Factor 
Statement 1 2 3 4 
Factor 1  Social context view of depression not 
amenable to intervention     
6. Becoming depressed is a way that people  with 
 poor stamina deal with life difficulties. .658 -.234 2.81 .073 
9. Depression reflects a characteristic response 
 in patients that is not amenable to change. .737 -.087 .109 .012 
10. Becoming depressed is a natural part of being 
 old. .668 -.188 .127 -.125 
14. There is little to be offered to those depressed  
 patients who do not respond to what general 
 practitioners do. .665 .009 -.019 .097 
Factor 2  Professional ease     
4. It is difficult to differentiate whether patients 
 are presenting with unhappiness or a clinical 
 depressive disorder that needs treatment. .206 -.722 .045 .101 
8. I feel comfortable in dealing with depressed 
 patients’ needs. -.212 .728 -.027 .189 
15. It is rewarding to spend time looking after 
 depressed patients. .038 .757 -.005 .192 
Factor 3  Pharmacologic treatment is not entirely 
effective     
3. An underlying biochemical abnormality is the 
 basis of severe cases of depression. -.105 -.103 -.671 .193 
12. Most depressive disorders seen in general 
 practice improve without medication. .207 -.042 .770 -.025 
22. If psychotherapy were freely available, this 
 would be more beneficial than antidepressants 
 for most depressed patients. .028 -.125 .728 .082 
Factor 4  Pharmacologic treatment knowledge     
17. If depressed patients need antidepressants, 
 they should be started on tricyclics as first-
 line treatment. .429 .079 .131 -.635 
18. If depressed patients need antidepressants, 
 they should be started on selective serotonin 
 reuptake inhibitors as first-line treatment. .220 .079 -.007 .807 
20. Antidepressants usually produce a satisfactory 
 result in the treatment of depression in general 
 practice. .044 .224 -.024 .694 
% Variance 17.2 13.9 13.1 13.0 
Eigenvalue 2.2 1.8 1.7 1.7 
Cronbach’s α  .68 .62 .58 .57 
Sum Mean (range, SD) 7.8  
(4-17, 2.7) 
10.5  
(6-15, 2.0) 
8.0 
(3-14, 2.1) 
12.2 
(7-15, 1.5) 
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Note. The initial 22-factor scale had a Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy of .72, and a significant Bartlett’s Test of Sphericity (<.001). Although the KMO 
measure is lower than that recommended to support factor analysis (.80 to 1.0 is recommended 
by Munro, 2005), Bartlett’s Test supports the use of factor analysis (a low probability is 
recommended by Munro, 2005). The number of respondents in this sample (n=152) falls within 
the recommended range of 100 to 200 respondents (Munro, 2005). Cronbach’s α for the 13-item 
scale was .45. To perform the factor analysis, for all variables 1=Strongly Disagree, 5=Strongly 
Agree. To calculate the mean and perform the reliability analysis, reversed items included 3, 4, 
and 17, so that for these three variables, 1=Strongly Agree, 5=Strongly Disagree.  
 
5.7.3.2 Anxiety Attitude Scale 
 The Depression Attitude Questionnaire was adapted for this study to develop the Anxiety 
Attitude Questionnaire. The 22 items contained within the subscales examined attitudes and 
knowledge regarding anxiety, similar to those with respect to depression (Table 5.20). For the 
most part, physicians agreed that the number of patients presenting with symptoms of anxiety 
had risen in the past 5 years (66%), and agreed that the community nurse could be useful in 
supporting anxious patients (78%). Most respondents felt “comfortable in dealing with anxious 
patients’ needs” (78%). However, the majority of physicians also found that “working with 
anxious patients is heavy going” (75%), and only 47% of physicians found it “rewarding to 
spend time looking after depressed patients”. Physicians were fairly split on the belief that 
“anxious patients are more likely to have experienced deprivation in early life”, and that most 
cases of anxiety are the result of “patients’ recent misfortunes”. In sum, of the 22 items, a 
majority of physicians agreed with nine (1, 3, 4, 8, 11, 13, 17, 20, and 22), disagreed with seven 
(6, 9, 10, 14, 16, 19, and 21), and were neutral on six (2, 5, 7, 12, 15, and 18).  
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Table 5.20 
Responses to the Full 22-item Anxiety Attitude Scale (N=171) 
Statement 
Strongly 
Agree/ 
Agree 
n (n%) 
Neutral 
n (n%) 
Strongly 
Disagree/ 
Disagree 
n (n%) 
 
 
Missing 
n (n%) 
1. During the past 5 years I have seen an  
 increase in the number of patients presenting  
 with symptoms of anxiety. 112 (65.5) 38 (22.2) 18 (10.5) 3 (1.8) 
2. The majority of anxiety seen in general  
 practice originates from patients’ recent  
 misfortunes.  64 (37.4) 53 (31.0) 51 (29.8) 3 (1.8) 
3. An underlying biochemical abnormality is the 
 basis of severe cases of anxiety.  104 (60.8) 43 (25.1) 23 (13.5) 1 (0.6) 
4. It is difficult to differentiate whether patients 
 are presenting with stress or a clinical anxiety 
 disorder that needs treatment. 92 (53.8) 36 (21.1) 42 (24.6) 1 (0.6) 
5. It is possible to distinguish two main groups  
 of anxiety, one psychological in origin and  
 the other caused by biochemical mechanisms. 50 (29.2) 67 (39.2) 53 (31.0) 1 (0.6) 
6. Becoming anxious is a way that people with  
 poor stamina deal with life difficulties.  32 (18.7) 24 (14.0) 111 (64.9) 4 (2.3) 
7. Anxious patients are more likely to have  
 experienced deprivation in early life than  
 other people.  49 (28.7) 66 (38.6) 54 (31.6) 2 (1.2) 
8. I feel comfortable in dealing with anxious  
 patients’ needs. 134 (78.4) 26 (15.2) 11 (6.4) 0 
9. Anxiety reflects a characteristic response in  
 patients that is not amenable to change.  19 (11.1) 24 (14.0) 126 (73.7) 2 (1.2) 
10. Becoming anxious is a natural part of being  
 old.  19 (11.1) 24 (14.0) 127 (74.3) 1 (0.6) 
11. The community nurse could be a useful  
 person to support anxious patients.  134 (78.4) 29 (17.0) 8 (4.7) 0 
12. Most anxiety disorders seen in general  
 practice improve without medication. 77 (45.0) 46 (26.9) 47 (27.5) 1 (0.6) 
13. Working with anxious patients is heavy 
  going.  128 (74.9) 24 (14.0) 19 (11.1) 0 
14. There is little to be offered to those anxious  
 patients who do not respond to what general  
 practitioners do. 18 (10.3) 30 (17.5) 121 (70.8) 2 (1.2) 
15. It is rewarding to spend time looking after 
 anxious patients. 81 (47.4) 56 (32.7) 32 (18.7) 2 (1.2) 
16. Cognitive-behaviour therapy tends to be  
 unsuccessful with anxious patients. 19 (11.1) 34 (19.9) 116 (67.8) 2 (1.2) 
17. If anxious patients need pharmacologic  
 management, they should be started on  136 (79.5) 25 (14.6) 10 (5.8) 0 
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Statement 
Strongly 
Agree/ 
Agree 
n (n%) 
Neutral 
n (n%) 
Strongly 
Disagree/ 
Disagree 
n (n%) 
 
 
Missing 
n (n%) 
 selective serotonin reuptake  
 inhibitors as first-line treatment. 
18. If anxious patients need pharmacologic  
 management, benzodiazepines are considered 
 second-line treatment.  90 (52.6) 34 (19.9) 45 (26.3) 2 (1.2) 
19. If anxious patients need pharmacologic  
 management, they are better off with a  
 psychiatrist than with a general practitioner. 11 (6.4) 35 (20.5) 124 (72.5) 1 (0.6) 
20. Pharmacotherapy usually produces a  
 satisfactory result in the treatment of anxiety 
 in general practice. 114 (66.7) 37 (21.6) 20 (11.7) 0 
21. Psychotherapy for anxious patients should be 
 left to a specialist.  40 (23.4) 25 (14.6) 104 (60.8) 2 (1.2) 
22. If psychotherapy were freely available, this  
 would be more beneficial than  
 pharmacotherapy for most anxious patients. 107 (62.6) 47 (27.5) 17 (9.9) 0 
  
 Twelve of the original 22 items remained after principal components analysis (factor 
analysis). The four-factor model which best fit these data explained 59.4% of the variance, and 
included 13 of the original 22 items (Table 5.21). Mean scores above 2.5 on individual items 
indicated agreement with the item, and scores below suggest disagreement. Higher scores on 
each of the four factors suggested stronger agreement with each attitude dimension represented 
by the factor.  
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Table 5.21 
Responses to the Reduced 12-item Anxiety Attitude Scale (n = 162) 
Statement 
Strongly 
Agree/ 
Agree 
n (n%) 
Neutral 
n (n%) 
Strongly 
Disagree/ 
Disagree 
n (n%) 
 
 
 
Mean (SD) 
5. It is possible to distinguish two main 
 groups of anxiety, one psychological in 
 origin and the other caused by biochemical 
 mechanisms. 47 (29.0) 64 (39.5) 51 (31.5) 2.99 (1-5, 0.90) 
6. Becoming anxious is a way that people 
 with poor stamina deal with life 
 difficulties.  30 (18.5) 23 (14.2) 109 (67.3) 2.36 (1-5, 1.05) 
7. Anxious patients are more likely to have  
 experienced deprivation in early life than  
 other people.  46 (28.4) 64 (39.5) 52 (32.1) 2.93 (1-5, 1.00) 
8. I feel comfortable in dealing with anxious  
 patients’ needs. 128 (79.0) 23 (14.2) 11 (6.8) 3.84 (1-5, 0.74) 
9. Anxiety reflects a characteristic response 
 in  patients that is not amenable to change. 19 (11.7) 23 (14.2) 120 (74.1) 2.28 (1-5, 0.86) 
13. Working with anxious patients is heavy 
  going.  121 (74.7) 22 (13.6) 19 (11.7) 3.84 (1-5, 0.91) 
14. There is little to be offered to those 
 anxious patients who do not respond to 
 what general practitioners do. 17 (10.5) 30 (18.5) 115 (71.0) 2.30 (1-5, 0.91) 
15. It is rewarding to spend time looking after 
 anxious patients. 77 (47.5) 53 (32.7) 32 (19.8) 3.30 (1-5, 0.94) 
16. Cognitive-behaviour therapy tends to be  
 unsuccessful with anxious patients. 17 (10.5) 33 (20.4) 112 (69.1) 2.32 (1-5, 0.90) 
19. If anxious patients need pharmacologic  
 management, they are better off with a  
 psychiatrist than with a general 
 practitioner. 10 (61.7) 31 (19.1) 121 (74.7) 2.18 (2-5, 0.76) 
20. Pharmacotherapy usually produces a  
 satisfactory result in the treatment of 
 anxiety 
 in general practice. 108 (66.7) 35 (21.6) 19 (11.7) 3.61 (1-5, 0.77) 
21. Psychotherapy for anxious patients should 
 be left to a specialist.  38 (23.5) 24 (14.8) 100 (61.7) 2.57 (1.10) 
 Note. There has been no reversing for this table 
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 Factor 1, “Social context view of anxiety amenable to intervention” represented the attitude 
that anxiety is a natural outcome of difficult experiences, yet is amenable to pharmacologic 
intervention. A sum mean of 8.9 (range 4-15) on this subscale indicated that physicians 
disagreed with the social context view of anxiety (Table 5.22). Factor 2, “Professional ease” 
indicated confidence in diagnosing and managing patients with anxiety. A sum mean of 10.1 
(range 5-15) suggested that physicians were neutral in their confidence in caring for patients 
with anxiety. The third factor, “Professional disinterest” indicated a tendency to minimize one’s 
role in caring for patients with anxiety, and to shift the burden of care to the patients. A sum 
mean of 6.8 (range 3-15) was evidence that physicians strongly disagreed with minimizing their 
role in managing patients with anxiety. Factor 4, “Professional inefficacy” encompassed the 
view that management of patients with anxiety is difficult, and best left to other professionals. A 
sum mean of 8.7 (range 4-15) was evidence that physicians did not exhibit professional 
inefficacy in caring for patients with anxiety. 
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Table 5.22 
Rotated Component Matrix of the Reduced 12-Item Anxiety Attitude Scale 
 Factor 
Statement 1 2 3 4 
Factor 1  Social context view of anxiety amenable 
to intervention     
6. Becoming anxious is a way that people with  
 poor stamina deal with life difficulties.  .711 -.015 .311 .107 
7. Anxious patients are more likely to have  
 experienced deprivation in early life than  
 other people.  .744 .019 .127 .095 
20. Pharmacotherapy usually produces a  
 satisfactory result in the treatment of anxiety 
 in general practice. .592 .278 -.110 -.059 
Factor 2  Professional ease     
5. It is possible to distinguish two main groups  
 of anxiety, one psychological in origin and  
 the other caused by biochemical mechanisms. .356 .540 -.032 .463 
8. I feel comfortable in dealing with anxious  
 patients’ needs. -.023 .746 .118 -.160 
15. It is rewarding to spend time looking after 
 anxious patients. .116 .802 -.129 -.147 
Factor 3  Professional disinterest     
9. Anxiety reflects a characteristic response in  
 patients that is not amenable to change.  .501 -.041 .615 .128 
14. There is little to be offered to those anxious  
 patients who do not respond to what general  
 practitioners do. .175 -.073 .824 -.113 
19. If anxious patients need pharmacologic  
 management, they are better off with a  
 psychiatrist than with a general practitioner. -.152 .207 .595 .357 
Factor 4 Professional efficacy     
13. Working with anxious patients is heavy 
  going.  .117 -.433 .004 .527 
16. Cognitive-behaviour therapy tends to be  
 unsuccessful with anxious patients. .173 -.121 .498 .515 
21. Psychotherapy for anxious patients should be 
 left to a specialist.  -.002 -.129 .083 .757 
% Variance 15.8 15.4 15.2 13.0 
Eigenvalue 1.9 1.9 1.8 1.6 
Cronbach’s α  .57 .58 .59 .548 
Sum Mean (range, SD) 8.9 
(4-15, 2.1) 
10.1  
(5-15, 3.6) 
6.8 
(3-15, 1.9) 
8.7 
(4-15, 2.1) 
Note. The initial 22-factor scale had a Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy of .69, and a significant Bartlett’s Test of Sphericity (<.001). While the KMO measure 
is lower than .80 (.80 to 1.0 is recommended by Munro, 2005), Bartlett’s Test supports the use of 
factor analysis (significant test is recommended by Munro, 2005). The number of respondents in 
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this sample (n=162) falls within the recommended range of 100 to 200 respondents (Munro, 
2005). Cronbach’s α for the 12-item scale was .64. For all of the analyses including Cronbach’s 
alpha, 1=Strongly Disagree, 5=Strongly Agree. For the Cronbach’s alpha, I did not reverse any 
variables. 
 
 
5.8 Patient Factors 
 The proportion of physicians who considered specific patient factors, when deciding upon the 
best treatment for a patient with anxiety or depression, varied according to the patient factor 
under consideration (Table 5.23). The greatest proportion of physicians considered patients’ 
preference for treatment (AQ 85.4%, DQ 81.3%) and age (AQ 84.8%, DQ 87.5%), followed by 
employment status (AQ 73.1%, DQ 71.3%) and children (AQ 62.6%, DQ 58.1%). However, 
relatively few physicians considered patients’ gender (AQ 52.0% DQ 45.6%) and the treatment 
preferences of patients’ families (AQ 32.7%, DQ 40.0%) when deciding upon the best treatment 
for their patients.  
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Table 5.23 
Patient Factors Considered when Deciding on Best Treatment 
 
 All/most 
of the time 
Some/a little 
of the time 
None of 
the time 
Missing 
Patient factor n (n%) n (n%) n (n%) n (n%) 
  Anxiety Questionnaire (N = 171)  
Age 145 (84.8) 21 (12.3) 4 (2.3) 1 (0.6) 
Gender 89 (52.0) 57 (33.3) 22 (12.9) 3 (1.8) 
Marital status 106 (62.0) 50 (29.2) 12 (7.0) 3 (1.8) 
Children 107 (62.6) 56 (32.7) 6 (35.1) 2 (1.2) 
Employment status 125 (73.1) 36 (21.1) 5 (2.9) 5 (2.9) 
Preference for treatment 146 (85.4) 21 (12.3) 1 (0.6) 3 (1.8) 
Family’s preference for treatment 56 (32.7) 104 (60.8) 8 (4.7) 3 (1.8) 
  Depression Questionnaire (N =160)  
Age 140 (87.5) 16 (10.0) 2 (1.3) 2 (1.3) 
Gender 73 (45.6) 57 (35.6) 27 (16.9) 3 (1.9) 
Marital status 77 (48.1) 57 (35.6) 22 (13.8) 4 (2.5) 
Children 93 (58.1) 50 (31.3) 14 (8.8) 3 (1.9) 
Employment status 114 (71.3) 36 (22.5) 8 (0.5) 3 (1.9) 
Preference for treatment 130 (81.3) 27 (16.9) 1 (0.6) 2 (1.3) 
Family’s preference for treatment 64 (40.0) 80 (50.0) 11 (6.9) 5 (3.1) 
 
 
5.9 Perceived Requirements for Effective Management 
 This study asked physicians to indicate their level of agreement with nine requirements to 
more effectively manage patients (presenting with anxiety or depression). Regardless of whether 
physicians were considering their requirements to more effectively manage patients with anxiety 
or patients with depression, approximately eight in 10 physicians agreed that they required four 
conditions (Table 5.24). Specifically, respondents required improved access to mental health 
professionals (other than psychiatrists) (AQ 87.7%, DQ 88.1%); ability to prescribe affordable 
medication (AQ 80.1%, DQ 88.0%); more time to spend with patients (AQ 87.1%, DQ 86.9%); 
and up-to-date information on effective non-pharmacological treatments (AQ 88.3%, DQ 81.3%). 
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Table 5.24 
Perceived Requirements to More Effectively Manage Patients 
 
 Strongly 
Agree/ 
Agree 
Neutral Strongly 
Disagree/ 
Disagree 
Missing 
Requirement n (n%) n (n%) n (n%) n (n%) 
 Anxiety Questionnaire (N = 171) 
Improved access to psychiatrists 117 (68.4) 28 (16.4) 21 (12.3)   5 (2.9) 
Able to prescribe affordable medication 137 (80.1)   19 (11.1) 13 (7.6) 2 (1.2) 
More time to spend with patients 149 (87.1) 16 (9.4) 6 (3.5) 0 
Improved access to mental health   
    professionals (other than psychiatrists) 150 (87.7) 13 (7.6) 5 (2.9) 3 (1.8) 
More training on counseling techniques 130 (76.0) 24 (14.0) 16 (9.4) 1 (0.6) 
More personal experience managing 
patients with mental disorders 76 (44.4) 57 (33.3) 35 (20.5) 3 (1.8) 
Up-to-date information on effective  
    pharmacological treatments 129 (75.4) 31 (18.1) 8 (4.7) 3 (1.8) 
Up-to-date information on effective non- 
    pharmacological treatments 151 (88.3) 15 (8.8) 2 (1.2) 3 (1.8) 
More time to spend on accessing and  
    reading research on mental disorders 96 (56.1) 44 (25.7) 25 (14.6) 6 (3.8) 
 Depression Questionnaire (N =160) 
Improved access to psychiatrists 128 (80.0) 20 (12.5) 11 (6.9) 1 (0.6) 
Able to prescribe affordable medication 140 (88.0) 14 (8.8) 5 (3.1) 1 (0.6) 
More time to spend with patients 139 (86.9) 16 (10.0) 4 (2.5) 1 (0.6) 
Improved access to mental health  
    professionals (other than psychiatrists) 141 (88.1) 15 (9.4) 3 (1.9) 1 (0.6) 
More training on counseling techniques 109 (68.1) 39 (24.4) 9 (5.6) 3 (1.8) 
More personal experience managing  
    patients with mental disorders 81 (50.6) 51 (31.9) 21 (13.1) 7 (4.4) 
Up-to-date information on effective  
    pharmacological treatments 126 (78.8) 22 (13.8) 8 (5.0) 4 (2.5) 
Up-to-date information on effective non- 
    pharmacological treatments 130 (81.3) 20 (12.5) 6 (3.8) 4 (2.5) 
More time to spend on accessing and  
    reading research on mental disorders 91 (56.9) 51 (31.9) 10 (6.3) 8 (5.0) 
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5.10  Bivariate Analysis of Responses to Clinical Scenarios by Attributes, Organizational  
 Setting, and Information/Resource Use 
 
 The following analyses compare physicians on attributes (personal and professional), 
organizational setting, information/resource use, and perceived barriers to care with respect to 
responses to the clinical scenarios which indicated 1) inaccurate tentative diagnosis, 2) 
delayed/no treatment, and 3) follow-up after two weeks. 
5.10.1 Tentative Diagnosis 
 Physicians who provided an inaccurate tentative diagnosis of the major depressive episode 
clinical scenario patient (DP) did not include at least one of the following terms in their response: 
depression, major depression, depressive disorder, depressive illness, major depressive disorder, 
MDD, MDE, mood, mood disorder, or dysthymia.  
 Twelve percent (n=21/171, 12.3%) of physicians provided an inaccurate tentative diagnosis of 
depression; 85% of physicians (n=146/171, 85.4%) provided an accurate tentative diagnosis. 
Bivariate analysis determined that none of the variables hypothesized as associated with 
inaccurate tentative diagnosis of depression were associated with this particular outcome at a 
0.05 significance level (Table 5.25). 
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Table 5.25 
Tentative Diagnosis of Clinical Scenario Patient (Depression), by Selected Characteristics 
 Inaccurate (n=21) Accurate (n=146) P value 
Factor n (Row %) n (Row %)  
FP personal attributes    
 Gender    
 Male 15 (13.6) 95 (86.4) 0.592 
 Female 6 (10.7) 50 (89.3)  
 Age 51.0 (28-71, 10.5) 48.3 (28-81, 11.7) 0.247e 
 Number of years in practice 21.2 (2-42, 11.7) 17.6 (1-43, 11.2) 0.200e 
 Education    
 Undergraduate training in Canada 5 (7.2) 64 (92.8) 0.311 
  Undergraduate training outside Canada 10 (12.2) 72 (87.8)  
 Postgraduate training in Canada 7 (10.0) 63 (90.0) 0.869 
   Postgraduate training outside Canada 6 (10.9) 49 (89.1)  
Organizational setting    
 Number of total patient visits/week    
 Low (<100) 6 (10.9) 49 (89.1) 0.675 
 Medium (100-150) 6 (9.8) 55 (90.2)  
 High (151-450) 7 (15.2) 39 (84.8)  
 Private office/clinic 11 (10.0) 99 (90.0) 0.150 
 Otherb office 10 (17.9) 46 (82.1)  
 Solo practice 3 (11.5) 23 (88.5)  
 Group and other practice type 18 (12.9)               122 (87.1)  
 Internet access in main patient setting 18 (12.3) 128 (87.7) 0.480a 
 No internet access in main patient setting 3 (15.0) 17 (85.0)  
 Internet access during patient consultations 12 (15.6) 65 (84.4) 0.290 
 No internet access during patient  
 consultations 9 (10.1) 
80 (89.9) 
 
 Urban main patient setting (>10,000) 16 (13.9) 99 (86.1) 0.438 
 Rural main patient setting (<10,000) 5 (9.6) 47 (90.4)  
FP professional attributes    
 Resistance to diagnosis of anxiety 2.6 (0-7, 1.7) 2.3 (0-8, 1.3) 0.573e 
 Knowledge regarding anxiety disorders 68.3 (42-100, 15.3) 73.8 (42-100, 12.8) 0.120e 
 Anxiety attitude Factor 1 9.0 (4-13, 2.5) 8.9 (4-15, 2.0) 0.833e 
 Anxiety attitude Factor 2 10.0 (5-13, 2.0) 10.2 (5-15, 1.8) 0.923e 
 Anxiety attitude Factor 3 6.9 (4-11, 1.7) 6.8 (3-15, 1.9) 0.501e 
 Anxiety attitude Factor 4 8.7 (4-12, 1.9) 8.7 (4-15, 2.1) 0.742e 
Information/resource use to update GMK    
 Medical journals 20 (12.8) 136 (87.2) 0.586a 
 Do not use medical journals 1 (9.1) 10 (90.9)  
 Medical textbooks 10 (13.0) 67 (87.0) 0.882 
 Do not use medical textbooks 11 (12.2) 79 (87.8)  
 Colleagues in main patient setting 9 (13.4) 58 (86.6) 0.784 
 Do not use inside colleagues 12 (12.0) 88 (88.0)  
 Colleagues outside main patient setting 4 (6.9) 54 (93.1) 0.106 
 Do not use outside colleagues 17 (15.6) 92 (84.4)  
 Pharmaceutical sales representatives 8 (10.5) 68 (89.5) 0.466 
 Do not use pharmaceutical sales reps 13 (14.3) 78 (85.7)  
 Clinical practice guidelines 13 (11.1) 104 (88.9) 0.383 
 Do not use clinical practice guidelines 8 (16.0) 42 (84.0)  
 Personal Digital Assistance (PDA) 6 (10.5) 51 (89.5) 0.565 
 Do not use PDA 15 (13.6) 95 (86.4)  
 Other decision aids 4 (10.8) 33 (89.2) 0.482a 
 Do not use other decision aids 17 (13.1) 113 (86.9)  
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 Inaccurate (n=21) Accurate (n=146) P value 
Factor n (Row %) n (Row %)  
 Drug manuals 5 (8.6) 53 (91.4) 0.261 
 Do not use drug manuals 16 (14.7) 93 (85.3)  
 Psychiatrist(s) 5 (10.2) 44 (89.8) 0.552 
 Do not use psychiatrist(s) 16 (13.6) 102 (86.4)  
 MH professional(s) 1 (3.3) 29 (96.7) 0.074a 
 Do not use MH professional(s) 20 (14.6) 117 (85.4)  
 Pharmacist(s) 8 (16.0) 42 (84.0) 0.383 
 Do not use pharmacist(s) 13 (11.1) 104 (88.9)  
 Favorite internet site 13 (17.3) 62 (82.7) 0.094 
 Do not use favorite internet site 8 (8.7) 84 (91.3)  
Information/resource use to make specific 
clinical decisions  
 
 
 Medical journals 7 (18.4) 31 (81.6) 0.168a 
 Do not use medical journals 14 (10.9) 115 (89.1)  
 Medical textbooks 15 (12.4) 106 (87.6) 0.910 
 Do not use medical textbooks 6 (13.0) 40 (87.0)  
 Colleagues in main patient setting 13 (11.9) 96 (88.1) 0.729 
 Do not use inside colleagues 8 (13.8) 50 (86.2)  
 Colleagues outside main patient setting 11 (12.1) 80 (87.9) 0.835 
 Do not use outside colleagues 10 (13.2) 66 (86.8)  
 Pharmaceutical sales representatives 2 (33.3) 4 (66.7) 0.166a 
 Do not use pharmaceutical sales reps 19 (11.8) 142 (88.2)  
 Clinical practice guidelines 11 (12.0) 81 (88.0) 0.790 
 Do not use clinical practice guidelines 10 (13.3) 65 (86.7)  
 Personal Digital Assistance (PDA) 6 (10.7) 50 (89.3) 0.607 
 Do not use PDA 15 (13.5) 96 (86.5)  
 Other decision aids 5 (15.2) 28 (84.8) 0.402a 
 Do not use other decision aids 16 (11.9) 118 (88.1)  
 Drug manuals 8 (9.6) 75 (90.4) 0.255 
 Do not use drug manuals 13 (15.5) 71 (84.5)  
 Psychiatrist(s) 11 (11.1) 88 (88.9) 0.491 
 Do not use psychiatrist(s) 10 (14.7) 58 (85.3)  
 MH professional(s) 8 (11.4) 62 (88.6) 0.704 
 Do not use MH professional(s) 13 (13.4) 84 (86.6)  
 Pharmacist(s) 8 (10.5) 68 (89.5) 0.466 
 Do not use pharmacist(s) 13 (14.3) 78 (85.7)  
 Favorite internet site 8 (13.6) 51 (86.4) 0.777 
 Do not use favorite internet site 13 (12.0) 95 (88.0)  
Information/resource use during diagnostic 
uncertainty  
 
 
 Explicitc information 7 (10.0) 63 (90.0) 0.380 
 Do not use explicitc information 14 (14.6) 82 (85.4)  
 Tacitd information 17 (11.9) 126 (88.1) 0.326a 
 Do not use tacitd information 4 (17.4) 19 (82.6)  
Barriers to Care    
 System issue(s) 3 (8.3) 33 (91.7) 0.290a 
 No system issue(s) 18 (13.7) 113 (86.3)  
 Patient issue(s) 6 (15.8) 32 (84.2) 0.333a 
 No patient issue(s) 15 (11.6) 114 (88.4)  
 Physician issue(s) 8 (11.8) 60 (88.2) 0.794 
 No physician issue(s) 13 (13.1) 86 (86.9)  
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a Based on Fisher’s Exact Test of significance, given expected cell count of less than five. 
b Community clinic, community health centre, free-standing walk-in clinic, academic health 
sciences centre, community hospital, emergency department, and other type of organized 
practice.  
c Screening instrument or diagnostic manual 
d Colleague, psychiatrist, or mental health professional (other than a psychiatrist) 
e Based on Mann –Whitney 2-tailed test of significance. Using a Bonferroni correction,  
differences between the two comparison groups are considered significant if < 0.025 (.05/2). 
 
 Physicians who provided an inaccurate tentative diagnosis of the generalized anxiety disorder 
clinical scenario patient (AP) did not include at least one of the following terms in their response: 
anxiety, anxiety disorder, generalized anxiety disorder, GAD, panic, panic disorder, or panic 
attack.  
 Ten percent (n=16/160, 10.0%) of physicians provided an inaccurate tentative diagnosis of 
anxiety; 86% of physicians (n=138/160, 86.3%) provided an accurate tentative diagnosis. 
According to bivariate analysis, none of the variables hypothesized as associated with inaccurate 
tentative diagnosis of anxiety was associated with this particular outcome at a 0.05 level of 
significance (Table 5.26).  
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Table 5.26 
Tentative Diagnosis of Clinical Scenario Patient (Anxiety) by Selected Characteristics 
 
 Inaccurate (n=16) Accurate (n=138) P value 
Factor n (Row %) n (Row %)  
FP personal attributes    
 Gender    
 Male 11 (9.6) 104 (90.4) 0.360a 
 Female 5 (13.2) 33 (86.8)  
 Age 55.1 (33-88, 15.8) 49.9 (28-81, 11.5) 0.225e 
 Number of years in practice 24.1 (4-43, 13.0) 20.1 (1-50, 11.7) 0.206e 
 Education    
 Undergraduate training in Canada 7 (10.9) 57 (89.1) 0.994 
  Undergraduate training outside Canada 9 (11.0) 73 (89.0)  
 Postgraduate training in Canada 5 (8.6) 53 (91.4) 0.359 
   Postgraduate training outside Canada 8 (14.0) 49 (86.0)  
Organizational setting    
 Number of total patient visits/week    
 Low (<100) 6 (11.8) 45 (88.2) 0.295 
 Medium (100-150) 7 (11.9) 52 (88.1)  
 High (151-450) 1 (2.9) 34 (97.1)  
 Private office/clinic 12 (11.8) 90 (88.2) 0.433 
 Otherb office 4 (7.7) 48 (92.3)  
 Solo practice 12 (9.8) 111 (90.2) 0.407a 
 Group and other practice type 4 (12.9) 27 (87.1)  
 Internet access in main patient setting 12 (9.8) 110 (90.2) 0.435a 
 No internet access in main patient setting 5 (9.6) 47 (90.4)  
 Internet access during patient consultations 6 (9.7) 56 (90.3) 0.812 
 No internet access during patient 
 consultations 10 (10.9) 
 
82 (89.1)  
 Urban main patient setting (>10,000) 11 (10.0) 99 (90.0) 0.503a 
 Rural main patient setting (<10,000) 5 (11.4) 39 (88.6)  
FP professional attributes    
 Resistance to diagnosis of depression 1.9 (0-5, 1.3) 1.9 (0-8, 1.3) 0.908e 
 Knowledge regarding depression 70.5 (27-100, 18.9) 73.4 (27-100, 13.7) 0.824e 
 Depression attitude Factor 1 8.1 (4-12, 2.4) 8.0 (4-17, 2.7) 0.782e 
 Depression attitude Factor 2 9.7 (8-13, 1.7) 10.5 (6-15, 2.0) 0.095e 
 Depression attitude Factor 3 8.1 (4-11, 2.3) 7.9 (3-14, 2.1) 0.794e 
 Depression attitude Factor 4 12.6 (10-15, 1.7) 12.2 (7-15, 1.5) 0.341 
Information/resource use to update GMK    
 Medical journals 14 (9.7) 130 (90.3) 0.239a 
 Do not use medical journals 2 (22.2) 7 (77.8)  
 Medical textbooks 8 (10.5) 68 (89.5) 0.978 
 Do not use medical textbooks 8 (10.4) 69 (89.6)  
 Colleagues in main patient setting 9 (12.7) 62 (87.3) 0.404 
 Do not use inside colleagues 7 (8.5) 75 (91.5)  
 Colleagues outside main patient setting 8 (12.5) 56 (87.5) 0.484 
 Do not use outside colleagues 8 (9.0) 81 (91.0)  
 Pharmaceutical sales representatives 6 (8.6) 64 (91.4) 0.484 
 Do not use pharmaceutical sales reps 10 (12.0) 73 (88.0)  
 Clinical practice guidelines 14 (12.6) 97 (87.4) 0.129a 
 Do not use clinical practice guidelines   2 (4.8)  40 (95.2)  
 Personal Digital Assistance (PDA) 5 (10.9) 41 (89.1) 0.559a 
 Do not use PDA 11 (10.3) 96 (89.7)  
 Other decision aids 1 (4.0) 24 (96.0) 0.222a 
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 Inaccurate (n=16) Accurate (n=138) P value 
Factor n (Row %) n (Row %)  
 Do not use other decision aids 15 (11.7) 113 (88.3)  
 Drug manuals 6 (9.4) 58 (90.6) 0.711 
 Do not use drug manuals 10 (11.2) 79 (88.8)  
 Psychiatrist(s) 7 (13.7) 44 (86.3) 0.350 
 Do not use psychiatrist(s) 9 (8.8) 93 (91.2)  
 MH professional(s) 4 (9.5) 38 (90.5) 0.540a 
 Do not use MH professional(s) 12 (10.8) 99 (89.2)  
 Pharmacist(s) 5 (11.1) 40 (88.9) 0.534a 
 Do not use pharmacist(s) 11 (10.2) 97 (89.8)  
 Favorite internet site 12 (14.3) 72 (85.7) 0.088 
 Do not use favorite internet site 4 (5.8) 65 (94.2)  
Information/resource use to make specific 
clinical decisions  
 
 
 Medical journals 4 (9.3) 39 (90.7) 0.515a 
 Do not use medical journals 12 (10.9) 98 (89.1)  
 Medical textbooks 10 (10.8) 83 (89.2) 0.882 
 Do not use medical textbooks 6 (10.0) 54 (90.0)  
 Colleagues in main patient setting 10 (10.9) 82 (89.1) 0.838 
 Do not use inside colleagues 6 (9.8) 55 (90.2)  
 Colleagues outside main patient setting 9 (11.3) 71 (88.8) 0.737 
 Do not use outside colleagues 7 (9.6) 66 (90.4)  
 Pharmaceutical sales representatives 0  8 (100.0) 0.404a 
 Do not use pharmaceutical sales reps 16 (11.0) 129 (89.0)  
 Clinical practice guidelines 9 (10.2) 79 (89.8) 0.914 
 Do not use clinical practice guidelines 7 (10.8) 58 (89.2)  
 Personal Digital Assistance (PDA) 6 (10.3) 52 (89.7) 0.972 
 Do not use PDA 10 (10.5) 85 (89.5)  
 Other decision aids 0  27 (100.0) 0.037a 
 Do not use other decision aids 16 (12.7) 110 (87.3)  
 Drug manuals 9 (11.7) 68 (88.3) 0.617 
 Do not use drug manuals 7 (9.2) 69 (90.8)  
 Psychiatrist(s) 11 (12.1) 80 (87.9) 0.425 
 Do not use psychiatrist(s) 5 (8.1) 57 (91.9)  
 MH professional(s) 4 (7.4) 50 (92.6) 0.363 
 Do not use MH professional(s) 12 (12.1) 87 (87.9)  
 Pharmacist(s) 5 (9.1) 50 (90.9) 0.679 
 Do not use pharmacist(s) 11 (11.2) 87 (88.8)  
 Favorite internet site 8 (12.9) 54 (87.1) 0.414 
 Do not use favorite internet site 8 (8.8) 83 (91.2)  
Information/resource use during diagnostic 
uncertainty  
 
 
 Explicitc information 8 (8.5) 86 (91.5) 0.339 
 Do not use explicitc information 8 (13.3) 52 (86.7)  
 Tacitd information 12 (9.4) 116 (90.6) 0.273a 
 Do not use tacitd information 4 (15.4) 22 (84.6)  
Barriers to Care    
 System issue(s) 1 (3.3) 29 (96.7) 0.158a 
 No system issue(s) 15 (12.1) 109 (87.9)  
 Patient issue(s) 7 (17.5) 33 (82.5) 0.087a 
 No patient issue(s) 9 (7.9) 105(92.1)  
 Physician issue(s) 8 (11.8) 60 (88.2) 0.794 
 No physician issue(s) 13 (13.1) 86 (86.9)  
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a Based on Fisher’s Exact Test of significance, given expected cell count of less than five. 
b Community clinic, community health centre, free-standing walk-in clinic, academic health 
sciences centre, community hospital, emergency department, and other type of organized 
practice.  
c Screening instrument or diagnostic manual 
d Colleague, psychiatrist, or mental health professional (other than a psychiatrist) 
e Based on Mann –Whitney 2-tailed test of significance. Using a Bonferroni correction, 
differences between the two comparison groups are considered significant if < 0.025 (.05/2). 
 
5.10.2 Treatment Plan 
 Physicians’ treatment plans for the major depressive episode clinical scenario patient (DP) 
were considered ineffective if their responses included mention of delaying treatment until lab 
results were received, delaying a decision regarding treatment, or mention of ‘none’. Statements 
which did not refer to delayed/no treatment indicated effective (immediate) treatment.  
 Forty-two percent (n=71/171, 41.5%) of physicians suggested an ineffective treatment plan 
(delayed/no treatment) for the depressed patient; 56% of physicians (n=95/171, 55.6%) provided 
an effective treatment plan (immediate treatment). Bivariate analysis established that five of the 
variables hypothesized as associated with delayed/no treatment were associated with this 
outcome at a 0.05 level of significance (Table 5.27). Specifically, physicians were more likely 
than their counterparts to recommend delayed/no treatment of the DP patient if they were female, 
had completed their undergraduate training in Canada, scored lower on anxiety attitude factor 1 
(social context view of anxiety amenable to intervention), saw fewer than 100 patients on a 
weekly basis, and used medical textbooks to make specific clinical decisions. 
 
 
 
126 
Table 5.27 
Treatment Plan for Clinical Scenario Patient (Depression) by Selected Characteristics 
 Delayed/ 
no treatment (n=71) 
Immediate 
treatment (n=95) P value 
Factor n (Row %) n (Row %)  
FP personal attributes    
 Gender    
 Male 40 (36.7) 69 (63.3) 0.038 
 Female 30 (53.6) 26 (46.4)  
 Age 48.1 (28-81, 11.0) 48.8 (28-76, 11.9) 0.678e 
 Number of years in practice 17.5 (2-42, 10.0) 18.4 (1-43, 12.3) 0.644e 
 Education    
 Undergraduate training in Canada 35 (51.5) 33 (48.5) 0.047 
  Undergraduate training outside Canada 29 (35.4) 53 (64.6)  
 Postgraduate training in Canada 32 (46.4) 37 (53.6) 0.232 
   Postgraduate training outside Canada 21 (38.2) 34 (61.8)  
Organizational setting    
 Number of total patient visits/week    
 Low (<100) 30 (54.5) 25 (45.5) 0.004 
 Medium (100-150) 27 (44.3) 34 (55.7)  
 High (151-450) 10 (22.2) 35 (77.8)  
 Private office/clinic 41 (37.6) 68 (62.4) 0.050 
 Otherb office 30 (53.6) 26 (46.4)  
 Solo practice 13 (50.0) 13 (50.0) 0.434 
 Group and other practice type 58 (41.7) 81 (58.3)  
 Internet access in main patient setting 62 (42.8) 83 (57.2) 0.815 
 No internet access in main patient setting 8 (40.0) 12 (60.0)  
 Internet access during patient consultations 31 (40.8) 45 (59.2) 0.695 
 No internet access during patient 
 consultations 39 (43.8) 
 
50 (56.2)  
 Urban main patient setting (>10,000) 46 (40.4) 68 (59.6) 0.351 
 Rural main patient setting (<10,000) 25 (48.1) 27 (51.9)  
FP professional attributes    
 Resistance to diagnosis of anxiety 2.5 (0-7, 1.3) 2.3 (0-8, 1.4) 0.264e 
 Anxiety attitude Factor 1 8.6 (4-13, 1.9) 9.2 (5-15, 2.1) 0.044e 
 Anxiety attitude Factor 2 9.8 (5-14, 1.9) 10.4 (5-15, 1.9) 0.093e 
 Anxiety attitude Factor 3 6.7 (3-11, 1.7) 6.9 (4-15, 2.0) 0.568e 
 Anxiety attitude Factor 4 8.8 (5-13, 1.6) 8.7 (4-15, 2.4) 0.668e 
 Knowledge regarding anxiety disorders 71.1 (42-100, 11.8) 74.7 (42-100, 14.1) 0.085e 
Information/resource use to update GMK    
 Medical journals 65 (41.9) 90 (58.1) 0.305a 
 Do not use medical journals 6 (54.5) 5 (45.5)  
 Medical textbooks 32 (42.1) 44 (57.9) 0.873 
 Do not use medical textbooks 39 (43.3) 51 (56.7)  
 Colleagues in main patient setting 28 (42.4) 38 (57.6) 0.942 
 Do not use inside colleagues 43 (43.0) 57 (57.0)  
 Colleagues outside main patient setting 23 (40.4) 34 (59.6) 0.649 
 Do not use outside colleagues 48 (44.0) 61 (56.0)  
 Pharmaceutical sales representatives 31 (40.8) 45 (59.2) 0.635 
 Do not use pharmaceutical sales reps 40 (44.4) 50 (55.6)  
 Clinical practice guidelines 51 (44.0) 65 (56.0) 0.636 
 Do not use clinical practice guidelines 20 (40.0) 30 (60.0)  
 Personal Digital Assistance (PDA) 22 (38.6) 35 (61.4) 0.432 
 Do not use PDA 49 (45.0) 60 (55.0)  
 Other decision aids 12 (32.4) 25 (67.6) 0.149 
127 
 Delayed/ 
no treatment (n=71) 
Immediate 
treatment (n=95) P value 
Factor n (Row %) n (Row %)  
 Do not use other decision aids 39 (30.7) 88 (69.3)  
 Drug manuals 23 (39.7) 35 (60.3) 0.552 
 Do not use drug manuals 48 (44.4) 60 (55.6)  
 Psychiatrist(s) 24 (50.0) 24 (50.0) 0.230 
 Do not use psychiatrist(s) 47 (39.8) 71 (60.2)  
 MH professional(s) 10 (33.3) 20 (66.7) 0.248 
 Do not use MH professional(s) 61 (44.9) 75 (55.1)  
 Pharmacist(s) 24 (49.0) 25 (51.0) 0.295 
 Do not use pharmacist(s) 47 (40.2) 70 (59.8)  
 Favorite internet site 28 (37.3) 47 (62.7) 0.199 
 Do not use favorite internet site 43 (47.3) 48 (52.7)  
Information/resource use to make specific 
clinical decisions  
 
 
 Medical journals 17 (44.7) 21 (55.3) 0.780 
 Do not use medical journals 54 (42.2) 74 (57.8)  
 Medical textbooks 57 (47.5) 63 (52.5) 0.047 
 Do not use medical textbooks 14 (30.4) 32 (69.6)  
 Colleagues in main patient setting 44 (40.7) 64 (59.3) 0.471 
 Do not use inside colleagues 27 (46.6) 31 (53.4)  
 Colleagues outside main patient setting 39 (43.3) 51 (56.7) 0.873 
 Do not use outside colleagues 32 (42.1) 44 (57.9)  
 Pharmaceutical sales representatives 1 (16.7) 5 (83.3) 0.188a 
 Do not use pharmaceutical sales reps 70 (43.8) 90 (56.3)  
 Clinical practice guidelines 37 (40.2) 55 (59.8) 0.458 
 Do not use clinical practice guidelines 34 (45.9) 40 (54.1)  
 Personal Digital Assistance (PDA) 27 (48.2) 29 (51.8) 0.312 
 Do not use PDA 44 (40.0) 66 (60.0)  
 Other decision aids 11 (33.3) 22 (66.7) 0.221 
 Do not use other decision aids 60 (45.1) 73 (54.9)  
 Drug manuals 36 (43.4) 47 (56.6) 0.875 
 Do not use drug manuals 35 (42.2) 48 (57.8)  
 Psychiatrist(s) 41 (41.8) 57 (58.2) 0.770 
 Do not use psychiatrist(s) 30 (44.1) 38 (55.9)  
 MH professional(s) 25 (35.7) 45 (64.3) 0.117 
 Do not use MH professional(s) 46 (47.9) 50 (52.1)  
 Pharmacist(s) 35 (46.7) 40 (53.3) 0.357 
 Do not use pharmacist(s) 36 (39.6) 55 (60.4)  
 Favorite internet site 23 (39.0) 36 (61.0) 0.464 
 Do not use favorite internet site 48 (44.9) 59 (55.1)  
Information/resource use during diagnostic 
uncertainty  
 
 
 Explicitc information 34 (48.6) 36 (51.4) 0.217 
 Do not use explicitc information 37 (38.9) 58 (61.1)  
 Tacitd information 63 (44.4) 79 (55.6) 0.389 
 Do not use tacitd information 8 (34.8) 15 (65.2)  
Barriers to Care    
 System issue(s) 18 (50.0) 18 (50.0) 0.322 
 No system issue(s) 53 (40.8) 77 (59.2)  
 Patient issue(s) 17 (44.7) 21 (55.3) 0.780 
 No patient issue(s) 54 (42.2) 74 (57.8)  
 Physician issue(s) 31 (45.6) 37 (54.4) 0.541 
 No physician issue(s) 40 (40.8) 58 (59.2)  
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a Based on Fisher’s Exact Test of significance, given expected cell count of less than five. 
b Community clinic, community health centre, free-standing walk-in clinic, academic health 
sciences centre, community hospital, emergency department, and other type of organized 
practice.  
c Screening instrument or diagnostic manual 
d Colleague, psychiatrist, or mental health professional (other than a psychiatrist) 
e Mean (range, sd) based on Mann –Whitney 2-group comparison test with the continuous 
variable as the dependent variable; p-value based on logistic regression test, with the continuous 
variable as the independent variable. 
 
 Physicians’ treatment plans for the generalized anxiety disorder clinical scenario patient (AP) 
were considered ineffective if their responses included mention of delaying treatment until lab 
results were received, delaying a decision regarding treatment, or mention of ‘none’. Statements 
which did not refer to delayed/no treatment indicated effective (immediate) treatment.  
 Thirty percent (n=48/160, 30.0%) of physicians suggested an ineffective treatment plan 
(delayed/no treatment) for the anxious patient; 66% of physicians (n=105/160, 65.6%) provided 
an effective treatment plan (immediate treatment). According to bivariate analysis, six of the 
variables hypothesized as associated with delayed/no treatment were associated with this 
outcome at a 0.05 level of significance (Table 5.28). Specifically, physicians were more likely 
than their counterparts to recommend delayed/no treatment of the AP patient if they had 
completed their undergraduate training in Canada, had completed their postgraduate training in 
Canada, saw fewer than 100 patients on a weekly basis, were not in a private office/clinic, used 
colleagues in their main patient care setting to update their general medical knowledge, and used 
colleagues outside of their main patient care setting to update their general medical knowledge. 
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Table 5.28 
Treatment Plan for Clinical Scenario Patient (Anxiety) by Selected Characteristics 
 Delayed/ 
no treatment (n=48) 
Immediate 
treatment (n=105) P value 
Factor n (Row %) n (Row %)  
FP personal attributes    
 Gender    
 Male 33 (28.9) 81 (71.1) 0.227 
 Female 15 (39.5) 23 (60.5)  
 Age 51.5 (30-88, 12.9) 49.9 (28-81, 11.7) 0.461e 
 Number of years in practice 21.0 (1-50, 12.1) 20.0 (1-50, 11.8) 0.628e 
 Education    
 Undergraduate training in Canada 26 (41.3) 37 (58.7) 0.020 
  Undergraduate training outside Canada 19 (23.2) 63 (76.8)  
 Postgraduate training in Canada 25 (43.1) 33 (56.9) 0.005 
   Postgraduate training outside Canada 11 (19.3) 46 (80.7)  
Organizational setting    
 Number of total patient visits/week    
 Low (<100) 21 (42.0) 29 (58.0) 0.047 
 Medium (100-150) 13 (22.0) 46 (78.0)  
 High (151-450) 8 (22.9) 27 (77.1)  
 Private office/clinic 25 (24.8) 76 (75.2) 0.014 
 Otherb office 23 (44.2) 29 (55.8)  
 Solo practice 39 (31.7) 84 (68.3) 0.587 
 Group and other practice type 9 (30.0) 21 (70.0)  
 Internet access in main patient setting 40 (32.8) 82 (67.2) 0.454 
 No internet access in main patient setting 87 (25.8) 23 (74.2)  
 Internet access during patient consultations 19 (30.6) 43 (69.4) 0.873 
 No internet access during patient 
 consultations 29 (31.9) 
 
62 (68.1)  
 Urban main patient setting (>10,000) 38 (34.5) 72 (65.5) 0.176 
 Rural main patient setting (<10,000) 10 (23.3) 33 (76.7)  
FP professional attributes    
 Resistance to diagnosis of depression 1.9 (0-6, 1.4) 1.9 (0-8, 1.3) 0.992e 
 Depression attitude Factor 1 8.0 (4-15, 2.3) 8.0 (4-17, 2.9) 0.954e 
 Depression attitude Factor 2 10.2 (6-13, 1.8) 10.6 (6-15, 2.0) 0.892e 
 Depression attitude Factor 3 7.8 (3-12, 2.1) 8.0 (3-14, 2.1) 0.544e 
 Depression attitude Factor 4 11.9 (7-15, 1.5) 12.3 (8-15, 1.5) 0.129e 
 Knowledge regarding depression 72.0 (2-100, 16.5) 73.7 (27-100, 13.2) 0.491e 
Information/resource use to update GMK    
 Medical journals 46 (31.9) 98 (68.1) 0.510a 
 Do not use medical journals 2 (25.0) 6 (75.0)  
 Medical textbooks 26 (34.2) 50 (65.8) 0.485 
 Do not use medical textbooks 22 (28.9) 54 (71.1)  
 Colleagues in main patient setting 29 (40.8) 42 (59.2) 0.021 
 Do not use inside colleagues 19 (23.5) 62 (76.5)  
 Colleagues outside main patient setting 26 (40.6) 38 (59.4) 0.041 
 Do not use outside colleagues 22 (25.0) 66 (75.0)  
 Pharmaceutical sales representatives 18 (25.7) 52 (74.3) 0.151 
 Do not use pharmaceutical sales reps 30 (36.6) 52 (63.4)  
 Clinical practice guidelines 34 (30.6) 77 (69.4) 0.679 
 Do not use clinical practice guidelines 14 (34.1) 27 (65.9)  
 Personal Digital Assistance (PDA) 15 (32.6) 31 (67.4) 0.857 
 Do not use PDA 33 (31.1) 73 (68.9)  
 Other decision aids 9 (36.0) 16 (64.0) 0.603 
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 Delayed/ 
no treatment (n=48) 
Immediate 
treatment (n=105) P value 
Factor n (Row %) n (Row %)  
 Do not use other decision aids 39 (30.7) 88 (69.3)  
 Drug manuals 19 (29.7) 45 (70.3) 0.669 
 Do not use drug manuals 29 (33.0) 59 (67.0)  
 Psychiatrist(s) 19 (37.3) 32 (62.7) 0.285 
 Do not use psychiatrist(s) 29 (28.7) 72 (71.3)  
 MH professional(s) 14 (33.3) 28 (66.7) 0.774 
 Do not use MH professional(s) 34 (30.9) 76 (69.1)  
 Pharmacist(s) 14 (31.1) 31 (68.69) 0.936 
 Do not use pharmacist(s) 34 (31.8) 73 (68.2)  
 Favorite internet site 30 (36.1) 53 (63.9) 0.184 
 Do not use favorite internet site 18 (26.1) 51 (73.9)  
Information/resource use to make specific 
clinical decisions  
 
 
 Medical journals 10 (23.3) 33 (76.7) 0.166 
 Do not use medical journals 38 (34.9) 71 (65.1)  
 Medical textbooks 27 (29.0) 66 (71.0) 0.396 
 Do not use medical textbooks 21 (35.6) 38 (64.4)  
 Colleagues in main patient setting 24 (26.1) 68 (73.9) 0.071 
 Do not use inside colleagues 24 (40.0) 36 (60.0)  
 Colleagues outside main patient setting 22 (27.5) 58 (72.5) 0.254 
 Do not use outside colleagues 26 (36.1) 46 (63.9)  
 Pharmaceutical sales representatives 1 (12.5) 7 (87.5) 0.218a 
 Do not use pharmaceutical sales reps 47 (32.6) 97 (67.4)  
 Clinical practice guidelines 26 (29.5) 62 (70.5) 0.527 
 Do not use clinical practice guidelines 22 (34.4) 42 (65.6)  
 Personal Digital Assistance (PDA) 16 (27.6) 42 (72.4) 0.405 
 Do not use PDA 32 (34.0) 62 (66.0)  
 Other decision aids 8 (29.6) 19 (70.4) 0.810 
 Do not use other decision aids 40 (32.0) 85 (68.0)  
 Drug manuals 23 (29.9) 54 (70.1) 0.646 
 Do not use drug manuals 25 (33.3) 50 (66.7)  
 Psychiatrist(s) 26 (28.6) 65 (71.4) 0.330 
 Do not use psychiatrist(s) 22 (36.1) 39 (63.9)  
 MH professional(s) 15 (27.8) 39 (72.2) 0.454 
 Do not use MH professional(s) 33 (33.7) 65 (66.3)  
 Pharmacist(s) 14 (25.5) 41 (74.5) 0.221 
 Do not use pharmacist(s) 34 (35.1) 63 (64.9)  
 Favorite internet site 17 (27.9) 44 (72.1) 0.420 
 Do not use favorite internet site 31 (34.1) 60 (65.9)  
Information/resource use during diagnostic 
uncertainty  
 
 
 Explicitc information 30 (31.9) 64 (68.1) 0.855 
 Do not use explicitc information 18 (30.5) 41 (69.5)  
 Tacitd information 42 (32.8) 86 (67.2) 0.385 
 Do not use tacitd information 6 (24.0) 19 (76.0)  
Barriers to Care    
 System issue(s) 9 (30.0) 21 (70.0) 0.857 
 No system issue(s) 39 (31.7) 84 (68.3)  
 Patient issue(s) 13 (32.5) 27 (67.5) 0.858 
 No patient issue(s) 35 (31.0) 78 (69.0)  
 Physician issue(s) 17 (27.0) 46 (73.0) 0.328 
 No physician issue(s) 59 (65.6) 31 (34.4)  
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a Based on Fisher’s Exact Test of significance, given expected cell count of less than five. 
b Community clinic, community health centre, free-standing walk-in clinic, academic health 
sciences centre, community hospital, emergency department, and other type of organized 
practice.  
c Screening instrument or diagnostic manual 
d Colleague, psychiatrist, or mental health professional (other than a psychiatrist) 
e Mean (range, sd) based on Mann –Whitney 2-group comparison test with the continuous 
variable as the dependent variable; p-value based on logistic regression test, with the continuous 
variable as the independent variable. 
 
5.10.3 Follow-up Return 
 Physicians were considered ineffective in their follow-up of the major depressive episode 
clinical scenario patient (DP) if they suggested the first follow-up to occur more than 2 weeks 
after the initial visit.  
 Eleven percent (n=18/171, 10.5%) of physicians were ineffective in their follow-up of the DP 
patient (follow-up after 2 weeks); 83% of physicians (n=141/171, 82.5%) suggested an effective 
follow-up (2 weeks or earlier). Bivariate analysis indicated that physicians in solo practices 
(26.9%) were more likely than their counterparts (8.3%) to suggest follow-up after 2 weeks 
(p=0.013) [Table 5.29]. Physicians who used drug manuals to update their general medical 
knowledge (20.0%) were also significantly more likely than those who did not use drug manuals 
(6.7%) to suggest follow-up after 2 weeks for the DP patient (p=0.012). 
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Table 5.29 
Follow-up Return for Clinical Scenario Patient (Depression) by Selected Characteristics 
 
Follow-up after 
2 weeks (n=18) 
Follow-up at 2 
weeks or sooner 
(n=141) P value 
Factor n (Row %) n (Row %)  
FP personal attributes    
 Gender    
 Male 14 (13.3) 91 (86.7) 0.280 
 Female 4 (7.5) 49 (92.5)  
 Age 46.1 (28-71, 12.9) 49.1 (28-81, 11.5) 0.344e 
 Number of years in practice 15.7 (1-42, 13.1) 18.5 (1-43, 11.2) 0.264e 
 Education    
 Undergraduate training in Canada 6 (9.5) 57 (90.5) 0.738 
  Undergraduate training outside Canada 9 (11.3) 71 (88.8)  
 Postgraduate training in Canada 8 (12.5) 56 (87.5) 0.552 
   Postgraduate training outside Canada 5 (9.1) 50 (90.9)  
Organizational setting    
 Number of total patient visits/week    
 Low (<100) 7 (13.7) 44 (86.3) 0.632 
 Medium (100-150) 5 (8.5) 54 (91.5)  
 High (151-450) 6 (13.3) 39 (86.7)  
 Private office/clinic 11 (10.5) 94 (89.5) 0.871 
 Otherb office 6 (11.3) 47 (88.7)  
 Solo practice 7 (26.9) 19 (73.1) 0.013a 
 Group and other practice type 11 (8.3) 121 (91.7)  
 Internet access in main patient setting 14 (10.1) 125 (89.9) 0.151a 
 No internet access in main patient setting 4 (21.1) 15 (78.9)  
 Internet access during patient consultations 6 (8.5) 65 (91.5) 0.293 
 No internet access during patient  
 consultations 12 (13.8) 
 
75 (86.2)  
 Urban main patient setting (>10,000) 13 (12.1) 94 (87.9) 0.636 
 Rural main patient setting (<10,000) 5 (9.6) 47 (90.4)  
FP professional attributes    
 Resistance to diagnosis of anxiety 2.1 (1-5, 1.1) 2.4 (0-8, 1.4) 0.287e 
 Anxiety attitude Factor 1 8.9 (7-12, 1.6) 9.0 (4-15, 2.1) 0.986e 
 Anxiety attitude Factor 2 10.0 (6-12, 1.8) 10.2 (5-15, 1.9) 0.889e 
 Anxiety attitude Factor 3 6.7 (4-10, 2.0) 6.9 (3-15, 1.9) 0.411e 
 Anxiety attitude Factor 4 8.6 (4-13, 2.2) 8.8 (4-15, 2.1) 0.961e 
 Knowledge regarding anxiety disorders 74.1 (50-92, 12.4) 73.2 (42-100, 13.4) 0.851e 
Information/resource use to update GMK    
 Medical journals 17 (11.4) 132 (88.6) 0.290a 
 Do not use medical journals 1 (10.0) 9 (90.0)  
 Medical textbooks 9 (11.8) 67 (88.2) 0.843 
 Do not use medical textbooks 9 (10.8) 74 (89.2)  
 Colleagues in main patient setting 7 (10.9) 57 (89.1) 0.900 
 Do not use inside colleagues 11 (11.6) 84 (88.4)  
 Colleagues outside main patient setting 4 (7.1) 52 (92.9) 0.220 
 Do not use outside colleagues 14 (13.6) 89 (86.4)  
 Pharmaceutical sales representatives 9 (12.2) 65 (87.8) 0.755 
 Do not use pharmaceutical sales reps 9 (10.6) 76 (89.4)  
 Clinical practice guidelines 11 (9.7) 102 (90.3) 0.322 
 Do not use clinical practice guidelines 7 (15.2) 39 (84.8)  
133 
 
Follow-up after 
2 weeks (n=18) 
Follow-up at 2 
weeks or sooner 
(n=141) P value 
Factor n (Row %) n (Row %)  
 Personal Digital Assistance (PDA) 6 (11.3) 47 (88.7) 1.000 
 Do not use PDA 12 (11.3) 94 (88.7)  
 Other decision aids 6 (17.1) 29 (82.9) 0.218a 
 Do not use other decision aids 12 (9.7) 112 (90.3)  
 Drug manuals 11 (20.0) 44 (80.0) 0.012 
 Do not use drug manuals 7 (6.7) 97 (93.3)  
 Psychiatrist(s) 5 (10.6) 42 (89.4) 0.860 
 Do not use psychiatrist(s) 13 (11.6) 99 (88.4)  
 MH professional(s) 6 (20.0) 24 (80.0) 0.094a 
 Do not use MH professional(s) 12 (9.3) 117 (90.7)  
 Pharmacist(s) 7 (14.3) 42 (85.7) 0.431 
 Do not use pharmacist(s) 11 (10.0) 99 (90.0)  
 Favorite internet site 8 (11.0) 65 (89.0) 0.894 
 Do not use favorite internet site 10 (11.6) 76 (88.4)  
Information/resource use to make specific 
clinical decisions  
 
 
 Medical journals 4 (11.1) 32 (88.9) 0.615 
 Do not use medical journals 14 (11.4) 109 (88.6)  
 Medical textbooks 12 (10.4) 103 (89.6) 0.375a 
 Do not use medical textbooks 6 (13.6) 38 (86.4)  
 Colleagues in main patient setting 12 (11.7) 91 (88.3) 0.859 
 Do not use inside colleagues 6 (10.7) 50 (89.3)  
 Colleagues outside main patient setting 12 (14.0) 74 (86.0) 0.255 
 Do not use outside colleagues 6 (8.2) 67 (91.8)  
 Pharmaceutical sales representatives 0  6 (100.0) 0.480 
 Do not use pharmaceutical sales reps 18 (11.8) 135 (88.2)  
 Clinical practice guidelines 13 (14.9) 74 (85.1) 0.113 
 Do not use clinical practice guidelines 5 (6.9) 67 (93.1)  
 Personal Digital Assistance (PDA) 7 (13.5) 45 (86.5) 0.553 
 Do not use PDA 11 (10.3) 96 (89.7)  
 Other decision aids 4 (12.9) 27 (87.1) 0.482 
 Do not use other decision aids 14 (10.9) 114 (89.1)  
 Drug manuals 8 (10.1) 71 (89.9) 0.637 
 Do not use drug manuals 10 (12.5) 70 (87.5)  
 Psychiatrist(s) 13 (13.8) 81 (86.2) 0.230 
 Do not use psychiatrist(s) 5 (7.7) 60 (92.3)  
 MH professional(s) 10 (15.2) 56 (84.8) 0.199 
 Do not use MH professional(s) 8 (8.6) 85 (91.4)  
 Pharmacist(s) 11 (15.7) 59 (84.3) 0.121 
 Do not use pharmacist(s) 7 (7.9) 82 (92.1)  
 Favorite internet site 6 (10.7) 50 (89.3) 0.859 
 Do not use favorite internet site 12 (11.7) 941 (88.3)  
Information/resource use during diagnostic 
uncertainty  
 
 
 Explicitc information 7 (10.6) 59 (89.4) 0.792 
 Do not use explicitc information 11 (12.0) 81 (88.0)  
 Tacitd information 16 (11.8) 120 (88.2) 0.526 
 Do not use tacitd information 2 (9.1) 20 (90.9)  
Barriers to Care    
 System issue(s) 2 (5.7) 33 (94.3) 0.192a 
 No system issue(s) 16 (12.9) 108 (87.1)  
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Follow-up after 
2 weeks (n=18) 
Follow-up at 2 
weeks or sooner 
(n=141) P value 
Factor n (Row %) n (Row %)  
 Patient issue(s) 2 (5.7) 33 (94.3) 0.192a 
 No patient issue(s) 16 (12.9) 108 (87.1)  
 Physician issue(s) 8 (12.3) 57 (87.7) 0.744 
 No physician issue(s) 10 (10.6) 84 (89.4)  
a Based on Fisher’s Exact Test of significance, given expected cell count of less than five. 
b Community clinic, community health centre, free-standing walk-in clinic, academic health 
sciences centre, community hospital, emergency department, and other type of organized 
practice.  
c Screening instrument or diagnostic manual 
d Colleague, psychiatrist, or mental health professional (other than a psychiatrist) 
e Based on Mann –Whitney 2-tailed test of significance. Using a Bonferroni correction,  
differences between the two comparison groups are considered significant if < 0.025 (.05/2). 
 
 Physicians were considered ineffective in their follow-up of the generalized anxiety disorder 
clinical scenario patient (AP) if they indicated that the first follow-up would occur more than 2 
weeks after the initial visit.  
 Eleven percent (n=18/160, 11.3%) of physicians were ineffective in their follow-up (follow-
up after 2 weeks) of the AP patient; 79% of physicians (n=127/160, 79.4%) indicated an 
effective follow-up (follow-up 2 weeks or earlier). According to bivariate analysis, female 
physicians (23.5%) were more likely than male physicians (9.1%) to recommend follow-up of 
the AP patient after 2 weeks (p=0.032) [Table 5.30]. In addition, physicians who did not use 
mental health professionals to update their general medicial knowledge (16.0%) were more 
likely than those who used mental health professionals for this purpose (2.6%) to recommend 
follow-up after 2 weeks for the AP patient (p=0.023). 
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Table 5.30 
Follow-up Return for Clinical Scenario Patient (Anxiety) by Selected Characteristics 
 After 
2 weeks (n=18) 
2 weeks  
or sooner (n=127) P value 
Factor n (Row %) n (Row %)  
FP personal attributes    
 Gender    
 Male 10 (9.1) 100 (90.9) 0.032a 
 Female 8 (23.5) 26 (76.5)  
 Age 51.3 (30-78, 13.6) 50.2 (28-88, 11.9) 0.771e 
 Number of years in practice 20.3 (1-42, 13.9) 20.4 (2-50, 11.7) 0.985e 
 Education    
 Undergraduate training in Canada 8 (13.1) 53 (86.9) 0.822 
  Undergraduate training outside Canada 9 (11.8) 67 (88.2)  
 Postgraduate training in Canada 9 (16.7) 45 (83.3) 0.792 
   Postgraduate training outside Canada 8 (14.8) 46 (85.2)  
Organizational setting    
 Number of total patient visits/week    
 Low (<100) 6 (12.8) 41 (87.2) 0.441a 
 Medium (100-150) 8 (14.3) 48 (85.7)  
 High (151-450) 2 (5.7) 33 (94.3)  
 Private office/clinic 11 (11.2) 87 (88.8) 0.531 
 Otherb office 7 (14.9) 40 (85.1)  
 Solo practice 2 (7.4) 25 (92.6) 0.305a 
 Group and other practice type 16 (13.6) 102 (86.4)  
 Internet access in main patient setting 15 (13.0) 100 (87.0) 0.464a 
 No internet access in main patient setting 3 (10.0) 27 (90.0)  
 Internet access during patient consultations 6 (10.2) 53 (89.8) 0.497 
 No internet access during patient  
 consultations 12 (14.0) 
 
74 (86.0)  
 Urban main patient setting (>10,000) 15 (14.4) 89 (85.6) 0.243 
 Rural main patient setting (<10,000) 3 (7.3) 38 (92.7)  
FP professional attributes    
 Resistance to diagnosis of anxiety 1.9 (0-5, 1.3) 1.9 (0-8, 1.3) 0.756e 
 Depression attitude Factor 1 8.3 (4-17, 3.2) 7.9 (4-15, 2.6) 0.942e 
 Depression attitude Factor 2 10.5 (6-14, 2.5) 10.4 (6-15, 1.9) 0.774e 
 Depression attitude Factor 3 7.6 (4-11, 1.9) 8.1 (3-14, 2.1) 0.428e 
 Depression attitude Factor 4 12.1 (8.15, 1.9) 12.2 (7-15, 1.5) 0.855e 
 Knowledge regarding depression 72.2 (27-100, 16.0) 73.6 (27-100, 14.1) 0.902e 
Information/resource use to update GMK    
 Medical journals 18 (13.3) 117 (86.7) 0.290a 
 Do not use medical journals 0 9 (100.0)  
 Medical textbooks 9 (12.7) 62 (87.3) 0.950 
 Do not use medical textbooks 9 (12.3) 64 (87.7)  
 Colleagues in main patient setting 9 (13.4) 58 (86.6) 0.752 
 Do not use inside colleagues 9 (11.7) 68 (88.3)  
 Colleagues outside main patient setting 4 (6.7) 56 (93.3)  0.074 
 Do not use outside colleagues 14 (16.7) 70 (83.3)  
 Pharmaceutical sales representatives 6 (8.8) 62 (91.2) 0.207 
 Do not use pharmaceutical sales reps 12 (15.8) 64 (84.2)  
 Clinical practice guidelines 10 (9.7) 93 (90.3) 0.108 
 Do not use clinical practice guidelines 8 (19.5) 33 (80.5)  
 Personal Digital Assistance (PDA) 2 (4.5) 42 (95.5) 0.056 
 Do not use PDA 16 (16.0) 84 (84.0)  
 Other decision aids 1 (4.0) 24 (96.0) 0.137a 
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 After 
2 weeks (n=18) 
2 weeks  
or sooner (n=127) P value 
Factor n (Row %) n (Row %)  
 Do not use other decision aids 17 (14.3) 102 (85.7)  
 Drug manuals 5 (8.3) 55 (91.7) 0.201 
 Do not use drug manuals 13 (15.5) 71 (84.5)  
 Psychiatrist(s) 7 (14.9) 40 (85.1) 0.545 
 Do not use psychiatrist(s) 11 (11.3) 86 (88.7)  
 MH professional(s) 1 (2.6) 37 (97.4) 0.023a 
 Do not use MH professional(s) 17 (16.0) 89 (84.0)  
 Pharmacist(s) 4 (9.3) 39 (90.7) 0.449 
 Do not use pharmacist(s) 14 (13.9) 87 (86.1)  
 Favorite internet site 9 (11.3) 71 (88.8) 0.612 
 Do not use favorite internet site 9 (14.1) 55 (85.9)  
Information/resource use to make specific 
clinical decisions  
 
 
 Medical journals 3 (7.5) 37 (92.5) 0.621 
 Do not use medical journals 15 (14.4) 89 (85.6)  
 Medical textbooks 9 (10.5) 77 (89.5) 0.369 
 Do not use medical textbooks 9 (15.5) 49 (84.5)  
 Colleagues in main patient setting 11 (12.6) 76 (87.4) 0.949 
 Do not use inside colleagues 7 (12.3) 50 (87.7)  
 Colleagues outside main patient setting 7 (9.3) 68 (90.7) 0.231 
 Do not use outside colleagues 11 (15.9) 58 (84.1)  
 Pharmaceutical sales representatives 0  8 (100.0) 0.334a 
 Do not use pharmaceutical sales reps 18 (13.2) 118 (86.8)  
 Clinical practice guidelines 10 (11.9) 74 (88.1) 0.798 
 Do not use clinical practice guidelines 8 (13.3) 52 (86.7)  
 Personal Digital Assistance (PDA) 8 (15.1) 45 (84.9) 0.473 
 Do not use PDA 10 (11.0) 81 (89.0)  
 Other decision aids 3 (11.5) 23 (88.5) 0.585a 
 Do not use other decision aids 15 (12.7) 103 (87.3)  
 Drug manuals 8 (11.0) 65 (89.0) 0.571 
 Do not use drug manuals 10 (14.1) 61 (85.9)  
 Psychiatrist(s) 10 (11.6) 76 (88.4) 0.700 
 Do not use psychiatrist(s) 8 (13.8) 50 (86.2)  
 MH professional(s) 6 (11.5) 46 (88.5) 0.793 
 Do not use MH professional(s) 12 (13.0) 80 (87.0)  
 Pharmacist(s) 6 (11.8) 45 (88.2) 0.843 
 Do not use pharmacist(s) 12 (12.9) 81 (87.1)  
 Favorite internet site 10 (16.7) 50 (83.3) 0.201 
 Do not use favorite internet site 8 (9.5) 76 (90.5)  
Information/resource use during diagnostic 
uncertainty  
 
 
 Explicitc information 11 (12.5) 77 (87.5) 0.969 
 Do not use explicitc information 7 (12.3) 50 (87.7)  
 Tacitd information 14 (11.8) 105 (88.2) 0.409a 
 Do not use tacitd information 4 (15.4) 22 (84.6)  
Barriers to Care    
 System issue(s) 6 (20.7) 23 (79.3) 0.118a 
 No system issue(s) 12 (10.3) 104 (89.7)  
 Patient issue(s) 5 (13.2) 33 (86.8) 0.535a 
 No patient issue(s) 13 (12.1) 94 (87.9)  
 Physician issue(s) 11 (18.0) 50 (82.0) 0.080 
 No physician issue(s) 7 (8.3) 77 (91.7)  
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a Based on Fisher’s Exact Test of significance, given expected cell count of less than five. 
b Community clinic, community health centre, free-standing walk-in clinic, academic health 
sciences centre, community hospital, emergency department, and other type of organized 
practice.  
c Screening instrument or diagnostic manual 
d Colleague, psychiatrist, or mental health professional (other than a psychiatrist) 
e Based on Mann –Whitney 2-tailed test of significance. Using a Bonferroni correction,  
differences between the two comparison groups are considered significant if < 0.025 (.05/2). 
 
5.11  Logistic Regression Analysis of Treatment Plan by Physician Attributes, 
Organizational Setting, and Information/Resource Use 
 
 Ideally, multivariable model-building begins with the selection of independent variables 
which demonstrate a bivariate association with the dependent variable at a significance level of 
0.25, as well as those variables thought to be of importance (Hosmer & Lemeshow, 2000). 
However, the ‘rule of 10’ limits the number of independent variables allowed in the initial 
model, based on the magnitude of the sample size (Hosmer & Lemeshow). The ‘rule of 10’ 
requires the frequency of the least frequent outcome (i.e. in this analysis, the number of subjects 
offering delayed/no treatment) to be at least 10 times the number of covariates included in the 
model. In this analysis, the rule of 10 suggested that the model for the treatment plan for 
depression should contain a maximum of seven covariates, and the model for the treatment plan 
for anxiety should contain a maximum of five covariates. Based on the rule of 10, the 
independent variables associated with delayed/no treatment at a 0.05 level (Table 5.27 and 5.28) 
were included in the logistic regression models (Tables 5.31 and 5.32). Given that the model for 
the treatment plan for anxiety could contain a maximum of five covariates, one variable that was 
significantly associated with treatment plan for anxiety was excluded from logisitic regression 
analysis (number of total patient visits/week, p=.047). 
 This analysis used the enter method, in which all variables were entered simultaneously rather 
than in a stepwise forward or backward fashion. The fit of each model was assessed with the 
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Hosmer and Lemeshow goodness-of-fit chi-square and Nagelkerke R-square test. The 
significance levels for the Hosmer and Lemeshow chi-square (DP = 13.37, p=.100; AP = 4.48, 
p=.723) were greater than .05, therefore the null hypothesis that there was no difference between 
the observed and predicted values was rejected (Munro, 2005). These values indicated that the 
models fit the data well. The Nagelkerke R-square test indicated that the model explained 14% of 
the variation in the outcome of delayed/no treatment for the DP patient, and 19% of the variation 
in the case of the AP patient. 
 The first model (Table 5.31) contains the significant (p<.05) unadjusted odds of family 
physicians offering delayed/no treatment to the DP patient, on the basis of gender, undergraduate 
education, anxiety attitude, number of total patient visits per week, and whether the physician 
used medical textbooks to make specific clinical decisions. Before controlling for the effects of 
all other variables in this model, the unadjusted odds of delayed/no treatment were greater for 
physicians who were female, educated at the undergraduate level in Canada, scored lower on 
anxiety attitude factor 1 (social context view of anxiety amenable to intervention), saw fewer 
than 100 patients on a weekly basis, and used medical textbooks to make specific clinical 
decisions.  
 This model also contains the adjusted odds of delayed/no treatment to the DP patient, holding 
the effects of all other variables in the model constant. However, the only covariate with 
significant adjusted odds of offering delayed/no treatment was the number of total patient visits 
per week. The odds of physicians offering delayed/no treatment were 3.14 greater for those who 
saw fewer than 100 patients on a weekly basis (<100) than for those who saw many patients 
(151-450) (p=.026) 
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 The second model (Table 5.32) contains the significant (p<.05) unadjusted odds of family 
physicians offering delayed/no treatment to the AP patient, with respect to knowledge of 
undergraduate education, postgraduate education, whether physicians practiced in a private 
office/clinic, and whether physicians used colleagues to update their general medical knowledge. 
Prior to holding the effects of all other variables in the model constant, the unadjusted odds of 
offering delayed no treatment were greater for physicians who received their undergraduate 
training in Canada, their postgraduate training in Canada, did not practice in a private 
office/clinic, used colleagues within their main patient care setting to update their general 
medical knowledge, as well as colleagues outside of their main patient care setting to update 
their general medical knowledge. 
 This model also contains the adjusted odds of delayed/no treatment to the AP patient, 
controlling for the effects all other variables in the model. However, the only covariate with 
significant adjusted odds of offering delayed/no treatment was postgraduate training in Canada 
versus elsewhere. The odds of physicians offering delayed/no treatment were 4.94 greater for 
physicians who obtained their postgraduate training in Canada than for physicians who obtained 
their postgraduate training in a country other than Canada (p=.048). 
  
Table 5.31 
Unadjusted and Adjusted Odds Ratios for Family Physicians’ Delayed/No Treatment for Clinical Scenario Patient (with 
Depression), by Selected Characteristics 
 Unadjusted 
odds ratio 
(95% CI) 
95% 
confidence 
interval P value 
Adjusted 
odds ratio 
(95% CI) 
95% 
confidence 
interval P value 
Factor       
FP personal attributes       
 Gender       
 Male 1.00   1.00   
 Female 1.99 1.04-3.82 0.039 1.44 0.66-3.16 0.36 
 Education       
  Undergraduate training in Canada 1.94 1.00-3.74 0.048 1.38 0.65-2.93 0.41 
  Undergraduate training outside  
  Canada 1.00 
 
 
 
1.00 
  
Organizational setting       
 Number of total patient visits per week        
 Low (<100) 4.20  1.74-10.13 0.001 3.14 1.15-8.55 0.026 
 Moderate (100-150) 2.78  1.17-6.61 0.021 2.35 0.91-6.09 0.078 
 High (151-450) 1.00   1.00   
FP professional attributes       
 Anxiety attitude Factor 1a 0.85 0.73-0.99 0.044 0.89 0.75-1.11 0.21 
Information/resource use to make specific 
clinical decisions  
 
 
   
 Use medical textbooks 2.07 1.00-4.26 0.049 1.98 0.85-4.60 0.11 
 Do not use medical textbooks 1.00    1.00   
Note: Hosmer and Lemeshow chi-square = 13.37; p = 0.100; Nagelkerke R-square = .142. 
aThe unadjusted odds ratio is the decrease in odds of ‘delayed/no treatment‘ that corresponds to a one-unit increase in Anxiety 
attitude Factor 1 (‘social context view of anxiety amenable to intervention’, range 4-15 . 
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 Table 5.32 
Unadjusted and Adjusted Odds Ratios for Family Physicians’ Delayed/No Treatment for Clinical Scenario Patient (with 
Anxiety), by Selected Characteristics 
 Unadjusted 
odds ratio 
(95% CI) 
95% 
confidence 
interval 
P 
value 
Adjusted 
odds ratio 
(95% CI) 
95% 
confidence 
interval P value 
Factor       
Personal attributes       
 Education       
  Undergrad training in Canada 2.33 1.14-4.78 0.021 1.79 0.37-8.68 0.468 
  Undergrad training outside Canada 1.00    1.00   
 Education       
  Postgrad training in Canada 3.17 1.37-7.33 0.007 4.94 1.02-23.96 0.048 
  Postgrad training outside Canada 1.00    1.00   
Organizational setting       
 Private office/clinic 1.00   1.00   
 Other 2.41  1.19-4.90 0.015 2.19 0.91-5.26 0.081 
Information/resource use to update 
GMK  
 
 
   
 Colleagues within main patient setting 2.25 1.12-4.53 0.023 2.08 0.81-5.33 0.127 
 Do not use colleagues within 1.00    1.00   
 Colleagues outside main patient setting 2.05 1.03-4.11 0.042 1.22 0.46-3.20 0.693 
 Do not use outside colleagues  1.00  0.24-0.98  1.00   
Note: Hosmer and Lemeshow chi-square = 4.48; p = .723; Nagelkerke R-square = .189  
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6.0 DISCUSSION AND CONCLUSION 
 The expanding role of family physicians in mental health care service provision cannot be 
understated. Although fewer than half of those who suffer from mental or substance dependence 
disorders ultimately seek help from service and support providers (Lesage et al., 2006), those 
who do use health services for mental health reasons more often consult family physicians than 
any other service provider (Vasiliadis et al., 2005). Given the prominence of family practice in 
mental health care provision, it is worthwhile to examine whether family physicians provide 
appropriate responses to patients presenting with mental health issues.  
 A common theme throughout several studies concerning diagnosis and treatment of mood and 
anxiety disorders is that family physicians fail to appropriately respond to patients with anxiety 
and depression. This conclusion is based on many studies which have found accurate recognition 
of depression to range considerably, from a low of 9% to a high of 75% of patients seen in 
general practice, according to two systematic literature reviews (Cepoiu et al., 2007; Kosteniuk, 
unpublished). Accurate recognition of anxiety has been found to range from 34% to 50% of 
patients in general practice (Ormel et al., 1991; Wittchen et al., 2002). On the basis of these 
many studies, researchers in the field of psychiatric under-diagnosis generally agree that fewer 
than half of patients presenting with depression are recognized by family physicians (Seelig & 
Katon, 2008; Simon, 2002; Tylee & Jones, 2005). Furthermore, on average, only slightly more 
than half of diagnosed patients receive some form of treatment (Harris et al., 1996; Linden et al., 
1999; Olsson et al., 2006b; Ormel et al., 1991). 
 However, another method used to gauge whether family physicians generally respond 
appropriately to patients with mood and anxiety disorders is to estimate the proportion of 
physicians who accurately recognize and treat such patients. When examined from this 
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perspective, most studies found that more than 50% of physicians accurately detected mood and 
anxiety disorders in their patients, from a low of 47% to a high of 100 percent (Andersen & 
Hawthorn, 1989; Badger et al., 1994; Carney et al., 1999; Kales et al., 2005; Yager et al., 1986). 
 The central purposes of this thesis were to 1) estimate the proportion of family physicians 
who provided appropriate responses (detection, treatment, and follow-up) to patients with 
depression or anxiety in family practice, 2) examine the associations between these responses 
and physicians’ personal attributes, organizational setting, professional attributes, and 
information/resource use, and 3) determine whether significant associations remained when 
controlling for the associations between physician response and all factors. 
6.1 Review of Hypotheses 
Hypothesis 1 
The majority of family physicians will respond appropriately to mood and anxiety disorders in 
clinical scenario patients. Specifically, physicians will accurately detect depression and anxiety, 
suggest effective treatment, and recommend adequate follow-up care. 
Tentative Diagnosis 
 A significant majority of physicians tentatively diagnosed depression and anxiety in the 
clinical scenario patients, with approximately the same proportion providing accurate tentative 
diagnoses of both disorders. Specifically, 85.4% of physicians provided an accurate tentative 
diagnosis of depression, and 86.3% provided an accurate tentative diagnosis of anxiety. These 
results were comparable to the findings of previous research, the majority of which found that 
more than 80% of physicians accurately recognized patients’ depression (Carney et al., 1999; 
Kales et al., 2005; Yager et al., 1986), and 49%-78% accurately recognized anxiety (Andersen & 
Harthorn, 1989; Yager et al.).  
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Treatment Plan 
 Only a slight majority of physicians suggested effective (immediate) treatment for the clinical 
scenario patients, with a greater proportion suggesting effective treatment for the anxious than 
for the depressed patient. Specifically, 65.6% of physicians indicated that they would 
immediately initiate treatment for the anxious patient, while 30.1% reported that they would 
delay treatment until follow-up or offer no treatment (4.4% did not respond to the question of 
treatment). For the depressed patient, 55.6% of physicians reported that they would immediately 
initiate treatment, while 41.5% would delay or offer no treatment (2.9% did not respond to the 
question of treatment). 
 The finding that 85.4% of family physicians accurately detected depression in the clinical 
scenario patient, and 59.6% of those physicians subsequently reported that they would 
immediately treat the patient (versus 39.7% of those physicians would delay/offer no treatment), 
indicates that most physicians preferred not to wait until follow-up to start the depression patient 
on treatment. A similar finding developed for the anxiety patient; however, physicians were even 
more likely to immediately begin treatment. Specifically, this study found that 86.3% of family 
physicians accurately detected anxiety in the clinical scenario patient, and 71.7% of those 
physicians reported that they would immediately treat the patient (versus 28.3% of those 
physicians would delay/offer no treatment).  
 Heneghan et al. (2009: p. 1005) suggests that the final stage in the three-stage model of 
diagnostic reasoning (initiation, refinement, and defining) does not require diagnostic certainty 
before general practitioners initiate treatment. That is, during the final stage of ‘defining the final 
diagnosis’, physicians may follow one of several strategies:  rely on the ‘test of time’ or order 
further tests to rule diagnoses in or out (‘wait and see’ approaches); or start treatment based on 
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diagnostic certainty or use their patient’s response to treatment to reject or confirm diagnosis 
(‘test of treatment’ approaches). The present study indicates that family physicians who 
tentatively diagnosed depression in the clinical scenario patient presenting with depression were 
slightly more likely to follow the test of treatment approach than the wait and see approach; 
family physicians who tentatively diagnosed anxiety in the clinical scenario patient presenting 
with anxiety were notably more likely to follow the test of treatment approach than the wait and 
see approach.  
Follow-up Return 
 A significant majority of physicians recommended adequate follow-up care for the clinical 
scenario patients, with approximately the same proportion recommending adequate follow-up for 
the depressed patient as for the anxious patient. Specifically, 82.5% recommended that the 
depressed patient return within two weeks, and 79.4% suggested that the anxious patient return 
within two weeks. These findings indicate that physicians were more likely to provide swift 
follow-up care than previous research suggested. For example, Williams and colleagues (1999) 
found that only 50% of physicians scheduled a follow-up within a 2-week period for patients 
with newly diagnosed major depression. Further, Carney et al. (1999) found that follow-up 
within 2 weeks for patients with recognized major depressive disorder was recommended by 
only 60% of physicians. 
Hypothesis 2 
Physician attributes, organizational setting, and information/resource use will be directly 
associated with physicians’ responses to mood and anxiety disorders. 
 Neither tentative diagnosis of depression nor tentative diagnosis of anxiety was significantly 
associated with any of the tested measures. 
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 Effective (immediate) treatment of the clinical scenario patients was significantly associated 
with measures of personal attributes, professional attributes, organizational setting, and 
information/resource use. Specifically, physicians significantly more likely to ineffectively treat 
the depressed patient were female, had completed their undergraduate medical training in 
Canada (versus elsewhere), were less likely to hold a social context view of anxiety amenable to 
intervention, had a low patient load (<100 /week), and used medical texts to make specific 
clinical decisions. Physicians significantly more likely to ineffectively treat the anxious patient 
had completed their undergraduate and postgraduate medical training in Canada (versus 
elsewhere), had a low patient load (<100 /week), did not practice in a private office/clinic, and 
used colleagues inside and outside their practice setting to update their general medical 
knowledge. 
 Adequate follow-up was significantly associated with measures of personal attributes, 
organizational setting, and information/resource use. In particular, physicians significantly more 
likely to provide inadequate follow-up care to the depressed patient were in solo practice and 
used drug manuals to update their general medical knowledge. Physicians significantly more 
likely to provide inadequate follow-up care to the anxious patient were female and did not use 
mental health professionals to update their general medical knowledge. 
 In sum, these findings suggest that physicians’ provision of care to patients with anxiety and 
depression was more likely to be significantly associated with their personal attributes, 
organizational setting, and information/resource use than with their professional attributes. 
Particularly surprising was the association between ineffective (delayed/no) treatment and low 
patient load, in light of contrary previous research which inferred that physicians with heavy 
patient loads were more likely to provide inappropriate care (Baik et al., 2005; Dew et al., 2005; 
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Hartley et al., 1998; Martin-Agueda et al., 2005). Also unexpected was the association between 
ineffective treatment and gender and country of medical education, given that the linkages 
between personal physician attributes and appropriate care have not often been addressed within 
the mood and anxiety literature. When these factors have been investigated, the accuracy of 
physicians in diagnosing depression has not been found to be associated with either gender 
(Fitzpatrick et al., 1997; Thompson et al., 2001) or university attended (Fitzpatrick et al.). 
Hypothesis 3 
The best fitting model of factors that predicts family physicians’ responses to mood and anxiety 
disorders will include physician attributes, organizational setting, and information/resource use. 
 Of the three physician responses examined (detection, treatment, and follow-up), effective 
treatment of the clinical scenario patients was the only measure with a sufficient number of cases 
to build a multivariate model. When controlling for the effects of other factors, physicians with 
low patient loads (<100/week) were three times more likely to provide ineffective treatment of 
the depressed patient than physicians with high patient loads (151-450/week). When holding the 
effects of all other factors constant, physicians who had completed postgraduate training in 
Canada were approximately five times more likely to provide ineffective treatment of the 
anxious patient than physicians who had completed their postgraduate training outside of 
Canada. 
6.2 Secondary Analyses 
 In addition to testing hypotheses regarding family physicians’ general responses to patients 
with mood and anxiety disorders, this study investigated a number of other issues. These issues 
included physicians’ particular treatment plans with respect to the clinical scenario patients, as 
well as the duration of new and follow-up patient consultations, number of patients regularly 
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diagnosed and treated with depression and anxiety (weekly), their knowledge and attitudes with 
respect to depression and anxiety, barriers to care, perceived requirements for effectively 
managing patients with depression and anxiety, physician resistance to formal diagnosis, and 
information and resource use. 
 Physicians’ immediate treatment plans for the clinical scenario patient with generalized 
anxiety disorder most frequently included pharmacology, followed closely by a combination 
treatment of pharmacology and counseling. Immediate treatment plans for the depressed clinical 
scenario patient most frequently referred to a combination treatment of pharmacology and 
counseling, followed closely by pharmacology. The propensity of physicians to prefer 
pharmacology to counseling to treat mood and anxiety disorders is supported by the literature 
(Ormel et al., 1991; Kroenke et al., 2007; Wittchen et al., 2002). For this reason, it was 
somewhat surprising to find that family physicians preferred to immediately treat the depressed 
clinical scenario patient with a combination of pharmacology and counseling.  
 According to this study, the average duration of new visits with anxious and depressed 
patients was longer than the average duration of follow-up visits. That is, 32% to 40% of 
physicians spent 30 minutes or longer in new visits with patients with anxiety and depression, 
whereas only 8% to 13% of physicians spent 30 minutes or longer in follow-up visits with 
similar patients. 
 Physicians treated approximately twice the number of patients with anxiety and depression (8-
8.6) that they diagnosed every week with these disorders (3.7-4.3). Overall, patients diagnosed 
with these disorders made up 3.0% to 4.1% of total weekly visits, while patients treated with 
these disorders made up 7.3% to 7.4% of total patient visits.  
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 The results of this study indicated that physicians are generally quite knowledgeable about 
depression and anxiety, attaining an average score of 72.8 (over 100) on a depression knowledge 
scale, and 73.1 (over 100) on an anxiety knowledge scale.  
 Physicians held a range of attitudes toward anxiety and depression. In particular, physicians 
strongly disagreed with the social context view of depression and anxiety. These findings were 
consistent with previous research which indicated that most physicians held a medical etiology 
perspective of mental disorders (Andersson et al., 2005; Dowrick et al., 2000), yet somewhat 
contradictory of research which found physicians to hold multiple conceptualization of mental 
disorders and their causes (Andersson et al.; Chew-Graham et al., 2002; Thomas-MacLean & 
Stoppard, 2004). This study found that physicians were knowledgeable of current antidepressant 
treatment guidelines for patients with depression, strongly disagreed with the suggestion that 
psychotherapy or no treatment at all were superior to pharmacology, strongly disagreed with 
minimizing their role in managing patients with anxiety, and were neutral in their confidence in 
caring for patients with depression and anxiety yet did not exhibit professional inefficacy in 
caring for patients with anxiety. 
 Physicians raised a host of issues with respect to barriers they encountered when caring for 
patients with anxiety and depression. The majority of such barriers were physician-related rather 
than patient and system-related. In particular, physician-related barriers included perceptions of 
themselves as too busy, requiring specialist referral/consult, and lacking sufficient knowledge 
/skills/experience to provide the best possible care. Patient-related barriers referred to the 
problems of patient non-compliance and resistance to diagnosis and treatment. Physicians noted 
system-related issues such as lack of services, limited access to services, and long wait times for 
services.  
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 This study found that more than eight in ten physicians identified four requirements to 
effectively manage patients with depression and anxiety. These requirements included improved 
access to mental health professionals other than psychiatrists, an ability to prescribe affordable 
medication, more time to spend with patients, and up-to-date information on effective non-
pharmacological treatments. 
 With respect to resistance to formally diagnosing patients with depression or anxiety, by far 
the most popular reason was that physical causes first needed to be completely ruled out. 
Furthermore, more than one of every two physicians reported that they would not formally 
diagnose patients on the basis of patient refusal to accept such a diagnosis. More than one in five 
physicians also indicated that patient non-compliance and the low likelihood that a patient would 
be seen in time if referred to a specialist would cause them to not make a formal diagnosis. 
 With respect to updating their general medical knowledge, more than one in every two 
physicians reported that they used medical journals or clinical practice guidelines. Slightly fewer 
than one in two physicians used a favorite internet website, medical textbooks, and 
pharmaceutical sales representatives to update their general medical knowledge. In order to make 
specific clinical decisions, more than one in every two physicians used medical textbooks, 
colleagues in their main patient care setting, psychiatrists, clinical practice guidelines, and 
colleagues outside their main patient care setting. 
6.3 Study Limitations 
 The methodologies and measures used in this study are not without their limitations. First, this 
study achieved a low response rate (49.7%). However, this rate of response is comparable to 
response rates obtained by other published survey studies of Canadian family physicians, which 
ranged from a low of 29% (College of Family Physicians of Canada, 2007), 36% (Hillmer et al., 
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2006), 48% (Clatney et al., 2008; Arnold et al., 2005), and 53% (Singh et al., 2006), to a high of 
64% (Miller and Russell, 2004) and 75% (Ferrari et al., 2004). 
 Second, generalizability of study results to Saskatchewan family physicians may be limited by 
over-representation of family physicians who had been in practice for a longer period of time, 
and by under-representation of male physicians and physicians who completed their 
undergraduate and postgraduate training outside of Canada (College of Family Physicians of 
Canada, 2007). 
 Third, the use of clinical scenarios to measure physicians’ diagnostic practices may limit 
external validity (Epstein et al. 2001). For instance, Fortinsky and Wasson (1997) suggest that 
responses to clinical scenarios may differ from actual diagnostic practices. However, scenarios 
allow researchers an inexpensive method to effectively measure quality of care by controlling for 
the confounding effects of patient characteristics (Dresselhaus et al., 2004). Scenarios may also 
“produce better measures of quality of care than medical record reviews when used to measure 
differential diagnosis, selection of tests, and treatment decisions” (Veloski et al., 2005, p. 151). 
Furthermore, clinical scenarios have been found superior to medical chart abstraction, when 
compared to the gold standard of standardized patient checklists (Peabody et al., 2004).  
 Fourth, measures created specifically for use in this study may have low reliability. For 
instance, family physicians’ information and resource use was measured by self-reported items 
that required a check mark to indicate ‘yes’. Respondents who did not check the items were 
assumed to have replied ‘no’. This measure, and other similar measures throughout the survey, 
was employed to minimize the bias of non-response. However, it is possible that family 
physicians did not intend to answer ‘no’ when they did not place a check mark next to an item. 
For this reason, this study may have underestimated non-response by respondents. 
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6.4 Future Directions 
 The field of psychiatric diagnosis would benefit from attention to three issues. First, future 
studies of psychiatric under-diagnosis must attempt to obtain representative samples of both 
physicians and their patients. Past studies of psychiatric under-diagnosis have typically used 
large samples of patients (>200), but small samples of physicians (<100). Such small physician 
samples make it difficult to generalize to the larger population, and to obtain reliable estimates of 
the actual proportion of patients who are under-diagnosed. Second, future studies would benefit 
from employing longitudinal designs to explore the diagnostic process that unfolds over several 
visits. A small contingent of psychiatric diagnosis researchers have suggested that final 
diagnoses of psychiatric disorders, such as depression, are products of negotiation between 
patients and physicians. Final diagnoses should therefore be expected to emerge only after 
several visits, rather than after one visit as is currently the expectation by the majority of 
psychiatric diagnosis researchers. Third, the field of psychiatric diagnosis would benefit from a 
review of studies that more fully explores the issue of under-diagnosis within family practice. 
Such a review would likely provide evidence to suggest that psychiatric under-diagnosis attracts 
more attention than under-diagnosis of other common conditions in family practice. 
6.5 Conclusion 
 This study revealed that patients presenting to their family physicians with depression and 
anxiety generally received appropriate care with respect to recognition of their disorder and 
follow-up care; however, a notable proportion of physicians did not provide effective 
(immediate) treatment. That is, a significant majority of family physicians accurately detected 
depression and anxiety in clinical scenario patients, and recommended adequate follow-up (< 2 
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weeks) depression and anxiety care. However, only a slight majority of physicians suggested 
effective (immediate) treatment of clinical scenario patients. 
 With 5.4% of adult Canadians soliciting help for mental health reasons every year from 
family physicians and medical specialists other than psychiatrists and psychologists (Vasiliadis 
et al. 2005), appropriate and effective care is critical. Research is required which more fully 
describes the process of care, from recognition to diagnosis, treatment and compliance, to 
follow-up. A better understanding of the care process may eventually lead to improved care for 
those individuals with mental disorders who look first to their family physician for help.  
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APPENDIX B – Request for Evaluation of Survey Instrument 
 
 
 
 
 
Dear Family Physician, 
 
 
 
Thank you for agreeing to help evaluate this survey instrument “Diagnosing and Treating Patients 
in Family Practice”. Your answers will help to refine the questionnaire before it is distributed to 
family physicians in the pilot study phase.  
 
Please do not identify yourself when returning the questionnaire. Your evaluation is completely 
anonymous, and is intended for the sole purpose of instrument development. It would be most 
helpful if you answered the survey as you would answer any other survey.  
 
If you find that a question or a section could be improved upon, please note this directly in the 
questionnaire. I welcome any ideas that you might like to share about how to improve this 
questionnaire. 
 
Please return the questionnaire with your comments by enclosed self-addressed envelope or 
by fax to the attention of: Julie Kosteniuk (1.306.966.8774). Alternatively, email your 
comments to kosteniuk@usask.ca. 
 
Your help is greatly appreciated. 
 
Thank you, 
 
 
 
 
Julie Kosteniuk 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1.306.966.8773 collect 
Fax:     1.306.966.8774 
Email: kosteniuk@usask.ca 
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APPENDIX C – Pilot Study Consent Form 
 
Diagnosis and Treatment of Common Psychiatric Disorders in Family Practice 
 
CONSENT TO PARTICIPATE IN STUDY 
 
You are invited to participate in a study entitled Diagnosis and Treatment of Common Psychiatric Disorders in Family Practice. 
Please read this form carefully, and feel free to contact us with any questions you might have. 
 
The study researchers are: Julie Kosteniuk, MA and Carl D'Arcy, PhD., Applied Research, Department of Psychiatry, and 
Dr. Raymond Tempier, MD, FRCPC, Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan. 
 
This survey is part of a research project to learn more about how family physicians diagnose and treat common psychiatric disorders 
in their patients, and what their information and resource needs are to care for such patients. It will take approximately 15 minutes to 
complete.  
 
There are no known risks to you associated with completing this survey. The potential benefit of responding to this survey is an 
increase in our knowledge regarding the information and resources that physicians need to effectively diagnose and treat patients 
presenting with common psychiatric disorders. This benefit is not necessarily guaranteed. 
 
Analysis of the study results will take place in Applied Research, Department of Psychiatry, University of Saskatchewan, Saskatoon, 
Saskatchewan. The findings will be made available to the public and the media in a summary report, peer-reviewed scientific journal 
articles, and conference presentations. The study results will also be used as part of a doctoral thesis. 
 
Survey responses will be kept strictly confidential; only grouped or aggregate data from which individuals’ answers cannot be 
identified will ever be released. Direct quotations from participants’ answers will be used when reporting survey results; however, any 
information that may identify a participant or a participant’s community will be removed. 
 
Your participation is completely voluntary, and you may withdraw from the study for any reason, at any time. Answer only the 
questions with which you are comfortable. The sequence number on the questionnaire is used to delete your name from the mailing 
list for the survey. The mailing information and the survey data are kept in two separate files. Your name is never connected to your 
answers in any way. The survey data will be stored on a stand-alone computer in a locked room in Applied Research, Department of 
Psychiatry, at the University of Saskatchewan, for a period of five years upon completion of the study. This computer is not attached 
to the internet. No participants’ names will appear in any publication of results. If you withdraw from the study at any time, any data 
that you have contributed will be destroyed at your request. 
 
This study has received ethical approval from the University of Saskatchewan Behavioural Research Ethics Board (March 13, 2007). 
Any questions regarding your rights as a participant may be addressed to that committee through the Ethics Office 
(306-966-2084). Out of town participants may call collect. 
 
If you have any questions concerning the study, please feel free to contact the project coordinator, at Applied Research, 
Department of Psychiatry, University of Saskatchewan, by calling collect 1-306-966-8767. Alternatively, you may call collect 
or email any of the project principals. 
 
I have read and understood the description provided above; I acknowledge that I have been provided with an opportunity 
to ask questions. I consent to participate in the study described above, understanding that I may withdraw this consent at 
any time.  
 
               ___________________________________________                                 
_____________________________________ 
                        (Name of Participant)          (Date)     
 
 
               ___________________________________________                                 _____________________________________ 
                        (Signature of Participant)       (Signature of Researcher)     
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APPENDIX D  - Pilot Study Preletter 
 
 
«Dr» «Lastname»         June 14, 2007 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
We are writing to invite you to participate in a study of Saskatchewan family physicians. Your survey will 
be arriving in the mail within the next two weeks. The purpose of this study is to learn more about the 
information and resources that physicians use and need to effectively diagnose and treat patients with 
common mental health problems. 
 
This survey is completely voluntary and will take approximately 15 minutes to complete. Your name and 
address were selected at random from the Canadian Medical Directory and the College of Physicians and 
Surgeons of Saskatchewan mailing list. 
 
Your answers are strictly confidential. Only aggregate data will be reported; as such, your answers 
cannot be identified. The findings will be made available directly to the study participants, and will also 
be available to the public and the media in a summary report. Peer-reviewed scientific journal articles 
and conference presentations will also result from the successful completion of the study.  
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact any of the investigators involved in this survey, by emailing or calling collect to any of 
the phone numbers listed below.  
 
 
Sincerely, 
 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX E – Pilot Study First Package Letter 
 
«Dr» «Lastname»       June 21, 2007 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
About a week ago we sent you a letter inviting you to participate in a study of Saskatchewan family physicians. This 
enclosed package contains the study consent form, the study survey, and a stamped envelope for mailing the survey 
back to our office at Royal University Hospital. 
 
We hope that this study will improve our knowledge regarding information and resources physicians require to 
effectively diagnose and treat patients with common psychiatric disorders in family practice. Your participation in this 
study is important for achieving results representative of our province. The survey will take approximately 15 minutes 
to complete. Your answers are completely confidential. Answer only the questions with which you are comfortable. 
 
Your name and address came from the Canadian Medical Directory and the College of Physicians and Surgeons of 
Saskatchewan mailing list. Only aggregate data will be reported. Your individual answers cannot be identified. Please 
complete and return the questionnaire in the enclosed stamped envelope. The sequence number on the envelope is used 
to delete your name from the mailing list for the survey. Your name is never connected to your answers in any way. If 
you prefer not to respond, please let us know by returning the blank questionnaire in the enclosed stamped envelope. 
 
The survey data will be stored on a stand-alone computer in a locked room in Applied Research, Department of 
Psychiatry, at the University of Saskatchewan. This computer is not attached to the internet. No information from this 
survey will be sold.  
 
If you would like to receive a summary report of the study results, please indicate this by answering ‘yes’ to this 
question on the front page of the questionnaire. The findings will be made available to the public and the media in a 
summary report, peer-reviewed scientific journal articles, and conference presentations.  
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please feel free to 
contact any of the investigators involved in this survey, by emailing or calling collect to any of the phone numbers 
listed below.  
 
Sincerely, 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX F – Pilot Study First Thank You Letter 
 
  
 
 
 
«Dr» «Lastname»         July 6, 2007 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
 
About two weeks ago a questionnaire was mailed to you asking for your opinions about common 
psychiatric disorders and the information and resources necessary to effectively diagnose and treat 
patients with such disorders. 
 
Please accept our sincere thanks for returning the questionnaire. We are particularly grateful for your help 
because your contribution allows us to gain an understanding that is representative of family physicians in 
our province as a whole.  
 
Thank you again for your support of this important research.  
 
 
 
Sincerely, 
 
 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX G – Pilot Study First Reminder Letter 
 
 
«Dr» «Lastname»         July 6, 2007 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
 
About two weeks ago a questionnaire was mailed to you asking for your opinions about common 
psychiatric disorders and the information and resources necessary to effectively diagnose and treat 
patients with such disorders. 
 
If you have already completed and returned the questionnaire to us, please accept our sincere thanks. We 
are particularly grateful for your help because your contribution allows us to gain an understanding that is 
representative of family physicians in our province as a whole.  
 
If your questionnaire was misplaced, please call 1-306-966-8767 (collect) or email 
julie.kosteniuk@usask.ca and we will get another in the mail to you today.  
 
Thank you again for your support of this important research.  
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact any of the investigators involved in this survey, by emailing or calling collect to any of 
the phone numbers listed below.  
 
 
Sincerely, 
 
 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX H – Pilot Study Second Thank You Letter 
 
 
 
 
«Dr» «Lastname»         July 20, 2007 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
 
Recently, you completed a survey which asked for your opinions about common psychiatric disorders 
and the information and resources necessary to effectively diagnose and treat patients with such 
disorders. 
 
Please accept our sincere thanks for returning the questionnaire. We are particularly grateful for your help 
because your contribution allows us to gain an understanding that is representative of family physicians in 
our province as a whole.  
 
Thank you again for your support of this important research.  
 
 
 
Sincerely, 
 
 
 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX I – Pilot Study Second Reminder Letter 
 
«Dr» «Lastname»         July 20, 2007 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
About a month ago a questionnaire was mailed to you asking for your opinions about common 
psychiatric disorders and the information and resources necessary to effectively diagnose and treat 
patients with such disorders. 
 
We are writing again because of the importance that your questionnaire has for helping to attain 
accurate results that are representative of family physicians in our province as a whole. 
 
Other physicians across the province who have already completed and returned their questionnaires 
have contributed tremendously to our understanding of this significant issue.  
 
A few physicians have contacted us with questions regarding their eligibility to participate.  
• We would like you to participate if you are a family physician in full-time or part-time practice, 
or if you are a locum tenens, or on a leave of absence from active patient care.  
• If you are not a family physician, or if you are a retired family physician or a resident and 
received a questionnaire by mistake, please let us know on the cover of the questionnaire and 
return it in the enclosed envelope so that we can delete your name from the mailing list.  
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact any of the investigators involved in this survey, by emailing or calling collect to any of 
the phone numbers listed below.  
 
We hope that you will fill out and return the questionnaire soon, but if for any reason you prefer not to 
participate, please let us know by returning a note or blank questionnaire in the enclosed envelope. 
 
If you have already completed and returned the questionnaire to us, please accept our sincere thanks.  
 
Sincerely, 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
Fax:    1-306-966-8774 
julie.kosteniuk@usask.ca 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX J – Pilot Study Third Thank You Letter 
 
 
 
 
August 29, 2007 
 
«Dr» «Lastname»          
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
 
Recently, you completed a survey which asked for your opinions about common psychiatric disorders and 
the information and resources necessary to effectively diagnose and treat patients with such disorders. 
 
Please accept our sincere thanks for returning the questionnaire. We are particularly grateful for your help 
because your contribution allows us to gain an understanding that is representative of family physicians in 
our province as a whole.  
 
Thank you again for your support of this important research.  
 
 
 
Sincerely, 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX K – Pilot Study Third Reminder Letter 
 
August 29, 2007 
 
«Dr_»«Last_Name» 
«Address_Line_1» 
«Address_Line2» 
«City», «Prov» 
«Postal_Code» 
 
Dear «Dr_»«Last_Name», 
 
Last month we sent you a questionnaire regarding your opinions about common psychiatric disorders. 
 
Other physicians across the province who have already completed and returned their questionnaires 
have contributed tremendously to our understanding of this significant issue. Your response is 
important. You can help us obtain accurate results that are representative of family physicians in our 
province as a whole. 
 
A few physicians have contacted us with questions regarding their eligibility to participate.  
⋅ We would like you to participate if you are a family physician in full-time or part-time practice, or 
if you are a locum tenens, or on a leave of absence from active patient care.  
⋅ If you are not a family physician, or if you are a retired family physician or a resident and received 
a questionnaire by mistake, please let us know on the cover of the questionnaire and return it in the 
enclosed envelope so that we can delete your name from the mailing list.  
 
We have enclosed a small token of appreciation as a way of saying thanks for your help. 
 
We hope that you will fill out and return the questionnaire soon, but if for any reason you prefer not to 
participate, please let us know by returning a note or blank questionnaire in the enclosed envelope. 
 
Sincerely, 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
Fax:    1-306-966-8774 
julie.kosteniuk@usask.ca 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
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APPENDIX L – Pilot Study Final Letter 
 
 
 
October 10, 2007 
 
 
«Dr_»«Last_Name»   
«Address_Line_1» 
«Address_Line2» 
«City», «Prov» 
«Postal_Code» 
 
 
Dear «Dr_»«Last_Name», 
 
 
Recently, you completed a survey which asked for your opinions about common psychiatric disorders and 
the information and resources necessary to effectively diagnose and treat patients with such disorders. 
 
Please accept our sincere thanks for returning the questionnaire. We are particularly grateful for your help 
because your contribution allows us to gain an understanding that is representative of family physicians in 
our province as a whole.  
 
Thank you again for your support of this important research.  
 
 
 
Sincerely, 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
 
SaSkatchewan Family Practice Survey
Diagnosing anD TreaTing 
PaTienTs in Family PracTice 
   
  
Would you like a copy of our study results mailed to you?  o Yes   o No
If you have any questions regarding this survey, please contact:
Dr. Carl D’Arcy (carl.darcy@usask.ca)
Julie Kosteniuk (julie.kosteniuk@usask.ca)
Phone: 1-306-966-8767 (collect) 
Fax: 1-306-966-8774
Applied Research
Box 92, Royal University Hospital
103 Hospital Drive
Saskatoon, Saskatchewan
Canada    S7N 0W8
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       Please take a moment to ensure that you are eligible to complete this survey:
If you fall into one of the categories below, please indicate your status by checking (¸) the 
appropriate category. Then, please return your completed questionnaire in the enclosed 
stamped, self-addressed envelope.  
 o In full-time or part-time medical practice.
 o A locum tenens. Please complete the questionnaire in relation to the last 
  practice that you served, or are currently serving.
 o On a leave of absence or sabbatical from active patient care.  Please
  complete the questionnaire in relation to your most recent medical practice.
OR
If you fall into one of the categories below, please indicate your status by checking (¸) the 
appropriate category.  Then, please return your uncompleted questionnaire in the 
enclosed stamped, self-addressed envelope.  Thank you.
 o Medical student
 o Resident
 o Employed in a medical or medically related field (e.g. administration,  
  teaching, research)
 o Retired
 o Other (please specify):  _____________________________________
   
                            Please use pen or pencil to complete the questionnaire.
Saskatchewan Family Practice Survey
A. CLINICAL SCENARIO
 The following is a hypothetical clinical scenario of a patient whom you may encounter in your    
 practice. We are interested in how you would treat this patient. Please read the scenario and    
 respond to the questions below.
  Your patient is a 52 year-old woman, married for 26 years with 2 adult children. She has    
 worked part-time as a receptionist for a small local business for the past 15 years. She 
  typically takes art classes one evening a week, but has not felt like going to the class in a
   while. A detailed history reveals that for the past 4 weeks, she has been feeling a loss of 
  interest in her usual daily activities. Also, she cannot think clearly and has difficulty con-
  centrating. Your patient complains that she cannot sleep through the night, and feels little
   energy to do her daily tasks. She has lost 12 lbs. since she started feeling this way, and feels   
 that her situation is hopeless. She has no significant past medical or psychiatric history.
1. After reading the above scenario, what kind of diagnosis (if any) would you make?
2. What factors from the case scenario did you take into consideration in your diagnosis decision?
3. What treatment would you recommend to this patient (if any)?
4. If you recommended treatment to this patient, when would you like the patient to return for:
 a) 1st follow-up? 
 b) 2nd follow-up?
 c) 3rd follow-up?
 d) 4th follow-up?
5. List one or more reason that you may not be able to provide the best possible care for this patient.
 
Saskatchewan Family Practice Survey
B.  INFORMATION USE
1. Using check marks (¸) where applicable, indicate the information sources that you use on a regular basis 
 (at least once per month) to update your general medical knowledge and to make specific clinical decisions.
   Specific Purpose of Using the Information Source
                   To update your   To make a
  general medical   specific 
   knowledge     clinical decision
      Example:  Medical journals o     o 
    Information Source
a. Medical journals o     o 
b. Clinical practice guidelines  o     o  
c. Colleagues in your main patient care setting  o     o
d. Colleagues outside of your main patient care setting  o     o        
e. Pharmaceutical sales representatives  o     o       
f. Medical textbooks  o     o      
g. Drug manuals  o     o      
h. Decision aids  o o      
i. Psychiatrist(s)  o     o     
j. Mental health professional(s) (other than psychiatrist)  o     o      
k. Favorite internet search engine (please specify)
 _______________________________________________________ o     o     
l. Favorite internet website (please specify) 
 _______________________________________________________ o     o   
m. Other (please specify):
 _______________________________________________________ o     o     
 
2. Using check marks (¸) where applicable, please indicate whether you find the following information 
 sources to be (in general): reliable, easy to access, relevant to your needs, and easy to understand.
    Reliable      Relevant      
                       (You trust   Easy to   (to your   Easy to
   this source)    access   needs) understand
  Example:  Medical journals      o o o o
Information Source
a. Medical journals  o o o o 
b. Clinical practice guidelines   o o o o 
c. CME/CPD/CPL courses/programs   o o o o 
d. Colleagues in your main patient care setting o o o o 
e. Colleagues outside of your main patient care setting o o  o o 
f. Pharmaceutical sales representatives  o o o o
g. Medical textbooks   o o o o 
h. Drug manuals   o o o o 
i. Decision aids  o o o o 
j. Psychiatrist(s)  o o o o 
k. Mental health professional(s) (other than psychiatrist) o o o o 
l. Favorite internet website  o o o o 
¸ ¸
¸ ¸ ¸ ¸
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D. PATIENTS WITH DEPRESSION
1. Please indicate the two treatment interventions that you currently use most often for patients with 
 depressive disorders that are moderate and severe.  Indicate your first choice with “1” and second 
 choice with “2”.
          If depressive disorder is:
  Treatment      Moderate     Severe
 Exercise/recreation      _________  __________
 Counselor/psychological referral    _________  __________
 Medication       _________  __________
 Watchful waiting      _________  __________
 Psychiatric referral      _________  __________
 Psychotherapy provided by self    _________  __________
 Other (please specify): __________________________  _________  __________
C.  COLLEGIAL NETWORK
Do you have colleagues whom you can call on for consultation and/or professional support?
 o No   ‡ Please skip to Section D.
 o Yes   ‡ Please complete the chart below:
                      Primary mode 
                             Average level of accessibility   of contact             
                   Number                                                                        
                   of    Very                        Very                    
       Profession               colleagues accessible             inaccessible
Family physicians in your
main patient care setting          _____ o o o o o o o o
Family physicians outside 
of your main patient 
care setting       _____ o o o o o o o o
Mental health professionals 
Please specify the type,
(e.g. psychiatrists, 
psychologist, etc.)
   __________________      _____ o o o o o o o o
   __________________      _____ o o o o o o o o
   __________________      _____ o o o o o o o o
Other medical (please specify 
the type, eg: pharmacist)
   __________________      _____ o o o o o o o o
   __________________      _____ o o o o o o o o
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2. When deciding on the best treatment for a patient with depression, do you consider the following 
 factors?   Please mark ALL that apply with a check (¸) mark.
  
  age  o o o o o
  gender  o o o o o
   marital status  o o o o o
  The patient’s: children  o o o o o
  employment status  o o o o o
  preference for treatment  o o o o o
   family’s preference for treatment  o o o o o
 
3. Please check (¸) the square that is closest to your level of agreement with the following statements:
a. During the past 5 years I have seen an increase in the number of  patients 
 presenting with depressive symptoms. o o o o o
b. The majority of depression seen in general practice originates from patients’ 
 recent misfortunes. o o o o o
c. An underlying biochemical abnormality is the basis of severe cases of 
 depression. o o o o o
d. It is difficult to differentiate whether patients are presenting with 
 unhappiness or a clinical depressive disorder that needs treatment. o o o o o
e. It is possible to distinguish two main groups of depression, one
 psychological in origin and the other caused by biochemical mechanisms. o o o o o
f. Becoming depressed is a way that people with poor stamina deal with 
 life difficulties. o o o o o
g. Depressed patients are more likely to have experienced deprivation in 
 early life than other people. o o o o o
h. I feel comfortable in dealing with depressed patients’ needs. o o o o o
i. Depression reflects a characteristic response in patients that is not
 amenable to change. o o o o o
j. Becoming depressed is a natural part of being old. o o o o o
k. The community nurse could be a useful person to support depressed
 patients. o o o o o
l. Most depressive disorders seen in general practice improve without
 medication. o o o o o
m. Working with depressed patients is heavy going. o o o o o
n. There is little to be offered to those depressed patients who do not
 respond to what general practitioners do. o o o o o
o. It is rewarding to spend time looking after depressed patients. o o o o o
} All of the time Most of  the time Some ofthe time A little ofthe time None ofthe time
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p. Psychotherapy tends to be unsuccessful with depressed patients. o o o o o
q. If depressed patients need antidepressants, they should be started on 
 tricyclics as first-line treatment. o o o o o
r. If depressed patients need antidepressants, they should be started on 
 selective serotonin reuptake inhibitors as first-line treatment. o o o o o
s. If depressed patients need antidepressants, they are better off with a 
 psychiatrist than with a general practitioner. o o o o o
t. Antidepressants usually produce a satisfactory result in the treatment of 
 depression in general practice. o o o o o
u. Psychotherapy for depressed patients should be left to a specialist. o o o o o
v. If psychotherapy were freely available, this would be more beneficial 
 than antidepressants for most depressed patients. o o o o o
4. Please list your first choice of medication to treat depression, starting dosage, and duration of treatment 
  for patients in these 3 age groups.
      Starting Duration of 
  Patient’s age Medication   Dosage Treatment
  
  10-17 yrs _______________________________ _____ (mg) _____ (wks) 
  19-65 yrs _______________________________ _____ (mg) _____ (wks) 
  66+ yrs _______________________________ _____ (mg) _____ (wks) 
5. Although a patient may present with signs or symptoms of depression, you may choose not to make a 
  formal diagnosis.  Do any of the following reasons contribute to your decision? 
  Please mark ALL that apply with a check (¸) mark.
  o The stigma that the patient may suffer.
  o It is unlikely that the patient will be seen in time if I refer him/her to a specialist.
  o The patient is not likely to follow a course of treatment even if I prescribe it.
  o The patient will work through it on his/her own.
  o I don’t want it to show up on his/her medical record.
  o The patient lives too far away from a mental health specialist.
  o Other (please specify): ________________________________________________________________
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6. To what extent do you believe each of the following statements is true or false?  
 Please check ( ¸) the circle that is closest to your answer.
a. The maintenance phase of treatment for major depression focusses 
 on preventing recurrence. o o o o o
b. If psychotherapy for major depression has no effect within 6 weeks
 of regular sessions, medication is recommended. o o o o o
c. An appropriate trial of antidepressant medication for major depressive
 disorder requires use of therapeutic dosages daily for at least
 4-6 weeks. o o o o o
d. Side effects occur only in a small percentage of patients taking any
 antidepressant medication. o o o o o
e. Medication and psychotherapy are efficacious for depression in
 elderly adults as well as for the non-elderly. o o o o o
f. Evidence suggests that primary care clinicians prescribe appropriate 
 dosages of antidepressants to fewer than a third of patients with a 
 current major depressive disorder. o o o o o
g. Dysthymic disorder is mild, brief depression. o o o o o
h. The goal of cognitive therapy is to remove symptoms of depression by 
 identifying and correcting patients’ distorted, negatively biased thinking. o o o o o
i. In general, antidepressant medication should be discontinued after 
 4-9 months for patients with a single major depressive episode who 
 no longer have symptoms of depression. o o o o o
j. Anxiolytics and sedatives (minor tranquilizers) have equivalent
 efficacy in major depression as antidepressant medications. o o o o o
k. Psychotherapy with a trained therapist is appropriate as the sole
 treatment for moderate major depression that is not chronic,
 psychotic or melancholic. o o o o o
l. Tricyclic antidepressants and SSRIs have equivalent side effect profiles. o o o o o
7.   Imagine that you are unsure about diagnosing a patient with depression. Which of the 
  following actions might you take to confirm your decision? Please mark ALL that apply 
  with a check (¸) mark.
  o Conduct a thorough patient interview
  o Use a screening instrument (please specify instrument):  __________________________
  o Consult a diagnostic manual (please specify the manual): _________________________
  o Consult a colleague
  o Base it on my experience
  o Other (please specify):  ______________________________________________________
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F.  MAIN PATIENT CARE SETTING
1. What is your main patient care setting (i.e. where you spend the most time providing patient care)?
 o Private office/clinic (excluding free standing walk-in clinics)
 o Community clinic/Community health centre
 o Free-standing walk-in clinic
 o Academic health sciences centre
 o Community hospital
 o Emergency department (community hospital or academic health sciences centre)
 o Other (please specify):  ___________________________________________________
2. How is your main patient care setting organized?
 o Solo practice
 o Group practice
 o Other (please specify)   ___________________________________________________ 
3.  Do you have internet access in your main patient care setting?
 o No o Yes
4.  Do you have internet access during consultations with patients in your main patient care setting?
 o No o Yes
5. What is the population of your main patient care setting?
 o over 75,000
 o 50,001 to 75,000
 o 20,001 to 50,000
 o 10,001 to 20,000
 o 5,001 to 10,000
 o 2,501 to 5,000
 o 1,001 to 2,500
 o less than 1,000
6.  Indicate the types of health care providers with whom you share patient care within your main patient
 care setting.  Please mark ALL that apply.
 o Family physicians o Occupational therapists o Other (please specify below)
 o Specialist physicians o Physiotherapists      ____________________
 o Psychiatrists o Social workers      ____________________
 o Nurse practitioners o Pharmacists      ____________________ 
 o Nurses (eg. RN, LPN, RPN) o Technicians/Technologists      ____________________
 o Dieticians/Nutritionists o Psychologists     ____________________
 o Midwives
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G.  DEMOGRAPHICS
 
1. Gender:     o Male     o Female 
2. Year of birth:  19 __ __
2. Number of years you have been in practice as a family physician?  __ __
H.  EDUCATION
1.  Where and when did you complete your UNDERGRADUATE MEDICAL training?  
 Country Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
2.  Where and when did you complete your POSTGRADUATE MEDICAL training?   
 Country  Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 3.  Other medical training (please specify):
 ____________________________________________________________________________
 ____________________________________________________________________________
 
 ____________________________________________________________________________
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Do you have comments about caring for patients with depression? 
Do you have any general comments about this questionnaire?
Thank you for your time.
Saskatchewan Family Practice Survey
NOTES AND COMMENTS
SaSkatchewan Family Practice Survey
Diagnosing anD TreaTing 
PaTienTs in Family PracTice 
   
  
Would you like a copy of our study results mailed to you?  o Yes   o No
If you have any questions regarding this survey, please contact:
Dr. Carl D’Arcy (carl.darcy@usask.ca)
Julie Kosteniuk (julie.kosteniuk@usask.ca)
Phone: 1-306-966-8767 (collect) 
Fax: 1-306-966-8774
Applied Research
Box 92, Royal University Hospital
103 Hospital Drive
Saskatoon, Saskatchewan
Canada    S7N 0W8
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       Please take a moment to ensure that you are eligible to complete this survey:
If you fall into one of the categories below, please indicate your status by checking  (¸) the 
appropriate category. Then, please return your completed questionnaire in the enclosed 
stamped, self-addressed envelope.  
 o In full-time or part-time medical practice.
 o A locum tenens. Please complete the questionnaire in relation to the last 
  practice that you served, or are currently serving.
 o On a leave of absence or sabbatical from active patient care.  Please
  complete the questionnaire in relation to your most recent medical practice.
OR
If you fall into one of the categories below, please indicate your status by checking (¸) the 
appropriate category.  Then, please return your uncompleted questionnaire in the 
enclosed stamped, self-addressed envelope.  Thank you.
 o Medical student
 o Resident
 o Employed in a medical or medically related field (e.g. administration,  
  teaching, research)
 o Retired
 o Other (please specify):  _____________________________________
   
                            Please use pen or pencil to complete the questionnaire.
Saskatchewan Family Practice Survey
A. CLINICAL SCENARIO
 The following is a hypothetical clinical scenario of a patient whom you may encounter in your    
 practice. We are interested in how you would treat this patient. Please read the scenario and    
 respond to the questions below.
Your patient is a 30 year-old man, married with two young children. He is employed 
full-time as a construction worker, and has been with the same company for the past 6 
years. He spends most of his time at work, and socializes mainly with his co-workers. He 
and his wife typically go out once or twice a month for dinner or with friends, and leave 
their two young children with a babysitter. A detailed history reveals that he has been 
feeling anxious, almost daily, for the past 7 months. He feels edgy, which has affected 
his ability to concentrate on the job. Your patient complains of dizziness, sweaty palms, 
and tense muscles all over his body, when he feels anxious. He cannot name one specific 
worry, but says that he often finds it difficult to control. He is concerned that he will put 
his co-workers or himself in danger on the job if his situation does not improve.
1. After reading the above scenario, what kind of diagnosis (if any) would you make?
2. What factors from the case scenario did you take into consideration in your diagnosis decision?
3. What treatment would you recommend to this patient (if any)?
4. If you recommended treatment to this patient, when would you like the patient to return for:
 a) 1st follow-up? 
 b) 2nd follow-up?
 c) 3rd follow-up?
 d) 4th follow-up?
5. List one or more reason that you may not be able to provide the best possible care for this patient.
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B.  INFORMATION USE
1. Using check marks (¸) where applicable, indicate the information sources that you use on a regular basis 
 (at least once per month) to update your general medical knowledge and to make specific clinical decisions.
   Specific Purpose of Using the Information Source
                   To update your   To make a
  general medical   specific 
   knowledge     clinical decision
      Example:  Medical journals o     o
    Information Source
a. Medical journals o     o 
b. Clinical practice guidelines  o     o  
c. Colleagues in your main patient care setting  o     o
d. Colleagues outside of your main patient care setting  o     o       
e. Pharmaceutical sales representatives  o     o       
f. Medical textbooks  o     o      
g. Drug manuals  o     o      
h. Decision aids  o o      
i. Psychiatrist(s)  o     o   
j. Mental health professional(s) (other than psychiatrist)  o     o     
k. Favorite internet search engine (please specify)
 _______________________________________________________ o     o   
l. Favorite internet website (please specify) 
 _______________________________________________________ o     o     
m. Other (please specify):
 _______________________________________________________ o     o    
 
2. Using check marks (¸) where applicable, please indicate whether you find the following information 
 sources to be (in general): reliable, easy to access, relevant to your needs, and easy to understand.
    Reliable      Relevant      
                       (You trust   Easy to   (to your   Easy to
   this source)    access   needs) understand
  Example:  Medical journals      o o o   o 
Information Source
a. Medical journals  o o o o 
b. Clinical practice guidelines   o o o o 
c. CME/CPD/CPL courses/programs   o o o o 
d. Colleagues in your main patient care setting o o o o 
e. Colleagues outside of your main patient care setting o o  o o 
f. Pharmaceutical sales representatives  o o o o 
g. Medical textbooks   o o o o
h. Drug manuals   o o o o 
i. Decision aids  o o o o 
j. Psychiatrist(s)  o o o o 
k. Mental health professional(s) (other than psychiatrist) o o o o 
l. Favorite internet website  o o o o
¸ ¸
¸ ¸ ¸ ¸
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D. PATIENTS WITH ANXIETY
1. Please indicate the two treatment interventions that you currently use most often for patients with 
 anxiety disorders that are moderate and severe.  Indicate your first choice with “1” and second 
 choice with “2”.
          If anxiety disorder is:
  Treatment      Moderate     Severe
 Exercise/recreation      _________  __________
 Counselor/psychological referral    _________  __________
 Medication       _________  __________
 Watchful waiting      _________  __________
 Psychiatric referral      _________  __________
 Psychotherapy provided by self    _________  __________
 Other (please specify): __________________________  _________  __________
C.  COLLEGIAL NETWORK
Do you have colleagues whom you can call on for consultation and/or professional support?
 o No   ‡ Please skip to Section D.
 o Yes   ‡ Please complete the chart below:
                      Primary mode 
                             Average level of accessibility   of contact             
                   Number                                                                      
                   of          Very                                    Very     
       Profession               colleagues     accessible                 inaccessible 
 
Family physicians in your
main patient care setting          _____ o o o o o o o o
Family physicians outside 
of your main patient 
care setting       _____ o o o o o o o o
Mental health professionals 
Please specify the type,
(e.g. psychiatrists, 
psychologist, etc.)
   __________________      _____ o o o o o o o o
   __________________      _____ o o o o o o o o
   __________________      _____ o o o o o o o o
Other medical (please specify 
the type, eg: pharmacist)
   __________________      _____ o o o o o o o o
   __________________      _____ o o o o o o o o
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2. When deciding on the best treatment for a patient with anxiety, do you consider the following 
 factors?   Please mark ALL that apply with a check  (¸) mark.
  
  age  o o o o o
  gender  o o o o o
   marital status  o o o o o
  The patient’s: children  o o o o o
  employment status  o o o o o
  preference for treatment  o o o o o
  family’s preference for treatment  o o o o o
  
3. Please check (¸) the square that is closest to your level of agreement with the following statements:
a. During the past 5 years I have seen an increase in the number of  patients 
 presenting with symptoms of anxiety. o o o o o
b. The majority of anxiety seen in general practice originates from patients’ 
 recent misfortunes. o o o o o
c. An underlying biochemical abnormality is the basis of severe cases of 
 anxiety. o o o o o
d. It is difficult to differentiate whether patients are presenting with 
 stress or a clinical anxiety disorder that needs treatment. o o o o o
e. It is possible to distinguish two main groups of anxiety, one
 psychological in origin and the other caused by biochemical mechanisms. o o o o o
f. Becoming anxious is a way that people with poor stamina deal with 
 life difficulties. o o o o o
g. Anxious patients are more likely to have experienced deprivation in 
 early life than other people. o o o o o
h. I feel comfortable in dealing with anxious patients’ needs. o o o o o
i. Anxiety reflects a characteristic response in patients that is not
 amenable to change. o o o o o
j. Becoming anxious is a natural part of being old. o o o o o
k. The community nurse could be a useful person to support anxious
 patients. o o o o o
l. Most anxiety disorders seen in general practice improve without
 medication. o o o o o
m. Working with anxious patients is heavy going. o o o o o
n. There is little to be offered to those anxious patients who do not
 respond to what general practitioners do. o o o o o
o. It is rewarding to spend time looking after anxious patients. o o o o o
} All of the time Most of  the time Some ofthe time A little ofthe time None ofthe time
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p. Cognitive-behaviour therapy tends to be unsuccessful with  o o o o o
 anxious patients.
q. If anxious patients need pharmacologic management, they should be 
 started on selective serotonin reuptake inhibitors as first-line treatment. o o o o o
r. If anxious patients need pharmacologic management, benzodiazepines  
 are considered second-line treatment. o o o o o
s. If anxious patients need pharmacologic management, they are better 
 off with a psychiatrist than with a general practitioner. o o o o o
t. Pharmacotherapy usually produce a satisfactory result in the treatment 
 of anxiety in general practice. o o o o o
u. Psychotherapy for anxious patients should be left to a specialist. o o o o o
v. If psychotherapy were freely available, this would be more beneficial 
 than pharmacotherapy for most anxious patients. o o o o o
4. Please list your first choice of medication to treat anxiety, starting dosage, and duration of treatment for 
  patients in these 3 age groups.
      Starting Duration of 
  Patient’s age Medication   Dosage Treatment
  
  10-17 yrs _______________________________ _____ (mg) _____ (wks) 
  19-65 yrs _______________________________ _____ (mg) _____ (wks) 
  66+ yrs _______________________________ _____ (mg) _____ (wks) 
5. Although a patient may present with signs or symptoms of anxiety, you may choose not to make a 
  formal diagnosis.  Do any of the following reasons contribute to your decision? 
  Please mark ALL that apply with a check (¸) mark.
  o The stigma that the patient may suffer.
  o It is unlikely that the patient will be seen in time if I refer him/her to a specialist.
  o The patient is not likely to follow a course of treatment even if I prescribe it.
  o The patient will work through it on his/her own.
  o I don’t want it to show up on his/her medical record.
  o The patient lives too far away from a mental health specialist.
  o Other (please specify): ________________________________________________________________
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6. To what extent do you believe each of the following statements is true or false?  
 Please check (¸) the circle that is closest to your answer.
a. Anxiety disorders, with the exception of OCD, are more common 
 in men than women. o o o o o
b. Monitoring and follow-up of an anxiety disorder should occur for
 at least 12 months, regardless of whether treatment is pharmcological 
 or psychological. o o o o o
c. Benzodiazepines for treatment of anxiety should be used with great
 caution in the elderly. o o o o o
d. Pharmacotherapy and psychotherapy approaches to anxiety may be
 combined when a single treatment method is not effective. o o o o o
e. Cognitive behavior therapy (CBT) focuses on intervening in the 
 patient’s thoughts and behaviours that have a strong influence on  
 their experience of emotion. o o o o o
f. Relief of anxiety symptoms takes 2 to 4 weeks when the average 
 patient is treated with a selective serotonin reuptake inhibitor (SSRI). o o o o o
g. Pharmacotherapy and psychotherapy approaches are not equivalent
 in effectiveness for the average patient. o o o o o
h. Patients who fail to respond to two different first-line agents should be
 referred to a specialist. o o o o o
i. The first follow-up for a patient receiving pharmacotherapy for an o o o o o
 anxiety disorder should be at one week.
j. Full response to pharmacotherapy for an anxiety disorder can be 
 expected after 12 weeks. o o o o o
 
k. Cognitive behaviour therapy for a patient with an anxiety disorder
 includes weekly contact with a therapist for about 12 to 20 weeks. o o o o o
l. The most common side effects of SSRIs are gastrointestinal and
 sleep disturbances. o o o o o
      
7.   Imagine that you are unsure about diagnosing a patient with anxiety. Which of the following actions 
  might you take to confirm your decision? Please mark ALL that apply with a check (¸) mark.
  o Conduct a thorough patient interview
  o Use a screening instrument (please specify instrument):  __________________________
  o Consult a diagnostic manual (please specify the manual): _________________________
  o Consult a colleague
  o Base it on my experience
  o Other (please specify):  _______________________________________________________
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F.  MAIN PATIENT CARE SETTING
1. What is your main patient care setting (i.e. where you spend the most time providing patient care)?
 o Private office/clinic (excluding free standing walk-in clinics)
 o Community clinic/Community health centre
 o Free-standing walk-in clinic
 o Academic health sciences centre
 o Community hospital
 o Emergency department (community hospital or academic health sciences centre)
 o Other (please specify):  ___________________________________________________
2. How is your main patient care setting organized?
 o Solo practice
 o Group practice
 o Other (please specify)   ___________________________________________________ 
3.  Do you have internet access in your main patient care setting?
 o No o Yes
4.  Do you have internet access during consultations with patients in your main patient care setting?
 o No o Yes
5. What is the population of your main patient care setting?
 o over 75,000
 o 50,001 to 75,000
 o 20,001 to 50,000
 o 10,001 to 20,000
 o 5,001 to 10,000
 o 2,501 to 5,000
 o 1,001 to 2,500
 o less than 1,000
6.  Indicate the types of health care providers with whom you share patient care within your main patient
 care setting.  Please mark ALL that apply.
 o Family physicians o Occupational therapists o Other (please specify below)
 o Specialist physicians o Physiotherapists      ____________________
 o Psychiatrists o Social workers      ____________________
 o Nurse practitioners o Pharmacists      ____________________ 
 o Nurses (eg. RN, LPN, RPN) o Technicians/Technologists      ____________________
 o Dieticians/Nutritionists o Psychologists     ____________________
 o Midwives
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G.  DEMOGRAPHICS
 
1. Gender:     o Male     o Female 
2. Year of birth:  19 __ __
2. Number of years you have been in practice as a family physician?  __ __
H.  EDUCATION
1.  Where and when did you complete your UNDERGRADUATE MEDICAL training?  
 Country Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
2.  Where and when did you complete your POSTGRADUATE MEDICAL training?   
 Country  Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 3.  Other medical training (please specify):
 ____________________________________________________________________________
 ____________________________________________________________________________
 
 ____________________________________________________________________________
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Do you have comments about caring for patients with anxiety? 
Do you have any general comments about this questionnaire?
Thank you for your time.
Saskatchewan Family Practice Survey
NOTES AND COMMENTS
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APPENDIX O – Main Study Preletter 
 
 
 
 
 
«Dr» «Lastname»         January 4, 2008 
«Address1» 
«City», «SK» 
«Postcode» 
 
Dear «Dr» «Lastname», 
 
We are writing to invite you to participate in a study of Saskatchewan family physicians regarding the 
diagnosis and treatment of mood and anxiety disorders. Your survey will be arriving in the mail within the 
next two weeks. 
 
This survey is completely voluntary and will take approximately 20 minutes to complete. All family 
physicians in Saskatchewan are being surveyed in order to have accurate results that are representative of 
our province as a whole. Your name and address were obtained from the Canadian Medical Directory and 
the College of Physicians and Surgeons of Saskatchewan mailing lists. 
 
The findings of the survey will help us to learn more about the information and resources that physicians 
use and need to effectively diagnose and treat patients with mood and anxiety disorders. 
 
Your answers are strictly confidential and anonymous. Only aggregate data will be reported; as such, your 
answers cannot be identified. The findings will be made available directly to the study participants, and will 
be publicly available in a summary report, peer-reviewed scientific journal articles, and conference 
presentations.  
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact either of the study investigators, by emailing or calling collect to the phone number 
listed below.  
 
 
Sincerely, 
 
 
 
 
 
Julie Kosteniuk, MA, Project Coordinator 
Applied Research 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
Fax: 1-306-966-8774 
julie.kosteniuk@usask.ca 
Carl D'Arcy, PhD, Professor and Director 
Applied Research 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
Fax: 1-306-966-8774 
carl.darcy@usask.ca 
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APPENDIX P – Main Study First Package Letter 
 
Dr. «Initial» «Last_Name»         January 23, 2008 
«Address_Line_1» 
«City», «Province» 
«Postal_Code» 
 
Dear Dr. «Initial» «Last_Name», 
 
About two weeks ago we sent you a letter inviting you to participate in a study of Saskatchewan family physicians 
regarding the diagnosis and treatment of mood and anxiety disorders. The enclosed package contains the study survey 
and a stamped envelope for mailing the survey back to our office at Royal University Hospital. 
 
We hope that this study will improve our understanding of the information and resources physicians require to 
effectively diagnose and treat patients with mood and anxiety disorders in family practice. The survey will take 
approximately 20 minutes to complete. Your name and address came from the Canadian Medical Directory and the 
College of Physicians and Surgeons of Saskatchewan mailing lists.  
 
Your participation in this study is completely voluntary. Your answers are strictly confidential. Answer only the 
questions with which you are comfortable. Only aggregate data will be reported. Your name is never connected to 
your answers in any way. Direct quotations from participants’ answers will be used when reporting survey results; 
however, any information that may identify a participant or a participant’s community will be removed. No 
participants’ names will appear in any publication of results. 
 
The sequence number on the envelope is used to delete your name from the mailing list for the survey. The survey data 
will be securely stored in a locked room in Applied Research at the University of Saskatchewan.  
 
Please complete and return the questionnaire in the enclosed stamped envelope. Your participation in this study is 
important for achieving results representative of our province. The findings will be made available directly to study 
participants, and will be publicly available in a summary report, peer-reviewed scientific journal articles, and 
conference presentations.  
 
If you prefer not to respond, please let us know by returning the blank questionnaire in the enclosed stamped envelope. 
If you have questions or comments about this study, we would be happy to discuss them with you. Please feel free to 
contact either of the study investigators, by emailing or calling collect to the phone number listed below.  
 
This study has received ethical approval from the University of Saskatchewan Behavioural Research Ethics Board. 
Any questions regarding your rights as a participant may be addressed to that committee through the Ethics Office 
(306-966-2084). 
 
We have enclosed a small token of appreciation as a way of saying thanks for your help. 
 
Sincerely, 
 
 
 
 
 
Julie Kosteniuk, MA, Project Coordinator 
Applied Research 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
Fax: 1-306-966-8774 
julie.kosteniuk@usask.ca 
Carl D'Arcy, PhD, Professor and Director 
Applied Research 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
Fax: 1-306-966-8774 
carl.darcy@usask.ca 
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APPENDIX Q – Main Study First Followup Letter 
 
 
 
 
 
 
 
Dr. «Initial» «Last_Name»     February 6, 2008 
«Address_Line_1» 
«City», «Province» 
«Postal_Code» 
 
Dear Dr. «Initial» «Last_Name», 
 
About two weeks ago a survey package was mailed to you asking you to participate in a study of 
Saskatchewan family physicians regarding the diagnosis and treatment of mood and anxiety disorders. 
 
If you have already completed and returned the questionnaire to us, please accept our sincere thanks. We 
are particularly grateful for your help because your contribution allows us to gain an understanding that is 
representative of Saskatchewan family physicians as a whole.  
 
If your questionnaire was misplaced, please call 1-306-966-8767 (collect) or email 
julie.kosteniuk@usask.ca and we will get another in the mail to you today.  
 
This study has received ethical approval from the University of Saskatchewan Behavioural Research Ethics 
Board. Any questions regarding your rights as a participant may be addressed to that committee through the 
Ethics Office (306-966-2084). 
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact either of the study investigators by emailing or calling collect to the phone number listed 
below. 
 
Thank you again for your support of this important research.  
 
Sincerely, 
 
 
 
 
 
 
 
 
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
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APPENDIX R – Main Study Second Followup Letter 
 
 
 
 
Dr. «Initial» «Last_Name»     February 22, 2008 
«Address_Line_1» 
«City», «Province» 
«Postal_Code» 
 
Dear Dr. «Initial» «Last_Name», 
 
About a month ago a questionnaire was mailed to you asking you to participate in a study of 
Saskatchewan family physicians regarding the diagnosis and treatment of mood and anxiety disorders. 
We are writing again because your participation in this study will help us to attain results that are 
representative of your profession in this province as a whole. 
 
If you have already completed and returned the questionnaire to us, please accept our sincere thanks.  
You have contributed tremendously to our understanding of this significant issue.  
 
If you are not in family practice, or if you are a retired family physician and received a questionnaire 
by mistake, please let us know on the cover of the questionnaire and return it in the enclosed envelope. 
 
We hope that you will fill out and return the questionnaire at your earliest convenience, but if for any 
reason you prefer not to participate, please let us know by returning a note or blank questionnaire in the 
enclosed envelope. 
 
This study has received ethical approval from the University of Saskatchewan Behavioural Research Ethics 
Board. Any questions regarding your rights as a participant may be addressed to that committee through the 
Ethics Office (306-966-2084). 
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact either of the investigators involved in this survey, by emailing, faxing or calling collect 
to the phone number listed below.  
 
 
Sincerely, 
 
 
 
 
 
 Julie Kosteniuk, MA, Project Coordinator 
Applied Research 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
Fax: 1-306-966-8774 
julie.kosteniuk@usask.ca 
Carl D'Arcy, PhD, Professor and Director 
Applied Research 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
Fax: 1-306-966-8774 
carl.darcy@usask.ca 
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APPENDIX S – Main Study Third Followup Letter 
 
 
Dr. «Initial» «Last_Name»     March 14, 2008 
«Address_Line_1» 
«City», «Province» 
«Postal_Code» 
 
Dear Dr. «Initial» «Last_Name», 
 
During the last two months we have sent you a number of mailings about a study we are conducting of 
Saskatchewan family physicians regarding the diagnosis and treatment of mood and anxiety disorders. The 
study is drawing to a close and this is the last contact that we will be making with physicians who have not 
yet responded to the survey. 
 
We are making this one last attempt to contact everyone because we are concerned that physicians who 
have not responded may have different opinions and experiences than those who have responded. 
Hearing from everyone helps ensure that the survey results are as representative of your profession in 
this province as possible. 
 
If you have already completed and returned a questionnaire to us, please accept our sincere thanks.  
You have contributed tremendously to our understanding of this significant issue.  
 
If you are not in family practice, or if you are a retired family physician and received a questionnaire 
by mistake, please let us know on the cover of the questionnaire and return it in the enclosed envelope. 
 
We hope that you will fill out and return the enclosed questionnaire at your earliest convenience, but if for 
any reason you prefer not to participate, please let us know by returning a note or the blank questionnaire 
in the enclosed envelope. 
 
This study has received ethical approval from the University of Saskatchewan Behavioural Research Ethics 
Board. Any questions regarding your rights as a participant may be addressed to that committee through the 
Ethics Office (306-966-2084). 
 
If you have questions or comments about this study, we would be happy to discuss them with you. Please 
feel free to contact either of the investigators involved in this survey, by emailing, faxing or calling collect 
to the phone number listed below.  
 
 
Sincerely, 
 
 
 
 
 
 Julie Kosteniuk, MA, Project Coordinator 
Applied Research 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
Fax: 1-306-966-8774 
julie.kosteniuk@usask.ca 
Carl D'Arcy, PhD, Professor and Director 
Applied Research 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
Fax: 1-306-966-8774 
carl.darcy@usask.ca 
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APPENDIX T – Main Study Final Letter 
 
 
 
March 14, 2008 
 
 
«Dr_»«Last_Name»   
«Address_Line_1» 
«Address_Line2» 
«City», «Prov» 
«Postal_Code» 
 
 
Dear «Dr_»«Last_Name», 
 
 
Recently, you completed a survey which asked for your opinions about common psychiatric disorders and 
the information and resources necessary to effectively diagnose and treat patients with such disorders. 
 
Please accept our sincere thanks for returning the questionnaire. We are particularly grateful for your help 
because your contribution allows us to gain an understanding that is representative of family physicians in 
our province as a whole.  
 
Thank you again for your support of this important research.  
 
 
Sincerely, 
 
 
 
 
 
 
  
Julie Kosteniuk, MA 
Project Coordinator 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive  
Saskatoon, SK  S7N 0W8 
Phone: 1-306-966-8767  
julie.kosteniuk@usask.ca 
 
 
Carl D'Arcy, PhD, Professor and Director 
Applied Research/Psychiatry 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8767 
carl.darcy@usask.ca 
Dr. Raymond Tempier, MD, MSc, FRCPC, Professor and Director 
Department of Psychiatry and Mental Health Services of Saskatoon Health Region 
Room 119 Ellis Hall 
Royal University Hospital 
103 Hospital Drive 
Saskatoon, SK S7N 0W8 
Phone: 1-306-966-8223 
raymond.tempier@usask.ca 
 
   
  
Confidential when completed
If you have any questions regarding this survey, please contact:
Dr. Carl D’Arcy (carl.darcy@usask.ca)
Julie Kosteniuk (julie.kosteniuk@usask.ca)
Phone: 1-306-966-8767 (collect) 
Fax: 1-306-966-8774
Applied Research
Box 92, Royal University Hospital
103 Hospital Drive
Saskatoon, Saskatchewan
Canada    S7N 0W8
 
Sequence No:  A
Mood and Anxiety Disorders in
Saskatchewan Family Practice
 
Completion of this questionnaire implies 
consent to participate in this survey.
Appendix U - Main Study Anxiety Questionnaire
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This survey concerns your practices regarding the diagnosis and treatment of patients with 
mood and anxiety disorders.
This survey is completely voluntary and will take approximately 20 minutes to complete. All 
family physicians in Saskatchewan are being surveyed in order to have accurate results that 
are representative of our province as a whole. Your name and address were obtained from the 
Canadian Medical Directory and the College of Physicians and Surgeons of Saskatchewan 
mailing list.
 
The findings of the survey will help us to learn more about the information and resources that 
physicians use and need to effectively diagnose and treat patients with mood and anxiety 
disorders.
 
Your answers are strictly confidential and anonymous. Only aggregate data will be reported; 
as such, your answers cannot be identified. The findings will be made available directly to the 
study participants, and will also be available to the public and the media in a summary report. 
Peer-reviewed scientific journal articles and conference presentations will also result from the 
successful completion of the study. 
Your help is greatly appreciated
 INTRODUCTION
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A. CLINICAL SCENARIO
The following is a clinical scenario of a patient whom you may encounter in your practice. We are
interested in how you would treat this patient. Please read the scenario and respond to the questions below.
  Your patient is a 42 year-old employed woman, married for 21 years with 2 adult children. She is
 being seen for a four-week history of fatigue, insomnia, headache and abdominal pain. The pain is 
 generalized over the abdomen, constant in nature. She denies signs and symptoms of an acute 
 infectious process and was in relatively good health before the previous month. She has obtained 
intermittent relief from headache by using acetaminophen, and takes a multivitamin regularly. She 
complains, “food just doesn’t taste good anymore”. She has been finding it harder lately to concentrate 
at work, and to get up the energy to socialize with friends and family. Your patient has reached a point 
where she wonders if she will ever feel normal again, yet denies any stress or significant problems in 
her life. She does not smoke, and drinks 2 cups of coffee/day. She denies alcohol intake. Physical exam: 
General - tired but in no acute distress. Skin - normal, color - good, HEENT - unremarkable. Pelvic exam 
- normal. Abdomen - generalized tenderness. Extremities - unremarkable.  
1. What specific laboratory tests, medical procedures, and/or consults (if any) would you order at this point?
2. Although you may feel you need more information, please list the specific tentative diagnoses that you 
 are considering and make a tentative diagnosis.
3. What treatment plan would you initiate at this point (if any)?
4. If you recommended treatment to this patient, when would you like the patient to return for:
 a) 1st follow-up?  _______ weeks after 1st visit
 b) Subsequent follow-up?  _______ weeks after 1st visit
      _______ weeks after 1st visit
5. Please list one or more reasons that you may not be able to provide the best possible care for this patient.
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B.  INFORMATION USE
1. Using check marks (¸) where applicable, indicate the information sources that you use on a regular basis 
 (at least once per month) to update your general medical knowledge and to make specific clinical decisions.
   Specific Purpose of Using the Information Source
                   To update your   To make a
  general medical   specific 
   knowledge     clinical decision
      Example:  Medical journals o     o 
    Information Source
 a.   Medical journals o     o 
 b.   Medical textbooks  o     o  
 c.   Colleagues in your main patient care setting  o     o
 d.   Colleagues outside of your main patient care setting  o     o        
 e.   Pharmaceutical sales representatives  o     o       
 f.    Clinical practice guidelines o     o      
 g.   PDA (Personal Digital Assistant programs) o     o  
 h.  Other decision aids  o     o      
 i.   Drug manuals  o o      
 j.   Psychiatrist(s)  o     o     
 k.  Mental health professional(s) (other than psychiatrist)  o     o     
 l.   Pharmacist(s) o     o      
 m. Favorite internet website (please specify) 
 _______________________________________________________ o     o   
 n.  Other (please specify):
 _______________________________________________________ o     o     
2. Using check marks (¸) where applicable, please indicate whether you find the following information 
 sources to be (in general): reliable, easy to access, relevant to your needs, and easy to understand.
    Reliable      Relevant      
                       (You trust   Easy to   (to your   Easy to
   this source)    access   needs) understand
  Example:  Medical journals      o o o o
Information Source
a. Medical journals  o o o o 
b. Medical textbooks   o o o o 
c. CME/CPD/CPL courses/programs   o o o o 
d. Colleagues in your main patient care setting o o o o 
e. Colleagues outside of your main patient care setting o o  o o 
f. Pharmaceutical sales representatives  o o o o
g. Medical textbooks   o o o o 
h. PDA (Personal Digital Assistant programs) o o  o o 
i. Other decision aids  o o o o 
j. Drug manuals  o o o o 
k. Psychiatrist(s)  o o o o 
l. Mental health professional(s) (other than psychiatrist) o o o o
m.  Pharmacist(s)  o o o o 
n. Favorite internet website  o o o o 
¸ ¸
¸ ¸ ¸ ¸
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C. PATIENTS WITH ANXIETY
1. Please indicate the two treatment interventions that you currently use most often for patients with 
 anxiety disorders that are moderate and severe.  Indicate your first choice with “1” and second 
 choice with “2”.
            If anxiety disorder is:
    Treatment      Moderate     Severe
 Exercise/recreation _________   __________
 Counselor/psychological referral _________   __________
 Medication _________   __________
 Watchful waiting _________   __________
 Psychiatric referral _________   __________
 Psychotherapy provided by you _________   __________
 Other (please specify): __________________________ _________   __________
2. When deciding on the best treatment for a patient with anxiety, do you consider the following 
 factors?   Please mark ALL that apply with a check  (¸) mark.
   age o o o o o
   gender o o o o o
    marital status o o o o o
     The patient’s:  children o o o o o
   employment status o o o o o
   preference for treatment o o o o o
   family’s preference for treatment  o o o o o
3. Please estimate the following:
a. The length of time you spend with a patient presenting with anxiety for a new visit
  Average number of minutes __________
b. The length of time you spend with a patient you are treating for anxiety for a follow-up visit
  Average number of minutes  __________
c. The number of patients per week you recognize as presenting with anxiety
  Average number of patients/week  __________
d. The number of patients per week you diagnose with anxiety
  Average number of patients/week  __________
e. The number of patients per week you treat or manage for anxiety
  Average number of patients/week  ___________
f. EXCLUDING patient visits while on-call, please estimate the following:
  Number of TOTAL patient visits per week  __________
} All of the time Most of  the time Some ofthe time A little ofthe time None ofthe time
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4. Please check (¸) the square that is closest to your level of agreement with the following statements:
a. During the past 5 years I have seen an increase in the number of  patients 
 presenting with symptoms of anxiety. o o o o o
b. The majority of anxiety seen in general practice originates from patients’ 
 recent misfortunes. o o o o o
c. An underlying biochemical abnormality is the basis of severe cases of 
 anxiety. o o o o o
d. It is difficult to differentiate whether patients are presenting with 
 stress or a clinical anxiety disorder that needs treatment. o o o o o
e. It is possible to distinguish two main groups of anxiety, one
 psychological in origin and the other caused by biochemical mechanisms. o o o o o
f. Becoming anxious is a way that people with poor stamina deal with 
 life difficulties. o o o o o
g. Anxious patients are more likely to have experienced deprivation in 
 early life than other people. o o o o o
h. I feel comfortable in dealing with anxious patients’ needs. o o o o o
i. Anxiety reflects a characteristic response in patients that is not
 amenable to change. o o o o o
j. Becoming anxious is a natural part of being old. o o o o o
k. The community nurse could be a useful person to support anxious
 patients. o o o o o
l. Most anxiety disorders seen in general practice improve without
 medication. o o o o o
m. Working with anxious patients is heavy going. o o o o o
n. There is little to be offered to those anxious patients who do not
 respond to what general practitioners do. o o o o o
o. It is rewarding to spend time looking after anxious patients. o o o o o
p. Cognitive-behaviour therapy tends to be unsuccessful with  o o o o o
 anxious patients.
q. If anxious patients need pharmacologic management, they should be 
 started on selective serotonin reuptake inhibitors as first-line treatment. o o o o o
r. If anxious patients need pharmacologic management, benzodiazepines  
 are considered second-line treatment. o o o o o
s. If anxious patients need pharmacologic management, they are better 
 off with a psychiatrist than with a general practitioner. o o o o o
t. Pharmacotherapy usually produces a satisfactory result in the treatment 
 of anxiety in general practice. o o o o o
u. Psychotherapy for anxious patients should be left to a specialist. o o o o o
v. If psychotherapy were freely available, this would be more beneficial 
 than pharmacotherapy for most anxious patients. o o o o o
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5.   Imagine that you are unsure about diagnosing a patient with anxiety. Which of the following 
  actions might you take to confirm your decision? Please mark ALL that apply with a check (¸) mark.
 
  o Conduct a thorough patient interview
  o Use a screening instrument (please specify instrument):  _______________________________
  o Consult a diagnostic manual (please specify the manual): ______________________________
  o Consult a colleague
  o Consult a psychiatrist
  o Consult a mental health professional (other than a psychiatrist)
  o Base it on experience
  o Other (please specify):  ___________________________________________________________
6. Although a patient may present with signs or symptoms of anxiety, you may choose not to make a 
  formal diagnosis.  Do any of the following reasons contribute to your decision? 
  Please mark ALL that apply with a check (¸) mark.
  o Physical causes need to be completely ruled out first.
  o Patient refusal to accept diagnosis.
  o Patient noncompliance.
  o The patient will work through it on his/her own.
  o It is unlikely that the patient will be seen in time if I refer him/her to a specialist.
  o The patient lives too far away from a mental health specialist.
  o I don’t want the diagnosis to show up on the patient’s medical record.
  o The stigma that the patient may suffer.
  o Other (please specify): ________________________________________________________________
7. Please complete the following statements by indicating your level of agreement with a check (¸) mark.
To more effectively manage patients presenting with symptoms of anxiety,
I need...
a. Improved access to psychiatrists. o o o o o
b. To be able to prescribe affordable medication. o o o o o
c.  More time to spend with my patients. o o o o o
d. Improved access to mental health professionals (other than psychiatrists). o o o o o
e. More training on counselling techniques. o o o o o
f. More personal experience managing patients with mental disorders. o o o o o
g. Up-to-date information on effective pharmacological treatments. o o o o o
h. Up-to-date information on effective non-pharmacological treatments. o o o o o
i. More time to spend on accessing and reading research on mental disorders. o o o o o
j. Other (please specify): ______________________________________________ o o o o o
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8. To what extent do you believe each of the following statements is true or false?  
 Please check (¸) the circle that is closest to your answer.
a. Anxiety disorders, with the exception of OCD, are more common 
 in men than women. o o o o o
b. Monitoring and follow-up of an anxiety disorder should occur for
 at least 12 months, regardless of whether treatment is pharmacological 
 or psychological. o o o o o
c. Elderly patients are no more sensitive than adult patients to the
 side effects of benzodiazepines.  o o o o o
d. Pharmacotherapy and psychotherapy approaches to anxiety may be
 combined when a single treatment method is not effective. o o o o o
e. Cognitive behavior therapy (CBT) focuses on intervening in the 
 patient’s thoughts and behaviours that have a strong influence on  
 their experience of emotion. o o o o o
f. Relief of anxiety symptoms takes 2 to 4 weeks when the average 
 patient is treated with a selective serotonin reuptake inhibitor (SSRI). o o o o o
g. Pharmacotherapy and psychotherapy approaches are not equivalent in 
 effectiveness for the average patient undergoing treatment for anxiety. o o o o o
h. When a patient fails to respond to a first-line agent, s/he should be 
 referred to a specialist. o o o o o
i. The first follow-up for a patient receiving pharmacotherapy for an o o o o o
 anxiety disorder should be at one month.
j. Full response to pharmacotherapy for an anxiety disorder can be 
 expected after 12 weeks. o o o o o
 
k. Cognitive behaviour therapy for a patient with an anxiety disorder
 includes weekly contact with a therapist for about 12 to 20 weeks. o o o o o
l. The most common side effects of SSRIs are gastrointestinal and
 sleep disturbances.     o o o o o  
  
9. Please list your first choice of medication to treat anxiety, starting dosage, and duration of treatment   
 for patients in these 3 age groups:
                           Starting      Duration of  
  Patient’s age                  Medication      Dosage       Treatment
       
  
 10 - 17 yrs _________________________________     _____(mg)     _______(wks) 
 
  18 - 65 yrs _________________________________     _____(mg)     _______(wks) 
  66+ yrs _________________________________     _____(mg)     _______(wks) 
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D.  MAIN PATIENT CARE SETTING
1. What is your main patient care setting (i.e. where you spend the most time providing patient care)?
 o Private office/clinic (excluding free standing walk-in clinics)
 o Community clinic/Community health centre
 o Free-standing walk-in clinic
 o Academic health sciences centre
 o Community hospital
 o Emergency department (community hospital or academic health sciences centre)
 o Other (please specify):  ___________________________________________________
2. How is your main patient care setting organized?
 o Solo practice
 o Group practice
 o Other (please specify)   ___________________________________________________ 
3.  Do you have internet access in your main patient care setting?
 o No o Yes
4.  Do you have internet access during consultations with patients in your main patient care setting?
 o No o Yes
5. What is the population of the town/city of your main patient care setting?
 o over 75,000
 o 50,001 to 75,000
 o 20,001 to 50,000
 o 10,001 to 20,000
 o 5,001 to 10,000
 o 2,501 to 5,000
 o 1,001 to 2,500
 o less than 1,000
E.  DEMOGRAPHICS
1. Gender:     o Male     o Female 
2. Year of birth?  19  ______
3. Number of years you have been in practice as a family physician?  ________ years
4.  Your status: 
 o In full-time or part-time medical practice
 o Locum tenens
 o On a leave of absence or sabbatical from active patient care
 o Medical student
 o Resident
 o Employed in a medically related field (e.g. administration, teaching, research)
 o Retired
 o Other (please specify):  _____________________________________
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F.  EDUCATION
1.  Where and when did you complete your UNDERGRADUATE MEDICAL training?  
 Country    Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
2.  Where and when did you complete your POSTGRADUATE MEDICAL training?   
 Country  Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 3.  Other medical training (please specify):
 ____________________________________________________________________________
 ____________________________________________________________________________
 
Do you have comments about caring for patients with anxiety? 
Do you have any general comments about this questionnaire?
Saskatchewan Family Practice Survey
Thank you for taking the time to complete this questionnaire.
  Your help is greatly appreciated.
Please return your completed questionnaire in the enclosed envelope to:
Applied Research
University of Saskatchewan
Box 92, Royal University Hospital
103 Hospital Drive
Saskatoon, SK
Canada  S7N 0W8
   
  
Confidential when completed
If you have any questions regarding this survey, please contact:
Dr. Carl D’Arcy (carl.darcy@usask.ca)
Julie Kosteniuk (julie.kosteniuk@usask.ca)
Phone: 1-306-966-8767 (collect) 
Fax: 1-306-966-8774
Applied Research
Box 92, Royal University Hospital
103 Hospital Drive
Saskatoon, Saskatchewan
Canada    S7N 0W8
 
Sequence No:  D
Mood and Anxiety Disorders in
Saskatchewan Family Practice
 
Completion of this questionnaire implies 
consent to participate in this survey.
Appendix V - Main Study Depression Questionnaire
225
Saskatchewan Family Practice Survey
This survey concerns your practices regarding the diagnosis and treatment of patients with 
mood and anxiety disorders.
This survey is completely voluntary and will take approximately 20 minutes to complete. All 
family physicians in Saskatchewan are being surveyed in order to have accurate results that 
are representative of our province as a whole. Your name and address were obtained from the 
Canadian Medical Directory and the College of Physicians and Surgeons of Saskatchewan 
mailing list.
 
The findings of the survey will help us to learn more about the information and resources that 
physicians use and need to effectively diagnose and treat patients with mood and anxiety 
disorders.
 
Your answers are strictly confidential and anonymous. Only aggregate data will be reported; 
as such, your answers cannot be identified. The findings will be made available directly to the 
study participants, and will also be available to the public and the media in a summary report. 
Peer-reviewed scientific journal articles and conference presentations will also result from the 
successful completion of the study. 
Your help is greatly appreciated
 INTRODUCTION
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A. CLINICAL SCENARIO
The following is a clinical scenario of a patient whom you may encounter in your practice. We are
interested in how you would treat this patient. Please read the scenario and respond to the questions below.
Your patient is a 31 year-old man, married with two young children. He presents with muscle 
and joint discomfort, heart palpitations, and dizziness of more than one year duration. He com-
plains of being restless and edgy most of the time and believes that he’s “losing it” because he’s 
constantly apprehensive. His mind races and he “can’t seem to pin them (the thoughts) down”. 
He has come to see you because he’s concerned that his health is deteriorating to the point that 
sometimes he has to leave work when the symptoms become intolerable. As well, he has given 
up many social contacts aside from family and close friends. Shortly after he began feeling this 
way, he cut back his coffee intake to 1 cup/day. Physical exam: General - alert and oriented. Skin 
- moist, Color - good, HEENT - unremarkable, Chest - grade II murmur. Abdomen - unremarkable, 
Extremities - unremarkable. Reflexes - brisk bilaterally. 
1. What specific laboratory tests, medical procedures, and/or consults (if any) would you order at this point?
2. Although you may feel you need more information, please list the specific tentative diagnoses that you 
 are considering and make a tentative diagnosis.
3 What treatment plan would you initiate at this point (if any)?
4. If you recommended treatment to this patient, when would you like the patient to return for:
 a) 1st follow-up?  _______ weeks after 1st visit
 b) Subsequent follow-up?  _______ weeks after 1st visit
      _______ weeks after 1st visit
5. Please list one or more reasons that you may not be able to provide the best possible care for this patient.
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2. Using check marks (¸) where applicable, please indicate whether you find the following information 
 sources to be (in general): reliable, easy to access, relevant to your needs, and easy to understand.
    Reliable      Relevant      
                       (You trust   Easy to   (to your   Easy to
   this source)    access   needs) understand
  Example:  Medical journals      o o o o
Information Source
a. Medical journals  o o o o 
b. Medical textbooks   o o o o 
c. CME/CPD/CPL courses/programs   o o o o 
d. Colleagues in your main patient care setting o o o o 
e. Colleagues outside of your main patient care setting o o  o o 
f. Pharmaceutical sales representatives  o o o o
g. Clinical practice guidelines   o o o o 
h. PDA (Personal Digital Assistant programs) o o    o o 
i. Other decision aids   o o o o 
j. Drug manuals  o o o o 
k. Psychiatrist(s)  o o o o 
l. Mental health professional(s) (other than psychiatrist) o o o o 
m. Pharmacist(s)  o o o o 
n. Favorite internet website  o o o o 
¸ ¸
¸ ¸ ¸ ¸
B.  INFORMATION USE
1. Using check marks (¸) where applicable, indicate the information sources that you use on a regular basis 
 (at least once per month) to update your general medical knowledge and to make specific clinical decsions.
   Specific Purpose of Using the Information Source
                   To update your   To make a
  general medical   specific 
   knowledge     clinical decision
      Example:  Medical journals o     o 
     Information Source
 a.   Medical journals o     o 
 b.   Medical textbooks  o     o  
 c.   Colleagues in your main patient care setting  o     o
 d.   Colleagues outside of your main patient care setting  o     o        
 e.   Pharmaceutical sales representatives  o     o       
 f.   Clinical practice guidelines  o     o    
 g.   PDA (Personal Digital Assistant programs) o     o  
 h.  Other decision aids  o     o      
 i.   Drug manuals  o o      
 j.   Psychiatrist(s)  o     o     
 k.  Mental health professional(s) (other than psychiatrist)  o     o     
 l.   Pharmacist(s) o     o      
 m. Favorite internet website (please specify) 
 _______________________________________________________ o     o   
 n.  Other (please specify):
 _______________________________________________________ o     o       
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C. PATIENTS WITH DEPRESSION
1. Please indicate the two treatment interventions that you currently use most often for patients with 
 depressive disorders that are moderate and severe.  Indicate your first choice with “1” and second 
 choice with “2”.
          If depressive disorder is:
           Treatment      Moderate     Severe
 Exercise/recreation _________   __________
 Counselor/psychological referral _________   __________
 Medication _________   __________
 Watchful waiting _________   __________
 Psychiatric referral _________   __________
 Psychotherapy provided by you _________    __________
 Other (please specify): _____________________ _________    __________
2. When deciding on the best treatment for a patient with depression, do you consider the following 
 factors?   Please mark ALL that apply with a check (¸) mark.
  
   age o o o o o
   gender o o o o o
    marital status o o o o o
     The patient’s:  children o o o o o
   employment status o o o o o
   preference for treatment o o o o o
   family’s preference for treatment  o o o o o
3. Please estimate the following:
a. The length of time you spend with a patient presenting with depression for a new visit
  Average number of minutes __________
b. The length of time you spend with a patient you are treating for depression for a follow-up visit
  Average number of minutes  __________
c. The number of patients per week you recognize as presenting with depression
  Average number of patients/week  __________
d. The number of patients per week you diagnose with depression
  Average number of patients/week  __________
e. The number of patients per week you treat or manage for depression
  Average number of patients/week  ___________
f. EXCLUDING patient visits while on-call, please estimate the following:
  Number of TOTAL patient visits per week  __________
} All of the time Most of  the time Some ofthe time A little ofthe time None ofthe time
Saskatchewan Family Practice Survey
  
4. Please check (¸) the square that is closest to your level of agreement with the following statements:
a. During the past 5 years I have seen an increase in the number of  patients 
 presenting with depressive symptoms. o o o o o
b. The majority of depression seen in general practice originates from patients’ 
 recent misfortunes. o o o o o
c. An underlying biochemical abnormality is the basis of severe cases of 
 depression. o o o o o
d. It is difficult to differentiate whether patients are presenting with 
 unhappiness or a clinical depressive disorder that needs treatment. o o o o o
e. It is possible to distinguish two main groups of depression, one
 psychological in origin and the other caused by biochemical mechanisms. o o o o o
f. Becoming depressed is a way that people with poor stamina deal with 
 life difficulties. o o o o o
g. Depressed patients are more likely to have experienced deprivation in 
 early life than other people. o o o o o
h. I feel comfortable in dealing with depressed patients’ needs. o o o o o
i. Depression reflects a characteristic response in patients that is not
 amenable to change. o o o o o
j. Becoming depressed is a natural part of being old. o o o o o
k. The community nurse could be a useful person to support depressed
 patients. o o o o o
l. Most depressive disorders seen in general practice improve without
 medication. o o o o o
m. Working with depressed patients is heavy going. o o o o o
n. There is little to be offered to those depressed patients who do not
 respond to what general practitioners do. o o o o o
o. It is rewarding to spend time looking after depressed patients. o o o o o
p. Psychotherapy tends to be unsuccessful with depressed patients. o o o o o
q. If depressed patients need antidepressants, they should be started on 
 tricyclics as first-line treatment. o o o o o
r. If depressed patients need antidepressants, they should be started on 
 selective serotonin reuptake inhibitors as first-line treatment. o o o o o
s. If depressed patients need antidepressants, they are better off with a 
 psychiatrist than with a general practitioner. o o o o o
t. Antidepressants usually produce a satisfactory result in the treatment of 
 depression in general practice. o o o o o
u. Psychotherapy for depressed patients should be left to a specialist. o o o o o
v. If psychotherapy were freely available, this would be more beneficial 
 than antidepressants for most depressed patients. o o o o o
N
eu
tr
al
St
ro
ng
ly
  
A
gr
ee
St
ro
ng
ly
D
is
ag
re
e
D
is
ag
re
e
A
gr
ee
Saskatchewan Family Practice Survey
5.   Imagine that you are unsure about diagnosing a patient with depression. Which of the following 
  actions might you take to confirm your decision? Please mark ALL that apply with a check (¸) mark.
 
  o Conduct a thorough patient interview
  o Use a screening instrument (please specify instrument):  _______________________________
  o Consult a diagnostic manual (please specify the manual): ______________________________
  o Consult a colleague
  o Consult a psychiatrist
  o Consult a mental health professional (other than a psychiatrist)
  o Base it on experience
  o Other (please specify):  ___________________________________________________________
6. Although a patient may present with signs or symptoms of depression, you may choose not to make a 
  formal diagnosis.  Do any of the following reasons contribute to your decision? 
  Please mark ALL that apply with a check (¸) mark.
  o Physical causes need to be completely ruled out first.
  o Patient refusal to accept diagnosis.
  o Patient noncompliance.
  o The patient will work through it on his/her own.
  o It is unlikely that the patient will be seen in time if I refer him/her to a specialist.
  o The patient lives too far away from a mental health specialist.
  o I don’t want the diagnosis to show up on the patient’s medical record.
  o The stigma that the patient may suffer.
  o Other (please specify): ________________________________________________________________
7. Please complete the following statements by indicating your level of agreement with a check (¸) mark.
To effectively manage patients presenting with symptoms of depression, 
I need...
a. Improved access to psychiatrists. o o o o o
b. To be able to prescribe affordable medication. o o o o o
c.  More time to spend with my patients. o o o o o
d. Improved access to mental health professionals (other than psychiatrists). o o o o o
e. More training on counselling techniques. o o o o o
f. More personal experience managing patients with mental disorders. o o o o o
g. Up-to-date information on effective pharmacological treatments. o o o o o
h. Up-to-date information on effective non-pharmacological treatments. o o o o o
i. More time to spend on accessing and reading research on mental disorders. o o o o o
j. Other (please specify): ______________________________________________ o o o o o
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8. To what extent do you believe each of the following statements is true or false?  
 Please check ( ¸) the square that is closest to your answer.
a. The maintenance phase of treatment for major depression focuses 
 on preventing recurrence. o o o o o
b. If psychotherapy for major depression has no effect within 6 weeks
 of regular sessions, medication is recommended. o o o o o
c. An appropriate trial of antidepressant medication for major depressive
 disorder requires use of therapeutic dosages daily for at least
 4-6 weeks. o o o o o
d. Side effects occur only in a small percentage of patients taking any
 antidepressant medication. o o o o o
e. Medication and psychotherapy are efficacious for depression in
 elderly adults as well as for the non-elderly. o o o o o
f. Evidence suggests that primary care clinicians prescribe appropriate 
 dosages of antidepressants to fewer than a third of patients with a 
 current major depressive disorder. o o o o o
g. Dysthymic disorder is mild, brief depression. o o o o o
h. The goal of cognitive therapy is to remove symptoms of depression by 
 identifying and correcting patients’ distorted, negatively biased thinking. o o o o o
i. In general, antidepressant medication can be discontinued after 
 4-9 months for patients with a single major depressive episode who 
 no longer have symptoms of depression. o o o o o
j. Anxiolytics and sedatives (minor tranquilizers) have equivalent
 efficacy in major depression as antidepressant medications. o o o o o
k. Psychotherapy with a trained therapist is appropriate as the sole
 treatment for moderate major depression that is not chronic,
 psychotic or melancholic. o o o o o
l. Tricyclic antidepressants and SSRIs have equivalent side effect profiles. o o o o o
9. Please list your first choice of medication to treat depression, starting dosage, and duration of treatment  
  for patients in these 3 age groups:
                           Starting      Duration of  
  Patient’s age                  Medication      Dosage       Treatment
       
  
 10 - 17 yrs _________________________________     _____(mg)     _______(wks) 
 
  18 - 65 yrs _________________________________     _____(mg)     _______(wks) 
  66+ yrs _________________________________     _____(mg)     _______(wks) 
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D.  MAIN PATIENT CARE SETTING
1. What is your main patient care setting (i.e. where you spend the most time providing patient care)?
 o Private office/clinic (excluding free standing walk-in clinics)
 o Community clinic/Community health centre
 o Free-standing walk-in clinic
 o Academic health sciences centre
 o Community hospital
 o Emergency department (community hospital or academic health sciences centre)
 o Other (please specify):  ___________________________________________________
2. How is your main patient care setting organized?
 o Solo practice
 o Group practice
 o Other (please specify)   ___________________________________________________ 
3.  Do you have internet access in your main patient care setting?
 o No o Yes
4.  Do you have internet access during consultations with patients in your main patient care setting?
 o No o Yes
5. What is the population of the town/city of your main patient care setting?
 o over 75,000
 o 50,001 to 75,000
 o 20,001 to 50,000
 o 10,001 to 20,000
 o 5,001 to 10,000
 o 2,501 to 5,000
 o 1,001 to 2,500
 o less than 1,000
E.  DEMOGRAPHICS
1. Gender:     o Male     o Female 
2. Year of birth?  19  ______
3. Number of years you have been in practice as a family physician?  ________ years
4.  Your status: 
 o In full-time or part-time medical practice
 o Locum tenens
 o On a leave of absence or sabbatical from active patient care
 o Medical student
 o Resident
 o Employed in a medically related field (e.g. administration, teaching, research)
 o Retired
 o Other (please specify):  _____________________________________
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F.  EDUCATION
1.  Where and when did you complete your UNDERGRADUATE MEDICAL training?  
 Country    Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
2.  Where and when did you complete your POSTGRADUATE MEDICAL training?   
 Country  Graduation Year
 ___________________________________________________________________   _____________
 ___________________________________________________________________   _____________
 3.  Other medical training (please specify):
 ____________________________________________________________________________
 ____________________________________________________________________________
 
Do you have comments about caring for patients with depression? 
Do you have any general comments about this questionnaire?
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Thank you for taking the time to complete this questionnaire.
  Your help is greatly appreciated.
Please return your completed questionnaire in the enclosed envelope to:
Applied Research
University of Saskatchewan
Box 92, Royal University Hospital
103 Hospital Drive
Saskatoon, SK
Canada  S7N 0W8
Appendix W  Additional Questionnaire Measures 
 
Additional Questionnaire Measures 
Measure 
(Section in 
Questionnaire) 
Depression Questionnaire  
(clinical scenario of patient with GAD) 
Anxiety Questionnaire (clinical 
scenario of patient with MDE) 
Personal 
Attributes (E) 
Demographics: Gender, age (open-ended), years in practice as a family physician 
(open-ended), country of undergraduate medical training (open-ended), country of 
postgraduate medical training (open-ended). 
Organizational 
Setting (D) 
Private office vs. 6 other types; solo, group, or other practice; internet access; 
internet access during patient consultations; population of town/city 
To update general medical knowledge (at least once per month): 14 items (yes/no) 
To make specific clinical decisions (use at least once per month): 14 items (yes/no) 
Reliability (trustworthy in general): 14 items (yes/no) 
Physical accessibility (generally easy to access: 14 items (yes/no) 
Applicability (generally relevant to physicians’ needs): 14 items (yes/no) 
Intellectual accessibility (generally easy to understand: 14 items (yes/no) 
 
 
Information 
and Resource 
Use (B1, B2, 
C5) 
 
 
During diagnostic uncertainty of patient 
with depression: 8 items (yes/no)  
During diagnostic uncertainty of 
patient with anxiety: 8 items (yes/no) 
Length of time (minutes) in new and 
follow-up consultations of patients with 
depression 
Length of time (minutes) in new and 
follow-up consultations of patients 
with anxiety 
Number of patients (average/week) 
diagnosed with depression and 
treated/managed for depression  
Number of patients diagnosed 
(average/week) with anxiety and 
treated/managed for anxiety  
Requirements for effective management 
of patients with symptoms of depression: 
10 items (strongly agree, agree, neutral, 
disagree, strongly disagree) 
Requirements for effective 
management of patients with 
symptoms of anxiety: 10 items 
(strongly agree, agree, neutral, 
disagree, strongly disagree) 
Resistance to formal diagnosis of patient 
with depression: 7 items (yes/no) 
Resistance to formal diagnosis of 
patient with anxiety: 7 items (yes/no) 
Depression Attitude Scale: 22 items 
(strongly agree, agree, neutral, disagree, 
strongly disagree) 
Anxiety Attitude Scale: 22 items 
(strongly agree, agree, neutral, disagree, 
strongly disagree) 
Depression Knowledge Scale: 11 items 
(definitely true, mostly true, don’t know, 
mostly false, definitely false) 
Anxiety Knowledge Scale: 12 items 
(definitely true, mostly true, don’t 
know, mostly false, definitely false) 
Patient factors used in treatment decision 
for patients with depression: 7 items (all 
of the time, most of the time, some of the 
time, a little of the time, none of the time) 
Patient factors used in treatment 
decision for patients with anxiety: 7 
items (all of the time, most of the time, 
some of the time, a little of the time, 
none of the time) 
Professional 
Attributes (C2-
C4, C6-C8)  
 
 
Number of total patient visits per week 
